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Nitrogen-containing heterocycles are omnipresent in natural 
products and biologically active compounds. Among them, 
pyrrolizidine and indolizidine alkaloids have attracted a broad 
interest for their potential pharmacological applications. 
Furthermore, their polycyclic structures, frequently incorporating 
multiple chiral centers, have been the testing ground for new C-C 
and C-N bond forming methods since several decades.[1] 
In this context, we envisaged a novel strategy to access both 
pyrrolizidines and indolizidines involving the initial 
aminoalkynylation of olefins to afford 5-propargyl lactams (Figure 
1). This step allows both C-N bond formation and introduction of 
the two missing carbon atoms in a single transformation. The 
amination of olefin is still a major challenge in organic synthesis 
and only recently progress has been realized in intramolecular 
hydroamination,[2] aza-Wacker reaction[3] and more challenging 
multiple aminofunctionalization of alkenes.[4] In particular, the 
simultaneous formation of C-N and C-C bond has been focused 
mostly on aminoarylation and aminocarbonylation. In this context, 
the aminoalkynylation process is still unknown, despite its 
tremendous potential for further functionalization. We have reported 
in 2010 the intramolecular oxyalkynylation of alkenes.[5] However, 
we were unable to use our protocol efficiently in the case of 
amination. The second required cyclization could be envisaged via 
hydroamination of the triple bond,[2,6] or a two-steps alternative via 
vinyl halides.[7] Both approaches are well established for the 
intermolecular synthesis of enamides, but they have never been 
reported to access pyrrolizidinones or indolizidinones. 
Herein, we report the exceptional efficiency of lithium palladate 
catalysts for the intramolecular aminoalkynylation of olefins using 
hypervalent iodine reagents. The reaction is broadly applicable, 
working not only for  and -lactams but also for oxazolidinones, 
imidazolidinones and indole or pyrrole piperazinones. The 
importance of the aminoalkynylation reaction is demonstrated in the 
elaboration of the lactam acetylenes into pyrrolizidines and 
indolizidines using a two-steps procedure (In-mediated iodination[8] 
and Cu-catalyzed vinylation),[7c-d] which culminated in the total 
synthesis of the natural product (±)-trachelanthamidine. 
 
Figure 1. Strategy for the synthesis of pyrrolizidines and indolizidines. 
A preliminary screening was performed subjecting 
protected/activated amides derived from 4-pentenoic acid to the 
protocol developed for oxyalkynylation (triisopropylsilyl ethynyl 
benziodoxolone (TIPS-EBX (2a)), 10 mol % Pd(hfacac)2, 
dichloromethane).[5,9] N-tosyl amide 1a was the most promising 
substrate, but the yield was low (33%), due to decomposition (entry 
1, Table 1).  
Table 1. Optimization of the Aminoalkynylation Reaction. 
 
entry R catalyst additive solvent yield [a] 
1 TIPS Pd(hfacac)2 - CH2Cl2 33% 
2 TIPS PdCl2 - EtOH 57% 
3 TIPS PdCl2 LiCl EtOH 76%(75%)
[b] 
4 TIPS PdCl2 Bu4NCl EtOH 48% 
5 TIPS PdCl2 LiBF4 EtOH 20% 
6 TIPS PdCl2 LiCl EtOH 88%
[c] 
7 TIPS Li2[PdCl4] - EtOH 84%
[b] 
8 TMS PdCl2 LiCl EtOH 23%
[c] 
9 Ph PdCl2 LiCl EtOH 58%
[c] 
[a] Reaction conditions: 0.069 mmol 1a, 0.014 mmol catalyst, 0.084 
mmol R-EBX (2), 0.084 mmol additive in 1.75 mL solvent, 15 h, RT. 
Yield was determined via 1H-NMR. [b] Isolated yield using 0.40 mmol 
1a, 0.040 mmol catalyst, 0.48 mmol R-EBX (2), 0.48 mmol additive in 
10 mL solvent, 3.5 h, RT. [c] Isolated yield using 1.44 mmol LiCl. 
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Optimization of the reaction conditions using the previously 
discovered catalyst was not successful.[10] An interesting lead result 
was obtained with PdCl2 in EtOH (entry 2). Better yields were 
observed with LiCl as additive (entry 3), while other Li or chloride 
salts were less efficient (entries 4, 5). Three equivalents of LiCl in 
comparison to 2a were optimal (entry 6). Under these conditions, 
the active catalyst could be Li2[PdCl4] formed in situ. Indeed, when 
Li2[PdCl4] was used as the catalyst with 1a, 3a was isolated in the 
same yield as when using PdCl2/LiCl (entry 7).[11] One possible 
explanation for this effect would be that halide ions can slow down 
side reactions, in particular -hydride elimination.[12] To the best of 
our knowledge, this is the first example of the use of a palladate 
complex for the carboamination of olefins. The reaction was 
performed at room temperature using analytical grade EtOH under 
ambient atmosphere. LiCl is inexpensive, PdCl2 is the most broadly 
used Pd salt and TIPS-EBX (2a) is commercially available, 
contributing to make the method highly practical. The use of 
ethynylbenziodoxolone (EBX) reagents was required, as no product 
was obtained using alkynyl halides or alkynyliodonium salts. The 
smaller TMS group gave a lower yield (entry 8), but the introduction 
of phenyl acetylene was possible in 58% yield (entry 9).[13]  
The scope of the reaction was then examined (Table 2). 
Modification of the benzenesulfonyl group showed that tosyl amide 
1a was optimal (entry 1). 4-Methoxybenzenesulfonyl amide 1b gave 
a similar yield (entry 2). The lactam was obtained in 50% yield with 
the easily removable nosyl group (entry 3). Good results were 
obtained for the synthesis of N-protected 5-propargyl pyrrolidinones 
(entries 4–8). The reaction was tolerant to substitution  to the 
carbonyl (entries 4–6), allowing facile access to azaspiro 
compounds (entries 5, 6). Substitution at the allylic position with a 
phenyl group gave the trans product in 71% yield and 90:10 dr 
(entry 7). The reaction also worked for the synthesis of bicyclic 
heterocycle 3h (entry 8). Cyclization reactions to give 6-membered 
rings are usually more challenging. Nevertheless, simple N-tosyl 5-
hexenamide gave propargyl piperidone 3i in 57% yield (entry 9). 
The yield increased for more rigid substrates (entries 10-12). 
Arylpiperazines derived from pyrroles or indoles are key structural 
elements in bioactive compounds.[14] We then examined substitution 
on the double bond. While no reactivity was observed with vicinally 
disubstituted olefins, the cyclized product could be isolated in 62% 
yield with geminally disubstituted alkene 1m under modified 
reaction conditions (entry 13). This result is promising, as it 
indicates that the reaction could be extended to substituted olefins 
after adequate optimization. 
As our protocol has been successful for the synthesis of lactams, 
we wondered if a second heteroatom would be tolerated. We 
concentrated first on O-allyl and homoallyl carbamates (Table 3, 
entries 1–4). Allyl tosylcarbamate (6a) was converted to the 
corresponding 4-propargyl oxazolidinone 7a in 83% yield (entry 1). 
Substitution at the allylic position was also tolerated (entries 2, 3), 
although the diastereoselectivity was lower than for N-tosyl 
pentenamides. Homoallyl tosylcarbamate 6d afforded the six-
membered ring product in 59% yield (entry 4). Finally, we studied 
the behaviour of allyl ureas under the reaction conditions (entries 5–
7). Control of O- versus N- cyclization is more difficult for urea, due 
to the enhanced nucleophilicity of the oxygen atom. Nevertheless, 
only propargyl imidazolidinones were isolated in 65-79% yields 
using both free or allyl and benzyl protected ureas. 
As several new bonds are formed during the reaction, 
understanding the mechanism is challenging. Complete conversion 
of the hypervalent iodine reagent into 2-iodobenzoic acid and the 
dimerized acetylene was observed by 1H NMR when it was mixed 
with a stoichiometric amount of Li2[PdCl4]. A shift of the olefins 
and aliphatic signals was observed in the 1H NMR spectrum of the 
N-tosyl amide 1a when added to a stoichiometric amount of the 
catalyst.[15] The addition of TIPS-EBX (2a) to this mixture then 
resulted into rapid formation of the product. These preliminary 
results seemed to indicate that an initial aminopalladation followed 
by oxidative alkynylation could be envisaged. Further investigation 
is obviously required to elucidate the mechanism. 
Table 2. Aminoalkynylation of Activated Amides. 
entry substrate product yield[a] 
 
 
 
 
1 Ar = 4-MePh     1a Ar = 4-MePh       3a 88% 
2 Ar = 4-MeOPh     1b Ar = 4-MeOPh      3b 80% 
3 Ar = 4-NO2Ph     1c  Ar = 4-NO2Ph       3c 50% 
4 
1d 
3d 
84% 
5 
1e 3e 
88% 
6 
1f 3f 
77% 
7 
1g 
3g 
71% 
(dr 90:10) 
8 
1h 3h 
67% 
(dr 70:30) 
9 
1i 
3i 
57% 
10 
1j 3j 
84% 
11 
1k 3k 
88% 
12 
1l 3l 
89% 
13 
 
Ar = 4-NO2Ph      1m 3m 
62%[b] 
[a] Reaction conditions: 0.40 mmol 1, 0.040 mmol PdCl2, 0.48 mmol 
TIPS-EBX (2a), 1.44 mmol LiCl in 10 mL EtOH, 2-5 h, RT. [b] 0.40 
mmol 1, 0.040 mmol Pd(hfacac)2, 0.48 mmol TIPS-EBX (2a), 0.48 
mmol 4-chlorosalicylic acid in 10 mL CH2Cl2, 15 h, RT. 
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Table 3. Aminoalkynylation of Activated Carbamates and Ureas. 
entry substrate product yield 
 
 
 
 
1 R = H, R1 = H     6a R = H, R1 = H       7a 83% 
2 R = Me, R1 = H    6b R = Me, R1’ = H     7b 66% (dr 61:39) 
3 R = Cy, R1 = H    6c R = Cy, R1 = H      7c 58% (dr 66:34) 
4 
6d 
7d 
59% 
 
 
 
 
5 R = H           6e R = H               7e 79% 
6 R = allyl        6f R = allyl            7f 67% 
7 R = Bn         6g  R = Bn             7g 65% 
Reaction conditions: 0.40 mmol 6, 0.040 mmol PdCl2, 0.48 mmol 
TIPS-EBX (2a), 1.44 mmol LiCl in 10 mL EtOH, 2-5 h, RT. 
At this point, we turned our attention to the second cyclization 
step required to access pyrrolizidine and indolizidine heterocycles. 
Removal of the tosyl group from 3a could be performed in 97% 
yield by treatment with Li-naphthalenide. The desilylation of the 
triple bond was then accomplished with TBAF in 87% yield. 
Cyclization of pyrrolizidinone 8a was then examined (Scheme 1). 
As no product was obtained using Ru-catalyzed methods reported 
for the intermolecular hydroamination of alkynes with amides,[6b-c] 
we investigated a two-steps approach via a vinyl iodide intermediate. 
Hydroindiation of the acetylene with HInCl2 followed by quenching 
with iodine gave the Z-vinyl iodide in 99% yield (Z:E = 15:1).[8] 
This is the first example of the use of Oshima’s method in the 
presence of an amide group and demonstrates the strength of this 
underutilized protocol. The conditions described by Buchwald for 
the intermolecular vinylation of amides gave then pyrrolizidine 9a 
in 76% yield.[7c-d] The same procedure could be successfully applied 
to the cyclization of oxazolidinone 8b and indolizidinone 8c in 65% 
and 72% overall yields respectively. 
 
Scheme 1. Cyclization to Form Bicyclic Heterocycles. 
Our strategy was then applied to the synthesis of the 
pyrrolizidine alkaloid (±)-trachelanthamidine (16) (Scheme 2).[16] 
Amide 11 was obtained via Johnson-Claisen rearrangement of 
protected butene diol 10,[17] followed by hydrolysis and reaction 
with p-tosylisocyanate. The aminoalkynylation of tosyl amide 11 
proceeded in 72% yield and 83:17 dr. The tosyl and silyl groups 
were removed and cyclization on the triple bond proceeded in 69% 
yield. Separation of the two diastereoisomers could be achieved 
after cyclization. Reduction of the enamide and debenzylation of the 
alcohol was achieved in quantitative yield. Finally, reduction of the 
amide group using LiAlH4 gave racemic trachelanthamidine (16) in 
9 steps and 22% overall yield from 10. 
 
Scheme 2. Total Synthesis of (±)-Trachelanthamidine (16). Reaction 
conditions: a) CH3C(OEt)3, EtCO2H, 100°C to 160°C; then KOH, 
MeOH, reflux, 80%; b) p-TosylNCO, Et3N, THF, RT, 80%; c) 5 mol % 
PdCl2, LiCl, TIPS-EBX (2a), EtOH, RT, 72%; 83:17 dr; d) 
Li/Naphthalene, THF, -78°C, 77%; e) TBAF, THF, 0°C to RT, 98%; f) i. 
InCl3, DIBALH, ii. Et3B, iii. I2, THF, -50°C, 95%; g) 40 mol % CuI, 
Cs2CO3, N,N’-dimethylethylenediamine, toluene, 85°C, 73%; h) H2, 
Pd/C, MeOH, RT, quantitative; i) LiAlH4, THF, reflux, 94%. 
In summary, a novel strategy for the synthesis of nitrogen 
bridged bicyclic heterocycles has been reported. The Pd-catalyzed 
intramolecular aminoalkynylation of terminal olefins was 
operationally simple and could be successfully applied to tosyl 
amides, carbamates and ureas. Both five and six membered rings 
were obtained in good to excellent yields. After facile deprotection, 
iodination of the triple bond, followed by Cu-catalyzed vinylation of 
the amide gave access to the core of pyrrolizidine and indolizidine 
heterocycles and led to a new total synthesis of trachelanthamidine 
(16). Further work towards the elucidation of the reaction 
mechanism and the development of an asymmetric version is 
currently ongoing in our group. 
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2. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. For quantitative flash chromatography technical grade solvents were 
used. For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were 
used. THF, Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated 
alumina under nitrogen atmosphere (H2O content < 30 ppm, Karl-Fischer titration). NEt3 and 
pyridine were distilled under nitrogen from KOH. All chemicals were purchased from Acros, 
Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless stated otherwise. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was 
performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized 
with UV light, permanganate stain, CAN stain or Anisaldehyde stain. Melting points were 
measured on a Büchi B-540 melting point apparatus using open glass capillaries, the data is 
uncorrected. 1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer 
in chloroform-d, DMSO-d6, CD2Cl2 or CD3OD, all signals are reported in ppm with the 
internal chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm, the internal 
CD2Cl2 signal at 5.31 ppm, or the internal methanol signal at 3.30 ppm as standard. The data 
is being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = 
multiplet or unresolved, br = broad signal, coupling constant(s) in Hz, integration; 
interpretation). 13C-NMR spectra were recorded with 1H-decoupling on a Brucker DPX-400 
100 MHz spectrometer in chloroform-d, DMSO-d6, CD2Cl2 or CD3OD, all signals are 
reported in ppm with the internal chloroform signal at 77.0 ppm, the internal DMSO signal at 
39.5 ppm, the internal CD2Cl2 signal at 53.5 ppm or the internal methanol signal at 49.0 ppm 
as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer 
with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m = 
medium, s = strong, sh = shoulder). Gas chromatographic and low resolution mass 
spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas 
chromatographer and mass spectrometer using a Perkin-Elmer Elite fused silica column 
(length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass 
spectrometric measurements were performed by the mass spectrometry service of ISIC at the 
EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurement were done on a 
JASCO HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector 
and a SEDEX 85 (SEDERE) detector using a CHIRALPAK IC column from DAICEL 
Chemical Industries Ltd. HPLC grade solvents from Sigma-Aldrich were used. 
3. Preparation of Reagents 
Phenyl(triisopropylsilyl)iodonium triflate (18) 
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Following a slight modification of the reported procedure,[1] phenyliodonium diacetate (17) 
(2.53 g, 7.85 mmol, 1.00 equiv) was diluted with DCM (7 mL) and the mixture was stirred 
for 5 minutes. Tf2O (0.60 mL, 3.9 mmol, 0.50 equiv.) was added dropwise at 0 °C and the 
resulting yellow mixture was stirred 30 min. (Trimethylsilyl)(triisopropylsilyl)acetylene (2.00 
g, 7.86 mmol, 1.00 equiv) was added and the mixture was then stirred 2 h. Water was then 
added (30 mL) followed by extraction of the aqueous layer with DCM (2 x 30 mL). The 
combined organic layers were dried over MgSO4, filtered and the solvent was evaporated 
under reduced pressure. The resulting solid was triturated in hexane (10 mL). Filtration and 
removal of solvent in vacuo afforded phenyl(triisopropylsilyl)iodonium triflate (18) (2.90 g, 
11.2 mmol, 70% yield) as a colorless solid. 
1H NMR (400 MHz, CDCl3) δ 8.09 (m, 2 H, ArH), 7.65 (m, 1 H, ArH), 7.52 (m, 2 H, ArH), 
1.15-1.01 (m, 21 H, TIPS); 13C NMR (100 MHz, CDCl3) δ 133.7, 132.5, 132.4, 119.7, 117.6, 
117.6, 44.9, 18.3, 11.1; IR ν 3288 (w), 3088 (m), 2949 (m), 2894 (m), 2869 (w), 1563 (m), 
1467 (w), 1451 (w), 1388 (w), 1281 (s), 1236 (s), 1221 (s), 1174 (s), 1068 (w), 1028 (s), 988 
(m), 916 (m), 884 (m), 736 (s), 679 (m), 639 (s); Melting point: 109 – 114°C. HRMS (ESI) 
calcd for C17H26ISi+ (M-OTf) 385.0843; found 385.0812; the reported values corresponded to 
the ones in literature.[2] 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (20) 
 
Following the reported procedure,[3] NaIO4 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-
iodobenzoic acid (19) (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v:v) aq. 
AcOH (48 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction 
mixture was then diluted with cold water (180 mL) and allowed to cool to rt, protecting it 
from light. After 1 h, the crude product was collected by filtration, washed on the filter with 
ice water (3 x 20 mL) and acetone (3 x 20 mL), and air-dried in the dark to give the pure 
product 20 (8.3 g, 31 mmol, 98%) as a colorless solid. 
1H NMR (400 MHz, (CD3)2SO) δ 8.02 (dd, 1 H, J = 7.7, 1.4 Hz, ArH), 7.97 (m, 1 H, ArH), 
7.85 (dd, 1 H, J = 8.2, 0.7 Hz, ArH), 7.71 (td, 1 H, J = 7.6, 1.2 Hz, ArH); 13C NMR (100 
                                                            
[1]  T. Kitamura, M. Kotani, Y. Fujiwara, Synthesis 1998, 10, 1416. 
[2]  J. P. Brand, J. Waser, Angew. Chem., Int. Ed. 2010, 49, 7304. 
[3]  L. Kraszkiewicz, L. Skulski,  Arkivoc. 2003, 6, 120. 
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MHz, (CD3)2SO) δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4; IR ν 3083 (w), 3060 (w), 
2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 (m), 
1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m); the reported values 
correspond to the ones in literature.[3] 
Triisopropylsilyl trimethylsilylacetylene (22) 
 
Following a reported procedure,[4] n-butyllithium (2.5 M in hexanes, 12.0 mL, 29.9 mmol, 
0.98 equiv) was added dropwise to a stirred solution of ethynyltrimethylsilane (21) (3.0 g, 30 
mmol, 1.0 equiv) in THF (48 mL) at -78 °C. The mixture was then warmed to 0 °C and 
stirred for 5 min. The mixture was then cooled back to -78 °C and chlorotriisopropylsilane 
(6.4 mL, 30 mmol, 1.0 equiv) was added dropwise. The mixture was then allowed to warm to 
room temperature and stirred overnight. A saturated solution of ammonium chloride (40 mL) 
was added, and the reaction mixture was extracted with diethyl ether (2 x 60 mL). The 
organic layer was washed with water and brine, then dried over MgSO4, filtered and 
concentrated under reduced pressure to obtain a colorless liquid which was further purified 
by Kugelrohr distillation (56-57°C/0.25 mmHg) to yield 22 (7.16 g, 28.0 mmol, 92% yield) 
as a colorless liquid.  
1H NMR (400 MHz, CDCl3) δ 1.08 (m, 21 H, TIPS), 0.18 (s, 9 H, TMS). IR ν 2959 (m), 
2944 (m), 2896 (w), 2867 (m), 1464 (w), 1385 (w), 1250 (m), 996 (w), 842 (s), 764 (s), 675 
(m), 660 (m). Characterization data of 22 corresponded to the literature values.[4] 
1-[(Triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TIPS-EBX, 2a) 
 
Following a reported procedure,[2] 2-iodosylbenzoic acid (20) (21.7 g, 82.0 mmol, 1.0 equiv) 
was charged in oven-dried three-neck 1L flask equipped with a magnetic stirrer. After 3 
vacuum/nitrogen cycles, anhydrous acetonitrile (500 mL) was added via canula and cooled to 
4 °C. Trimethylsilyltriflate (16.4 mL, 90.0 mmol, 1.1 equiv) was added dropwise via a 
dropping funnel over 30 min (no temperature increase was observed). After 15 min, 
(trimethylsilyl)(triisopropylsilyl)acetylene (22) (23.0 g, 90.0 mmol, 1.1 equiv) was added via 
canula over 15 min (no temperature increase was observed). After 30 min, the suspension 
became an orange solution. After 10 min, pyridine (7.0 mL, 90 mmol, 1.1 equiv) was added 
via syringe. After 15 min, the reaction mixture was transferred in a one-neck 1L flask and 
reduced under vacuum until a solid was obtained. The solid was dissolved in DCM (200 mL) 
                                                            
[4] C J. Helal, P. A. Magriotis, E. J. Corey, J. Am. Chem. Soc. 1996, 118, 10938. 
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and transferred in a 1L separatory funnel. The organic layer was added and washed with 1 M 
HCl (200 mL) and the aqueous layer was extracted with CH2Cl2 (200 mL). The organic 
layers were combined, washed with a saturated solution of NaHCO3 (2 x 200 mL), dried over 
MgSO4, filtered and the solvent was evaporated under reduced pressure. Recrystallization 
from acetonitrile (ca 120 mL) afforded 2 (30.1 g, 70.2 mmol, 86%) as colorless cristals. 
1H NMR (400 MHz, CDCl3) δ 8.44 (m, 1 H, ArH), 8.29 (m, 1 H, ArH), 7.77 (m, 2 H, ArH), 1.16 
(m, 21 H, TIPS). 13C NMR (100 MHz, CDCl3) δ 166.4, 134.6, 132.3, 131.4, 131.4, 126.1, 115.6, 
114.1, 64.6, 18.4, 11.1. IR ν 2943 (m), 2865 (m), 1716 (m), 1618 (m), 1604 (s), 1584 (m), 1557 
(m), 1465 (m), 1439 (w), 1349 (m), 1291 (m), 1270 (w), 1244 (m), 1140 (m), 1016 (m), 999 (m), 
883 (m), 833 (m), 742 (m), 702 (s), 636 (m); Melting point (Dec.) 170-176°C;  characterization 
data of 2a corresponded to the literature values.[2] 
1-[(Trimethylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TMS-EBX, 2b) 
 
Following the reported procedure,[2] trimethylsilyl triflate (5.54 mL, 30.7 mmol, 1.1 equiv) 
was added to a suspension of 2-iodosylbenzoic acid (20) (7.36 g, 28.0 mmol, 1.0 equiv) in 
DCM (85 mL) at rt. The resulting yellow mixture was stirred for 1 h, followed by the 
dropwise addition of bis(trimethylsilyl)acetylene (6.98 mL, 30.7 mmol, 1.1 equiv). The 
resulting suspension was stirred for 6 h at rt, during this time a colorless solid was formed. A 
saturated solution of NaHCO3 was then added and the mixture was stirred vigorously until 
complete solubilization of the colorless solid. The two layers were separated and the 
combined organic extracts were washed with sat. NaHCO3, dried over MgSO4, filtered and 
evaporated under reduced pressure. Recrystallization from acetonitrile (50 mL) afforded 2b 
(7.17 g, 20.8 mmol, 74%) as a colorless solid. 
1H NMR (400 MHz, CDCl3) δ 8.42 (dd, 1 H, J = 6.4, 1.9 Hz, ArH), 8.19 (m, 1 H, ArH), 7.78 (m, 
2 H, ArH), 0.32 (s, 9 H, TMS); 13C NMR (100 MHz, CDCl3) δ 166.4, 134.9, 132.6, 131.7, 131.4, 
126.1, 117.2, 115.4, 64.2, -0.5; IR ν 3389 (w), 2967 (w), 1617 (s), 1609 (s), 1562 (m), 1440 (w), 
1350 (m), 1304 (w), 1254 (w), 1246 (w), 1112 (w), 1008 (w), 852 (s), 746 (m), 698 (m), 639 (m); 
Melting point (Dec.): 143-145°C; the reported values corresponded to the ones in literature.2 
1-(Phenylethynyl)-1,2-benziodoxol-3(1H)-one (Ph-EBX, 2c) 
 
Following a reported procedure,[2] trimethylsilyl triflate (7.50 mL, 41.5 mmol, 1.1 equiv) was 
added to a suspension of 2-iodosylbenzoic acid (20) (10.0 g, 37.7 mmol, 1 equiv) in DCM 
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(100 mL) at rt. The resulting yellow mixture was stirred for 1 h, followed by the dropwise 
addition of trimethyl(phenylethynyl)silane (8.10 mL, 41.5 mmol, 1.1 equiv) (slightly 
exothermic). The resulting suspension was stirred for 6 h at rt, during this time a white solid 
was formed. A saturated solution of NaHCO3 (100 mL) was then added and the mixture was 
stirred vigorously. The resulting suspension was filtered on porosity 4 glass filter. The two 
layers of the mother liquors were separated and the organic layer was washed with sat. 
NaHCO3, dried over MgSO4, filtered and evaporated under reduced pressure. The resulting 
mixture was combined with the solid obtained by filtration and boiled in CH3CN (300 mL). 
The mixture was cooled down, the formed solid was collected and dried under high vacuum 
to afford 2c (6.08 g, 17.4 mmol, 46 %) as a colorless solid 
1H NMR (400 MHz, CDCl3) δ 8.46 (m, 1 H, ArH), 8.28 (m, 1 H, ArH), 7.80 (m, 2 H, ArH), 
7.63 (m, 2 H, ArH), 7.48 (m, 3 H, ArH). 13C NMR (101 MHz, CDCl3) δ 163.9, 134.9, 132.9, 
132.5, 131.6, 131.3, 130.8, 128.8, 126.2, 120.5, 116.2, 106.6, 50.2; IR 3735 (w), 3649 (w), 
3096 (w), 3064 (w), 2150 (w), 1685 (m), 1653 (s), 1635 (m), 1623 (s), 1587 (w), 1570 (w), 
1559 (m), 1542 (w), 1508 (w), 1489 (w), 1457 (w), 1338 (w), 1330 (w), 1291 (m), 1241 (w), 
1215 (w), 1193 (w), 1179 (w), 1167 (w), 1160 (w), 1149 (w), 1123 (w), 1019 (w), 1005 (w), 
996 (w), 971 (w), 960 (w), 913 (w), 743 (s), 691 (m), 658 (w), 650 (m), 634 (m), 615 (s); 
Melting point (Dec.) 147-156°C; HRMS (ESI) calcd for C15H10IO2+ [M+H]+ 348.9720; found 
348.9716. 
2-Iodo-1-triisopropylsilyl acetylene (24) 
 
Following a reported procedure,[5] MeLi•LiBr (1.5 M in diethyl ether, 1.1.mL, 1.6 mmol, 1.0 
equiv) was added to a stirred solution of triisopropylsilylacetylene (23) (0.36 mL, 1.6 mmol, 
1.0 equiv) in dry THF (1.8 mL), cooled at -78 °C, and the mixture was allowed to react for 1 
h at that temperature. A solution of I2 (457 mg, 1.80 mmol, 1.25 equiv) in dry THF (2.7 mL) 
was then added dropwise and the mixture was stirred for 1.5 h at -78°C. The mixture was 
then diluted with brine (6 mL) and the aqueous layer was extracted with ether (3 x 10 mL). 
The combined organic layers were washed with a saturated aqueous solution of Na2S2O3 (3 x 
20 mL), dried over MgSO4 and concentrated under reduced pressure. Purification by column 
chromatography (SiO2, hexane) afforded 2-iodo-1-triisopropylsilyl acetylene (24) (470 mg, 
1.52 mmol, 94% yield) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 1.10-1.04 (m, 21 H, TIPS); 13C NMR (100 MHz, CDCl3) δ 100.8, 18.5, 
11.4 (one acetylene carbon was not resolved); the reported values correspond to the ones in 
literature.[5] 
2-Bromo-1-triisopropylsilyl acetylene (25) 
                                                            
[5] S. López, F. Fernández-Trillo, P. Midón, L. Castedo, C. Saá J. Org. Chem., 2005, 70, 6346. 
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Following a reported procedure,[6] triisopropylsilylacetylene (23) (813 mg, 4.45 mmol, 1.00 
equiv) was dissolved in acetone (30 mL). N-bromosuccinimide (925 mg, 5.19 mmol, 1.16 
equiv) was added, followed by AgNO3 (76 mg, 0.44 mmol, 0.1 equiv). The resulting mixture 
was stirred at room temperature for 3 h and it was then poured onto ice. After ice being 
allowed to melt, the aqueous layer was extracted with pentane (3 x 30 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo to afford pure 2-
bromo-1-triisopropylsilyl acetylene (25) (1.16 g, 4.43 mmol, 99%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 1.20-0.97 (m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 83.5, 61.7, 
18.5, 11.3; the reported values corresponded to the ones in literature.[6] 
 
4. Preparation of Substrates 
N-Tosylpent-4-enamide (1a) 
 
Following a reported procedure,[7] p-tosyl isocyanate (1.18 g, 6.00 mmol, 1.00 equiv) was 
added to a solution of 4-pentenoic acid 26 (0.60 g, 6.0 mmol, 1.0 equiv) in THF (12 mL). 
After stirring the resulting clear solution at rt for 10 min, triethyl amine (0.84 mL, 6.0 mmol, 
1.0 equiv) was added dropwise, with release of gas. After 1 h, the mixture was diluted with 
EtOAc (12 mL) and washed with 2 M HCl (12 mL) and NaCl (saturated solution, 12 mL). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The resulting 
crude solid was dissolved in Et2O in order to obtain a saturated solution and hexane was 
added to precipitate the pure tosyl amide. N-tosylpent-4-enamide (1a) was obtained as a 
colorless, crystalline solid (1.49 g, 5.87 mmol, 98% yield).  
Rf 0.78 (DCM/EtOAc 9/1); 1H NMR (400 MHz, CDCl3) δ 8.10 (br s, 1 H, NH), 7.92 (m, 2 H, 
tosyl CH), 7.33 (m, 2 H, tosyl CH), 5.74 (m, 1 H, CH=CH2), 5.05-4.95 (m, 2 H, CH=CH2), 
2.44 (s, 3 H, tosyl CH3), 2.40-2.26 (m, 4 H, CH2CH2); 13C NMR (101 MHz, CDCl3) δ 170.1, 
145.2, 135.7, 135.4, 129.6, 128.3, 116.3, 35.4, 28.1, 21.7; IR 3242 (m), 2980 (w), 2922 (w), 
2867 (w), 1723 (m), 1705 (m), 1643 (w), 1598 (w), 1491 (w), 1441 (s), 1344 (m), 1307 (w), 
1295 (w), 1211 (w), 1210 (w), 1172 (s), 1087 (s), 920 (w), 855 (m), 816 (w), 739 (w), 708 
(w), 661 (m), 649 (w), 622 (w); Melting point: expected: 88.0 – 89.0; found: 89.5 - 91.7°C; 
the reported values for 1a corresponded to the ones in literature.[7] 
N-(4-Methoxyphenylsulfonyl)pent-4-enamide (1b) 
                                                            
[6] M. X. Jiang, M. Rawat, W. D. Wulff, J. Am. Chem. Soc. 2004, 126, 5970. 
[7] P. Pinho, A. J. Minnaard, B. L. Feringa, Org. Lett. 2003, 5, 259. 
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Following a slightly modified version of a reported procedure,[8] DMAP (1.32 g, 10.8 mmol, 
3.60 equiv) was added to a suspension of EDCI•HCl (920 mg, 4.80 mmol, 1.30 equiv) in 
DCM (7.5 mL). The mixture was stirred at rt until all the solids dissolved and then it was 
cooled to 0°C. 4-pentenoic acid (26) (300 mg, 3.00 mmol, 1.00 equiv) was added, followed 
by p-methoxybenzenesulfonamide (27) (674 mg, 3.60 mmol, 1.20 equiv) and the mixture was 
stirred at rt for 24 h. Et2O (10 mL) was then added and the organic mixture was washed with 
2 N HCl (30 mL). The aqueous layer was extracted with EtOAc (3 x 20 mL). The combined 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 
Purification by column chromatography (SiO2, DCM/EtOAc/AcOH 90/10/1) afforded N-(4-
methoxyphenylsulfonyl)pent-4-enamide (1b) (527 mg, 1.85 mmol, 95% yield) as a colorless 
solid. 
Rf 0.21 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.59 (br s, 1 H, NH), 7.99 (m, 2 H, 
tosyl CH), 7.00 (m, 2 H, tosyl CH), 5.72 (m, 1 H, CH=CH2), 5.02-4.93 (m, 2 H, CH=CH2), 
3.88 (s, 3 H, OCH3), 2.39-2.27 (m, 4 H, CH2CH2); 13C NMR (101 MHz, CDCl3) δ 170.0, 
164.0, 135.8, 130.7, 130.7, 130.7, 129.7, 116.3, 114.1, 55.7, 35.4, 28.1; IR 3596 (w), 3595 
(w), 3345 (w), 3249 (w), 3081 (w), 3080 (w), 3014 (w), 3009 (w), 2906 (w), 2880 (w), 1798 
(w), 1774 (w), 1756 (w), 1719 (m), 1643 (w), 1596 (s), 1580 (m), 1499 (m), 1440 (s), 1415 
(m), 1342 (m), 1312 (m), 1263 (s), 1216 (w), 1210 (w), 1188 (w), 1165 (s), 1115 (m), 1088 
(s), 1027 (m), 1008 (w), 977 (w), 967 (w), 954 (w), 926 (w), 912 (m), 855 (s), 835 (s), 802 
(m), 783 (w), 759 (w), 730 (m), 711 (w), 689 (w), 676 (w), 666 (w), 650 (w), 627 (w), 605 
(w); Melting point: 73.3 – 75.8°C; HRMS (ESI) calcd for C12H16NO4S+ [M+H]+ 270.0795; 
found 270.0802. 
N-(4-Nitrophenylsulfonyl)pent-4-enamide (1c) 
 
Following a slightly modified version of a reported procedure,[8] DMAP (586 mg, 4.80 mmol, 
2.40 equiv) was added to a suspension of EDCI•HCl (498 mg, 2.60 mmol, 1.30 equiv) in 
DCM (5 mL). The mixture was stirred at room temperature until all the solids dissolved and 
then it was cooled to 0°C. 4-pentenoic acid (26) (200 mg, 2.00 mmol, 1.00 equiv) was added, 
followed by p-nitrobenzenesulfonamide (485 mg, 2.40 mmol, 1.20 equiv) and the mixture 
was stirred at rt for 24 h. Et2O (10 mL) was then added and the organic mixture was washed 
with 2 N HCl (15 mL). The aqueous layer was extracted with EtOAc (3 x 15 mL). The 
                                                            
[8] M. R. Manzoni, T. P. Zabawa, D. Kasi, S. R. Chemler, Organometallics 2004, 23, 5618. 
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combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM/EtOAc 90/10 to 
60/40) afforded N-(4-nitrophenylsulfonyl)pent-4-enamide (1c) (527 mg, 1.85 mmol, 95% 
yield) as a colorless solid. 
Rf 0.18 (Hex/EtOAc 4/1); 1H NMR (400 MHz, DMSO) δ 12.46 (br s, 1 H, NH), 8.47 (m, 2 H, 
Nosyl CH), 8.19 (m, 2 H, Nosyl CH), 5.71 (ddt, 1 H, J = 16.8, 10.3, 6.4 Hz, CH=CH2), 5.11-
4.81 (m, 2 H, CH=CH2), 2.38 (t, 2 H, J = 7.2 Hz, COCH2CH2), 2.19 (q, 2 H, J = 6.8 Hz, 
COCH2CH2); 13C NMR (101 MHz, DMSO) δ 172.2, 151.2, 145.5, 137.5, 130.1, 125.4, 
116.5, 35.4, 28.7; IR 3436 (s), 2959 (m), 2941 (m), 2866 (m), 2143 (w), 1717 (w), 1666 (w), 
1646 (w), 1610 (w), 1535 (m), 1462 (w), 1449 (w), 1436 (w), 1354 (m), 1315 (w), 1276 (w), 
1260 (w), 1180 (m), 1160 (w), 1140 (w), 1114 (w), 1088 (m), 1018 (w), 998 (w), 922 (w), 
882 (m), 851 (m), 832 (w), 815 (w), 804 (w), 794 (w), 781 (w), 767 (m), 753 (s), 729 (m), 
715 (w), 702 (m), 683 (m), 671 (w), 662 (w), 647 (m), 626 (w), 615 (m); Melting point: 
148.2°C; HRMS (ESI) calcd for C11H13N2O5S+ (M+H+) 285.0545; found: 285.0577. 
2,2-Dimethyl-N-tosylpent-4-enamide (1d) 
 
Following a modification of a reported procedure,[9] isobutyric acid (28) (950 mg, 10.8 mmol, 
1.0 equiv) was added dropwise to a stirred suspension of NaH (60% dispersion in mineral oil, 
483 mg, 12.1 mmol, 1.12 equiv) and diisopropylamine (1.7 mL, 12 mmol, 1.1 equiv) in THF 
(20 mL). The resulting suspension was heated at reflux for ca 1 h and then cooled to 0°C for 
15 min prior to the dropwise addition of n-BuLi (2.5 M in hexanes, 7.5 mL, 12 mmol, 1.1 
equiv). The resulting greenish suspension was stirred at 0°C for an additional 15 min and 
then at room temperature for 2 h. It was then cooled to 0°C and allyl bromide (0.95 mL, 11 
mmol, 1.0 equiv) was added dropwise to give an off-white suspension which was stirred at 
0°C for 1 h and then at room temperature overnight. The suspension was then cooled with an 
ice-bath and the excess of NaH was neutralized with water (20 mL). The organic layer was 
washed with a 1 M NaOH solution (3 x 40 mL) and the combined aqueous layers were then 
extracted with Et2O (40 mL). The aqueous layer was acidified by addition of a 1 M HCl 
solution until pH 3 and it was then extracted with ether (3 x 40 mL). The combined organic 
layers were dried over MgSO4, filtered and the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography (SiO2, PET/EtOAc/AcOH 95/5/0.1) to 
afford 2,2-dimethylpent-4-enoic acid (29) (379 mg, 3.00 mmol, 27%). 
1H NMR (400 MHz, CDCl3) δ 8.80 (br s, 1 H, COOH), 5.77 (m, 1 H, CH=CH2), 5.10 (m, 1 
H, CH=CH2), 5.06 (m, 1 H, CH=CH2), 2.31 (dt, 2H, J = 7.4, 1.0 Hz, CH2CH=CH2), 1.20 (s, 6 
H, C(CH3)2). 
                                                            
[9] D. E. Korte, L. S. Hegedus, R. K. Wirth, J. Org. Chem. 1977, 42, 1329. 
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Following a reported procedure,[7] p-tosyl isocyanate (584 mg, 3.00 mmol, 1.00 equiv) was 
added to a solution of 2,2-dimethylpent-4-enoic acid (29) (379 mg, 3.00 mmol, 1.00 equiv) in 
THF (8.5 mL). After stirring the resulting clear solution at room temperature for 10 min, 
triethyl amine (0.41 mL, 3.0 mmol, 1.00 equiv) was added dropwise, with release of gas. 
After 1 h, the mixture was diluted with EtOAc (8.5 mL) and washed with 2 M HCl (8.5 mL) 
and NaCl (saturated solution, 8.5 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. No further purification was needed. 2,2-Dimethyl-N-tosylpent-4-
enamide (1d) was obtained as a colorless solid (826 mg, 2.90 mmol, 99% yield). 
Rf 0.53 (Pet/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1 H, NH), 7.93 (m, 2 H, 
tosyl CH), 7.33 (m, 2 H, tosyl CH), 5.54 (m, 1 H, CH=CH2), 5.06-4.92 (m, 2 H, CH=CH2), 
2.45 (s, 3 H, tosyl CH3), 2.23-2.14 (m, 2 H, CH2CH=CH2), 1.13 (s, 6 H, C(CH3)2); 13C NMR 
(101 MHz, CDCl3) δ 175.2, 145.0, 135.4, 132.7, 129.5, 128.4, 119.0, 44.3, 43.4, 24.3, 21.6; 
IR 3552 (w), 3384 (w), 3264 (m), 3132 (w), 3122 (w), 3112 (w), 3111 (w), 3078 (w), 2979 
(w), 2931 (w), 2877 (w), 2363 (w), 1714 (m), 1641 (w), 1597 (w), 1469 (m), 1409 (s), 1339 
(s), 1294 (w), 1168 (s), 1114 (m), 1082 (s), 1016 (w), 999 (w), 912 (m), 860 (m), 812 (m), 
759 (w), 735 (m), 704 (w), 661 (s), 639 (s), 623 (w); Melting point: 144.8 – 148.0°C; HRMS 
(ESI) calcd for C14H20NO3S+ (M+H+) 282.1164; found: 282.1163. 
1-Allyl-N-tosylcyclohexanecarboxamide (1e) 
 
Following a reported procedure,[10] n-BuLi (2.5 M in hexanes) (10 mL, 25 mmol, 2.5 equiv) 
was added dropwise to a solution of diisopropylamine (2.53 g, 25.0 mmol, 2.50 equiv) in 
THF (15 mL) at -78°C. The mixture was allowed to warm to 0°C and stirred at this 
temperature for 20 min. A solution of cyclohexanecarboxylic acid (30) (1.28 g, 10.0 mmol, 
1.00 equiv) in THF (10 mL) was added dropwise to the resulting LDA solution still at 0°C. 
The mixture was stirred at room temperature for 40 min and then at reflux for 50 min. It was 
then cooled to 0°C and allyl bromide (3.02 g, 25.0 mmol, 2.50 equiv) was added dropwise. 
The resulting pale yellow solution was stirred overnight at room temperature. The reaction 
was quenched by adding NH4Cl (saturated solution, 50 mL). The aqueous layer was 
separated from the organic, acidified with 2 M HCl (ca. 25 mL) and extracted with Et2O (3 x 
50 mL). The combined ethereal layers were washed with K2CO3 (20% m/m solution, 3 x 50 
mL). The combined resulting aqueous layers were acidified to pH 3 with 6 N H2SO4 and 
extracted with Et2O (3 x 50 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. Purification by column chromatography (SiO2, 
DCM/EtOAc/AcOH 95/5/0 to 90/10/0.5) afforded 1-allylcyclohexanecarboxylic acid (31) 
(1.48 g, 8.79 mmol, 88% yield) as a colorless oil. 
                                                            
[10] R. D. Miller, P. Goelitz,  J. Org. Chem., 1981, 46, 1616. 
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1H NMR (400 MHz, CDCl3) δ 11.33 (br s, 1 H, COOH), 5.75 (m, 1 H, CH2CH=CH2), 5.09-
5.00 (m, 2 H, CH2CH=CH2), 2.29 (d, 2 H, J = 7.5 Hz, CH2CH=CH2), 2.04 (m, 2 H, C(CH2)2), 
1.58 (m, 2 H, C(CH2)2), 1.42 (m, 2 H, CH2CH2CH2), 1.33-1.17 (m, 4 H, CH2CH2CH2). 
Following a reported procedure,[7] p-tosyl isocyanate (690 mg, 3.49 mmol, 1.00 equiv) was 
added to a solution of 1-allylcyclohexanecarboxylic acid (31) (589 mg, 3.50 mmol, 1.00 
equiv) in THF (10 mL). After stirring the resulting clear solution at room temperature for 10 
min, triethylamine (0.49 mL, 3.5 mmol, 1.0 equiv) was added dropwise, with release of gas. 
After 1 h, the mixture was diluted with EtOAc (10 mL) and washed with 2 M HCl (10 mL) 
and NaCl (saturated solution, 10 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM) afforded 1-
allyl-N-tosylcyclohexanecarboxamide (1e) (778 mg, 2.42 mmol, 69% yield) as a colorless 
solid. 
Rf  0.44 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.10 (br s, 1 H, NH), 7.93 (m, 2 H, 
tosyl CH), 7.33 (m, 2 H, tosyl CH), 5.46 (m, 1 H, CH=CH2), 5.00-4.82 (m, 2 H, CH=CH2), 
2.44 (s, 3 H, tosyl CH3), 2.13 (d, 2 H, J = 7.5 Hz, CH2CH=CH2), 1.85 (m, 2 H, CH2 
cyclohexane), 1.62-1.45 (m, 4 H, CH2 cyclohexane), 1.29 (m, 4 H, CH2 cyclohexane); 13C 
NMR (101 MHz, CDCl3) δ 174.0, 144.9, 135.6, 131.9, 129.4, 128.5, 118.9, 47.9, 43.8, 33.4, 
25.5, 22.6, 21.7; IR 3276 (w), 2939 (w), 2867 (w), 1717 (m), 1596 (w), 1493 (w), 1457 (w), 
1442 (m), 1408 (s), 1344 (s), 1310 (w), 1294 (w), 1168 (s), 1151 (m), 1105 (m), 1086 (s), 
1070 (s), 1025 (w), 1000 (w), 961 (w), 921 (m), 906 (m), 865 (m), 837 (m), 820 (m), 782 
(m), 737 (m), 706 (m), 670 (s), 651 (m), 628 (m), 611 (m); Melting point: 153.4 – 157.0°C; 
HRMS (ESI) calcd for C17H24NO3S+ (M+H+) 322.1477; found: 322.1473. 
1-Allyl-N-tosylcyclopentanecarboxamide (1f) 
 
Following a reported procedure,[10] n-BuLi (2.5 M in hexanes) (8.0 mL, 20 mmol, 2.5 equiv) 
was added dropwise to a solution of diisopropylamine (2.03 g, 20.0 mmol, 2.5 equiv) in THF 
(12 mL) at -78°C. The mixture was allowed to warm to 0°C and stirred at this temperature for 
20 min. A solution of cyclopentanecarboxylic acid (32) (0.91 g, 8.0 mmol, 1.0 equiv) in THF 
(4 mL) was added dropwise to the resulting LDA solution still at 0°C. The mixture was 
stirred at room temperature for 1 h and then at reflux for 40 min. It was then cooled to 0°C 
and allyl bromide (2.40 g, 19.8 mmol, 2.50 equiv) was added dropwise. The resulting clear 
solution was stirred overnight at rt. The reaction was quenched by adding NH4Cl (saturated 
solution, 40 mL). The aqueous layer was separated from the organic, acidified with 2 M HCl 
(ca. 20 mL) and extracted with Et2O (3 x 40 mL). The combined etheral layers were washed 
with K2CO3 (20% m/m solution, 3 x 40 mL). The combined resulting aqueous layers were 
acidified to pH 3 with 6 N H2SO4 and extracted with Et2O (3 x 40 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
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column chromatography (SiO2, DCM/EtOAc/AcOH 100/0/1 to 90/10/1) afforded 1-
allylcyclopentanecarboxylic acid (33) (660 mg, 4.28 mmol, 53% yield) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 11.24 (br s, 1 H, COOH), 5.77 (m, 1 H, CH2CH=CH2), 5.15-
5.00 (m, 2 H, CH2CH=CH2), 2.38 (d, 2 H, J = 7.3 Hz, CH2CH=CH2), 2.11 (m, 2 H, C(CH2)2), 
1.79-1.48 (m, 6 H, cyclopentyl). 
Following a reported procedure,[7] p-tosyl isocyanate (848 mg, 4.30 mmol, 1.00 equiv) was 
added to a solution of 1-allylcyclopentanecarboxylic acid (33) (650 mg, 4.28 mmol, 1.00 
equiv) in THF (12 mL). After stirring the resulting clear solution at room temperature for 10 
min, triethylamine (0.60 mL, 4.3 mmol, 1.0 equiv) was added dropwise, with release of gas. 
After 1 h, the mixture was diluted with EtOAc (12 mL) and washed with 2 M HCl (12 mL) 
and NaCl (saturated solution, 12 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM/AcOH 100/0.5) 
afforded 1-allyl-N-tosylcyclopentanecarboxamide (1f) (1.00 g, 3.24 mmol, 76% yield) as a 
colorless solid. 
Rf 0.47 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.30 (br s, 1 H, NH), 7.93 (m, 2 H, 
tosyl CH), 7.33 (m, 2 H, tosyl CH), 5.50 (m, 1 H, CH2CH=CH2), 5.01-4.88 (m, 2 H, 
CH2CH=CH2), 2.44 (s, 3 H, tosyl CH3), 2.25 (d, 2 H, J = 7.3 Hz, CH2CH=CH2), 1.97 (m, 2 
H, cyclopentyl), 1.68-1.48 (m, 6 H, cyclopentyl); 13C NMR (101 MHz, CDCl3) δ 174.7, 
144.9, 135.5, 133.1, 129.4, 128.4, 118.6, 55.1, 42.7, 34.7, 24.5, 21.6; IR 3264 (m), 2956 (w), 
2924 (w), 2873 (w), 1713 (s), 1642 (w), 1596 (w), 1596 (w), 1409 (s), 1342 (s), 1191 (m), 
1169 (s), 1117 (m), 1086 (s), 1044 (w), 988 (w), 915 (m), 867 (m), 836 (w), 816 (m), 793 
(w), 734 (m), 664 (s), 628 (w), 605 (w); Melting point: 117.1 – 120.2°C; HRMS (ESI) calcd 
for C16H22NO3S+ (M+H+) 308.1320; found: 308.1312. 
3-Phenyl-N-tosylpent-4-enamide (1g) 
 
Following a modification of a reported procedure,[11] a flask equipped with a Dean-Stark and 
a condenser was charged with cinnamyl alcohol (34) (1.9 mL, 15 mmol, 1.0 equiv), 
triethylorthoacetate (14 mL, 75 mmol, 5.0 equiv) and propionic acid (7 μL, 0.09 mmol, 0.06 
equiv). The mixture was heated to reflux for 3 h, while ca 12.5 mL triethylorthoacetate where 
distilled away. The resulting pale yellow solution was allowed to cool to room temperature, 
MeOH (15 mL) and KOH (2.5 g, 45 mmol, 3.0 equiv) were added and the mixture was then 
refluxed for 5 h. MeOH was then removed under reduced pressure and the crude oil residue 
was dissolved in Et2O (ca 30 mL) and extracted with a saturated solution of NaHCO3 (ca 30 
mL). The aqueous layer was further washed with Et2O (3 x 25 mL), acidified with 2 N HCl to 
                                                            
[11] W. Li, C. E. Hanau, A. d’Avignon, K. D. Moeller, J. Org. Chem. 1995, 60, 8155. 
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pH 1 and extracted with DCM (3 x 25 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo to afford 3-phenylpent-4-enoic acid (35) (2.14 g, 
12.1 mmol, 81% yield) as a pale yellow oil, which was used without further purification. 
Following a reported procedure,[7] p-tosyl isocyanate (394 mg, 1.99 mmol, 1.00 equiv) was 
added to a solution of 3-phenylpent-4-enoic acid (35) (350 mg, 1.99 mmol, 1.00 equiv) in 
THF (6 mL). After stirring the resulting clear solution at room temperature for 10 min, 
triethylamine (0.28 mL, 2.0 mmol, 1.0 equiv) was added dropwise, with release of gas. After 
1 h, the mixture was diluted with EtOAc (6 mL) and washed with 2 M HCl (6 mL) and NaCl 
(saturated solution, 6 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, PET/EtOAc 80/20) 
afforded 3-phenyl-N-tosylpent-4-enamide (1g) (660 mg, 2.01 mmol, quantitative) as a very 
viscous, colorless oil.  
Rf 0.34 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.98 (br s, 1 H, NH), 7.81 (m, 2 H, 
tosyl CH), 7.31-7.15 (m, 5 H, Ph CH), 7.07 (m, 2 H, tosyl CH), 5.87 (ddd, 1 H, J = 17.5, 
10.3, 7.0 Hz, CH=CH2), 4.98 (d, 1 H, J = 10.3 Hz, CH=CH2), 4.93 (d, 1 H, J = 17.2 Hz, 
CH=CH2), 3.77 (dd, 1 H, J = 14.8, 7.4 Hz, allylic CH), 2.69 (dd, 1 H, J = 14.9, 7.9 Hz, 
COCH2), 2.61 (dd, 1 H, J = 14.8, 7.4 Hz, COCH2), 2.43 (s, 3 H, tosyl CH3); 13C NMR (101 
MHz, CDCl3) δ 169.3, 144.0, 140.5, 138.3, 134.2, 128.5, 127.7, 127.2, 126.3, 125.8, 114.3, 
44.3, 41.2, 20.6; IR 3595 (w), 3544 (w), 3243 (w), 3087 (w), 2924 (w), 2361 (w), 2343 (w), 
1698 (m), 1639 (w), 1598 (w), 1493 (w), 1441 (s), 1379 (w), 1344 (m), 1308 (w), 1295 (w), 
1189 (m), 1172 (s), 1144 (m), 1121 (w), 1087 (s), 997 (w), 915 (m), 857 (m), 815 (m), 759 
(m), 734 (m), 703 (s), 683 (m), 672 (m), 661 (s), 646 (w), 611 (w); HRMS (ESI) calcd for 
C18H20NO3S+ (M+H+) 330.1164; found: 330.1171. 
N-Tosyl-2-vinylcyclohexanecarboxamide (1h) 
 
Following a modification of a reported procedure,[12] 1,2-cyclohexanedicarboxylic anhydride 
(36) (1.54 g, 9.99 mmol, 1.00 equiv) was dissolved in THF (12.5 mL) and the resulting 
solution was cooled to -40°C. LiAl(Ot-Bu)3 (3.17 g, 12.5 mmol, 1.25 equiv) was dissolved in 
THF (20 mL) at -40°C and the resulting off-white solution was cannulated into the flask 
containing the anhydride solution. The mixture was allowed to warm to -20°C over 6 h 
                                                            
[12] P. Canonne, M. Akssira, Tetrahedron 1985, 41, 3695. 
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(attention was paid not to go over this temperature). The reaction mixture was then quenched 
by addition of a 10% HCl solution until all solids were dissolved. The aqueous layer was 
extracted with Et2O (4 x 30 mL) and the combined organic layers were washed with brine, 
dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (SiO2, PET/EtOAc 90/10) afforded lactol 37 (629 mg, 4.03 mmol, 40% 
yield) as a colorless, viscous oil. 
Following a reported procedure,[13] n-BuLi (1.6 M in hexanes) (5.4 mL, 8.6 mmol, 2.2 equiv) 
was added dropwise to a suspension of Ph3PCH2Br (3.07 g, 8.58 mmol, 2.20 equiv) in THF 
(14 mL) at 0°C. After 30 min, a solution of lactol 37 (610 mg, 3.91 mmol, 1.00 equiv) in 
THF (9.2 mL) was cannulated into the ylide solution and the resulting mixture was allowed to 
warm to room temperature under stirring. The reaction was then quenched by adding a 10% 
NaOH solution until all solids were dissolved. The aqueous layer was washed with EtOAc (3 
x 40 mL). The resulting aqueous solution was acidified with 4 N HCl until pH 3 and extracted 
with EtOAc (3 x 40 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, PET/EtOAc 90/10) 
afforded 2-vinylcyclohexanecarboxylic acid (38) (266 mg, 1.72 mmol, 44% yield) as a 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 11.59 (br s, 1 H, COOH), 5.98 (ddd, 1 H, J = 18.3, 10.4, 8.0 
Hz, CHCH=CH2), 5.15-4.99 (m, 2 H, CH=CH2), 2.68 (m, 1 H, CHCH=CH2), 2.61 (m, 1 H, 
CHCOOH), 1.90-1.29 (m, 10 H, cyclohexane). 
Following a reported procedure,[7] p-tosyl isocyanate (255 mg, 1.29 mmol, 1.00 equiv) was 
added to a solution of 2-vinylcyclohexanecarboxylic acid 38 (200 mg, 1.30 mmol, 1.00 
equiv) in THF (4 mL). After stirring the resulting clear solution at room temperature for 10 
min, triethyl amine (0.18 mL, 1.3 mmol, 1.0 equiv) was added dropwise, with release of gas. 
After 1 h, the mixture was diluted with EtOAc (4 mL) and washed with 2 M HCl (4 mL) and 
NaCl (saturated solution, 4 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. The resulting crude solid was dissolved in Et2O in order to obtain a 
saturated solution and hexane was added to precipitate the pure tosyl amide. N-tosyl-2-
vinylcyclohexanecarboxamide (1h) was obtained as a colorless solid (0.18 g, 0.59 mmol, 
45% yield). 
Rf 0.54 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.09-7.86 (m, 3 H, NH and tosyl 
CH), 7.31 (m, 2 H, tosyl CH), 5.79 (ddd, 1 H, J = 17.0, 10.5, 8.2 Hz, CH=CH2), 4.96-4.87 
(m, 2 H, CH=CH2), 2.51 (m, 1 H, cyclohexane CH), 2.47-2.36 (m, 1 H, COCHCH), 2.44 (s, 3 
H, tosyl CH3), 1.78-1.22 (m, 10 H, cyclohexane CH2); 13C NMR (101 MHz, CDCl3) δ 171.7, 
144.9, 137.3, 135.6, 129.4, 128.5, 116.8, 47.5, 41.7, 30.1, 24.5, 23.8, 21.9, 21.7; IR 3250 (w), 
2934 (m), 2861 (w), 2348 (w), 2339 (w), 1720 (m), 1641 (w), 1598 (w), 1492 (w), 1437 (s), 
1378 (w), 1342 (m), 1311 (w), 1293 (w), 1277 (w), 1257 (w), 1174 (s), 1162 (s), 1134 (m), 
1114 (m), 1087 (s), 1058 (w), 1018 (w), 997 (w), 956 (w), 915 (m), 894 (w), 846 (m), 816 
(w), 763 (s), 747 (s), 710 (w), 704 (w), 666 (s), 655 (m), 642 (s), 635 (m), 622 (w); Melting 
point: 123.5 – 124.5°C; HRMS (ESI) calcd for C16H22NO3S+ (M+H+) 308.1320; found: 
308.1307. 
                                                            
[13] W. H. Moser, L. S. Hegedus, J. Am. Chem. Soc. 1996,  118,  7873.  
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N-Tosylhex-5-enamide (1i) 
 
Following a reported procedure,[7] p-tosyl isocyanate (1.19 g, 6.05 mmol, 1.10 equiv) was 
added to a solution of 5-hexenoic acid (39) (627 mg, 5.49 mmol, 1.00 equiv) in THF (16 
mL). After stirring the resulting clear solution at rt for 10 min, triethylamine (0.84 mL, 6.0 
mmol, 1.1 equiv) was added dropwise, with release of gas. After 1 h, the mixture was diluted 
with EtOAc (16 mL) and washed with 2 M HCl (16 mL) and NaCl (saturated solution, 12 
mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The 
resulting crude solid was dissolved in Et2O in order to obtain a saturated solution and hexane 
was added to precipitate the pure tosyl amide. N-tosylhex-5-enamide (1i) was obtained as a 
colorless, crystalline solid (1.37 g, 5.14 mmol, 93% yield).  
Rf  0.75 (DCM/MeOH 95/5); 1H NMR (400 MHz, CDCl3) δ 8.82 (br s, 1 H, NH), 7.94 (m, 2 
H, tosyl CH),[14] 7.34 (m, 2 H, tosyl CH), 5.67 (ddt, 1 H, J = 17.1, 10.5, 6.5 Hz, CH=CH2), 
5.00-4.87 (m, 2 H, CH=CH2), 2.44 (s, 3 H, tosyl CH3), 2.26 (t, 2 H, J = 7.4 Hz, 
COCH2CH2CH2), 1.99 (q, 2 H, J = 6.9 Hz, COCH2CH2CH2), 1.66 (quint, 2 H, J = 7.4 Hz, 
COCH2CH2CH2); 13C NMR (101 MHz, CDCl3) δ 170.8, 145.2, 137.2, 135.5, 129.6, 128.3, 
115.7, 35.3, 32.6, 23.2, 21.7; IR 3591 (w), 3254 (w), 3071 (w), 2936 (w), 2867 (w), 1718 
(m), 1641 (w), 1598 (w), 1494 (w), 1489 (w), 1440 (s), 1341 (m), 1308 (w), 1294 (w), 1220 
(w), 1189 (m), 1171 (s), 1141 (m), 1087 (s), 1020 (w), 996 (w), 916 (w), 871 (m), 842 (m), 
816 (m), 743 (w), 706 (w), 665 (s), 625 (m), 614 (w), 606 (w); Melting point: 71.8 - 73.5 °C; 
the reported values for 1i corresponded to the ones in literature.[15] 
2-Allyl-N-tosylbenzamide (1j) 
 
Following a reported procedure,[16] i-PrMgCl (2.0 M in THF) (5.25 mL, 10.5 mmol, 1.50 
equiv) was added dropwise to a solution of ethyl 2-iodobenzoate (40) (1.84 g, 7.01 mmol, 
1.00 equiv) in THF (74 mL) at -40°C. The resulting mixture was stirred at -40°C for 1.5 h. A 
                                                            
[14] The value for the peak at 7.94 ppm is different from the reported one in the literature (7.65 ppm) but 
corresponds better to what is expected for this proton signal. 
[15] L. Wu, S. Qiu, G. Liu. Org. Lett. 2009, 11, 2707. 
[16] O. Querolle, J. Dubois, S. Thoret, F. Roussi, F. Guéritte, D. Guénard, J. Med. Chem. 2004, 47 , 5937. 
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freshly prepared solution of CuCN (627 mg, 7.00 mmol, 1.00 equiv) and LiCl (594 mg, 14.0 
mmol, 2.0 equiv) in THF (20 mL) was added, followed, after 15 min, by dropwise addition of 
allyl bromide (2.43 mL, 28.0 mmol, 4.0 equiv). After being stirred at -40°C, the mixture was 
allowed to warm to rt, diluted with EtOAc (50 mL) and filtered over celite. The organic 
solution was washed with a 25% ammonia aqueous solution (100 mL). The aqueous layer 
was extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with 
brine (1 x 100 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude product 
was subjected to a short chromatography column (SiO2, PET/EtOAc 90/10) and dissolved in 
EtOH (100 mL). 2 N NaOH (75 mL) was added and the resulting mixture was stirred at room 
temperature for 4 h.  EtOH was then removed under reduced pressure and the aqueous layer 
was extracted with Et2O (2 x 75 mL); it was then acidified to pH 3 with 2 N HCl and 
extracted with EtOAc (3 x 75 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo to afford 2-allyl benzoic acid (42) (1.07 g, 6.58 mmol, 
94% yield over two steps) as a colorless solid which did not require further purification. 
1H NMR (400 MHz, CDCl3) δ 11.64 (br s, 1 H, COOH), 8.06 (dd, 1 H, J = 8.3, 1.6 Hz, ArH), 
7.51 (m, 1 H, ArH), 7.32 (m, 2 H, ArH), 6.05 (ddt, 1 H, J = 17.0, 10.5, 6.5 Hz, 
CH2CH=CH2), 5.07 (m, 1 H, CH2CH=CH2), 5.04 (m, 1 H, CH2CH=CH2), 3.84 (d, 2 H, J = 
6.5 Hz, CH2CH=CH2). 
Following a reported procedure,[7] p-tosyl isocyanate (690 mg, 3.50 mmol, 1.00 equiv) was 
added to a solution of 2-allyl benzoic acid 42 (567 mg, 3.50 mmol, 1.00 equiv) in THF (10 
mL). After stirring the resulting clear solution at room temperature for 10 min, triethylamine 
(0.49 mL, 3.5 mmol, 1.0 equiv) was added dropwise, with release of gas. After 1 h, the 
mixture was diluted with EtOAc (10 mL) and washed with 2 M HCl (10 mL) and NaCl 
(saturated solution, 10 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM/EtOAc 90/10) 
afforded 2-allyl-N-tosylbenzamide (1j) (972 mg, 3.08 mmol, 88% yield) as a colorless solid. 
Rf 0.51 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.49 (s, 1 H, NH), 8.04 (m, 2 H, 
tosyl CH), 7.52-7.35 (m, 4 H, Ar and tosyl CH), 7.27 (m, 2 H, Ar H), 5.88 (m, 1 H, 
CH=CH2), 4.99 (dd, 1 H, J = 10.1, 1.4 Hz, CH=CH2), 4.85 (dq, 1 H, J = 17.1, 2.0 Hz, 
CH=CH2), 3.47 (d, 2 H, J = 6.2 Hz, CH2CH=CH2), 2.48 (s, 3 H, tosyl CH3); 13C NMR (101 
MHz, CDCl3) δ 166.1, 145.2, 138.9, 137.0, 135.5, 132.7, 132.0, 131.2, 129.6, 128.7, 127.9, 
126.7, 116.7, 37.3, 21.7; IR 3246 (w), 3235 (w), 3211 (w), 1699 (m), 1640 (w), 1598 (w), 
1598 (w), 1491 (w), 1429 (m), 1347 (m), 1309 (w), 1309 (w), 1293 (w), 1293 (w), 1245 (w), 
1168 (s), 1129 (w), 1129 (w), 1088 (w), 1060 (m), 996 (w), 955 (w), 912 (w), 894 (w), 847 
(m), 813 (w), 778 (w), 778 (w), 746 (w), 687 (w), 679 (w), 661 (m), 641 (w), 641 (w), 630 
(w); Melting point: 92.3 – 93.7°C; HRMS (ESI) calcd for C17H18NO3S+ (M+H+) 316.1007; 
found: 316.0993. 
1-Allyl-N-tosyl-1H-pyrrole-2-carboxamide (1k) 
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Following a reported procedure,[17] DCC (1.15 g, 5.58 mmol, 1.12 equiv) was dissolved in 
DCM (3.0 mL) and the resulting solution was cannulated into a suspension of pyrrole-2-
carboxylic acid (43) (555 mg, 4.99 mmol, 1.00 equiv) in EtOH (7.5 mL). DMAP (30.5 mg, 
0.249 mmol, 0.05 equiv) was added to the colorless mixture, which was stirred overnight at 
room temperature. The solvents were then evaporated under reduced pressure and the crude 
product was purified by column chromatography (PET/EtOAc 95/5 to 85/15) to afford ethyl 
pyrrole-2-carboxylate (44) (647 mg, 4.65 mmol, 93% yield) as a colorless solid). 
Ethyl pyrrole-2-carboxylate 44 (647 mg, 4.65 mmol, 1.0 equiv) was dissolved in DMF (1 
mL) and the resulting solution was added dropwise to a suspension of NaH (60% in mineral 
oil) (170 mg, 6.94 mmol, 1.5 equiv) in DMF (5 mL) at 0°C. The mixture was stirred for 20 
min at 0°C and allyl bromide (0.67 mL, 7.7 mmol, 1.7 equiv) was added dropwise. The 
mixture was allowed to warm to room temperature and stirred for 2 h, before quenching the 
reaction by pouring it onto ice (20 g). The organic layer was diluted with Et2O (10 mL) and 
separated from the aqueous one. The latter was extracted with Et2O (3 x 10 mL). The 
combined organic layers were washed with water (4 x 10 mL) and brine (10 mL), were dried 
over MgSO4, filtered and concentrated in vacuo to afford ethyl 1-allyl-pyrrole-2-carboxylate 
(45) (794 mg, 4.43 mmol, 95% yield) as an orange oil, which did not require further 
purification. 
1 M NaOH (12.5 mL) was added to a solution of ethyl 1-allyl-pyrrole-2-carboxylate (45) (794 
mg, 4.43 mmol) in EtOH (10 mL). The mixture was refluxed for 1.5 h. EtOH was then 
evaporated under reduced pressure and the resulting aqueous solution was acidified to pH 2 
with 4 N HCl and extracted with EtOAc (3 x 25 mL). The combined organic layers were dried 
over  MgSO4, filtered and concentrated in vacuo to afford 1-allyl-1H-pyrrole-2-carboxylic 
acid (46) (589 mg, 3.89 mmol, 91% yield) as a brown solid, which did not require further 
purification. 
1H NMR (400 MHz, CDCl3) δ 11.59 (br s, 1 H, COOH), 7.12 (dd, 1 H, J = 3.9, 1.8 Hz, 
pyrrole), 6.91 (t, 1 H, J = 2.1 Hz, pyrrole), 6.19 (dd, 1 H, J = 3.9, 2.6 Hz, pyrrole), 6.01 (ddt, 
1 H, J = 16.7, 10.6, 5.5 Hz, CH2CH=CH2), 5.16 (dd, 1 H, J = 10.2, 1.2 Hz, CH2CH=CH2), 
5.06-4.91 (m, 3 H, CH2CH=CH2). 
Following a reported procedure,[8] DMAP (1.13 g, 9.25 mmol, 3.70 equiv) was added to a 
suspension of EDCI•HCl (767 mg, 4.00 mmol, 1.60 equiv) in DCM (6.3 mL). The mixture 
                                                            
[17] L. Ruest, H. Ménard, V. Moreau, F. Laplante, Can. J. Chem. 2002, 80, 1662. 
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was stirred at room temperature until all the solids dissolved and then it was cooled to 0°C. 1-
Allyl-1H-pyrrole-2-carboxylic acid (46) (378 mg, 2.50 mmol, 1.00 equiv) was added, 
followed by p-toluenesulfonamide (514 mg, 3.00 mmol, 1.20 equiv) and the mixture was 
stirred at room temperature for 20 h. Et2O (10 mL) was then added and the organic mixture 
was washed with 2 N HCl (15 mL). The aqueous layer was extracted with EtOAc (3 x 20 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM/EtOAc 90/10) 
afforded 1-allyl-N-tosyl-1H-pyrrole-2-carboxamide (1k) (727 mg, 2.38 mmol, 95% yield) as 
a colorless solid. 
Rf 0.25 (Hex/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.43 (m, 1 H, NH), 8.00 (m, 2 H, 
tosyl CH), 7.34 (m, 2 H, tosyl CH), 6.87 (m, 1 H, pyrrole), 6.78 (m, 1 H, pyrrole), 6.14 (dd, 1 
H, J = 4.1, 2.6 Hz, pyrrole), 5.90 (m, 1 H, CH=CH2), 5.08 (dq, 1 H, J = 10.0, 1.0 Hz, 
CH=CH2), 4.95 (dq, 1 H, J = 17.1, 1.5 Hz, CH=CH2), 4.85 (dt, 2 H, J = 5.8, 1.4 Hz, 
NCH2CH=CH2), 2.44 (s, 3 H, tosyl CH3); 13C NMR (101 MHz, CDCl3) δ 157.4, 144.7, 
136.1, 134.0, 129.9, 129.5, 128.3, 121.8, 117.2, 116.4, 108.7, 51.2, 21.6; IR 3276 (w), 3275 
(w), 1682 (s), 1598 (w), 1529 (w), 1492 (w), 1426 (s), 1343 (m), 1235 (w), 1190 (w), 1165 
(s), 1069 (s), 1017 (m), 996 (w), 907 (w), 875 (m), 874 (m), 813 (w), 742 (s), 703 (w), 662 
(m), 615 (w), 614 (w); Melting Point: 128.0 – 130.9°C; HRMS (ESI) calcd for C15H17N2O3S+ 
[M+H]+ 305.0954; found 305.0958. 
1-Allyl-N-tosyl-1H-indole-2-carboxamide (1l) 
 
Following a reported procedure,[18] SOCl2 (0.92 mL, 13 mmol, 1.8 equiv) was added to a 
stirred solution of indole-2-carboxylic acid (47) (1.13 g, 7.00 mmol, 1.0 equiv) in EtOH (6.8 
mL) at -5°C. The mixture was allowed to warm to room temperature and stirred for 1 h, 
before being refluxed for 2 h. The mixture was then allowed to cool down to room 
temperature. The precipitated solid was washed with water, filtered and washed with water 
again (until pH 6) and cyclohexane. It was then dried under vacuum. Ethyl indole-2-
carboxylate (48) (1.154 g, 6.099 mmol, 87% yield) was obtained as an off-white solid. 
                                                            
[18] A. Tsotinis, P. A. Afroudakis, K. Davidson, A. Prashar, D. Sugden, J. Med. Chem. 2007, 50, 6436. 
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Ethyl indole-2-carboxylate (48) (1.135 g, 5.999 mmol, 1.00 equiv) was dissolved in DMF 
(13.3 mL) and the resulting solution was added dropwise to a suspension of NaH (158 mg, 
6.58 mmol, 1.10 equiv) in DMF (3.8 mL) at 0°C. The mixture was stirred for 30 min at room 
temperature and a solution of allyl bromide (0.73 mL, 8.4 mmol, 1.4 equiv) was added 
dropwise. The mixture was stirred at 100°C for 1.5 h and then allowed to cool down to room 
temperature and poured into ice-cold water (20 mL). The organic layer was diluted with Et2O 
(20 mL) and separated from the aqueous one. The latter was extracted with Et2O (3 x 25 mL). 
The combined organic layers were washed with water (5 x 25 mL) and brine (25 mL), were 
dried over MgSO4, filtered and concentrated in vacuo to afford ethyl 1-allyl-indole-2-
carboxylate (49) (1.38 g, 6.00 mmol, quantitative) as a yellow oil, which was not further 
purified. 
Ethyl 1-allyl-indole-2-carboxylate (49) (1.38 g, 6.00 mmol) was dissolved in EtOH (15 mL) 
and 1 N NaOH (15 mL) was added to the resulting solution. The mixture was refluxed for 2 h 
and then allowed to cool down to room temperature. EtOH was evaporated under reduced 
pressure and the aqueous layer was diluted with water (15 mL) and washed with Et2O (2 x 30 
mL). It was then acidified with 4 M HCl until pH 2 and extracted with EtOAc (3 x 30 mL). 
The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to 
afford 1-allyl-indole-2-carboxylic acid (50) (966 mg, 4.80 mmol, 80% yield) as an off-white 
solid, which did not required further purification. 
1H NMR (400 MHz, CDCl3) δ 10.92 (br s, 1 H, COOH), 7.72 (m, 1 H, indole), 7.50 (s, 1 H, 
indole), 7.38 (m, 2 H, indole), 7.18 (m, 1 H, indole), 6.02 (m, 1 H, CH2CH=CH2), 5.25 (dt, 2 
H, J = 4.9, 1.6 Hz, CH2CH=CH2), 5.12 (m, 1 H, CH2CH=CH2), 4.92 (m, 1 H, CH2CH=CH2). 
Following a reported procedure,[7] p-tosyl isocyanate (592 mg, 3.00 mmol, 1.00 equiv) was 
added to a solution of 1-allyl-indole-2-carboxylic acid (50) (604 mg, 3.00 mmol, 1.00 equiv) 
in THF (8.4 mL). After stirring the resulting clear solution at room temperature for 10 min, 
triethylamine (0.42 mL, 3.0 mmol, 1.0 equiv) was added dropwise, with release of gas. After 
1 h, the mixture was diluted with EtOAc (9 mL) and washed with 2 M HCl (9 mL) and NaCl 
(saturated solution, 9 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, PET/EtOAc 95/5 to 
90/10) afforded 1-allyl-N-tosyl-1H-indole-2-carboxamide (1l) (928 mg, 2.62 mmol, 87%) as 
a colorless solid.  
Rf 0.43 (PET/EtOAc 5/1); 1H NMR (400 MHz, CDCl3) δ 9.21 (s, 1 H, NH), 8.07 (m, 2 H, 
tosyl CH), 7.63 (d, 1 H, J = 8.1 Hz, indole), 7.38-7.31 (m, 4 H, tosyl CH and indole), 7.19 (m, 
1 H, indole), 7.14 (ddd, 1 H, J = 8.0, 5.5, 2.5 Hz, indole), 5.88 (m, 1 H, NCH2CH=CH2), 5.07 
(dt, 1 H, J = 5.0, 1.5 Hz, NCH2CH=CH2), 5.02 (m, 1 H; NCH2CH=CH2), 4.84 (dq, 1 H, J = 
17.6, 1.5 Hz, NCH2CH=CH2), 2.43 (s, 3 H, tosyl CH3); 13C NMR (101 MHz, CDCl3) δ 158.7, 
145.0, 139.6, 135.7, 133.4, 129.6, 128.4, 127.3, 125.8, 125.7, 122.8, 121.2, 116.5, 110.7, 
108.8, 46.9, 21.7; IR 3266 (w), 3070 (w), 2928 (w), 2362 (w), 1923 (w), 1757 (w), 1757 (w), 
1688 (m), 1646 (w), 1615 (w), 1615 (w), 1597 (w), 1597 (w), 1579 (w), 1578 (w), 1516 (m), 
1494 (w), 1494 (w), 1479 (m), 1458 (m), 1429 (m), 1396 (m), 1373 (w), 1341 (m), 1309 (w), 
1295 (w), 1257 (w), 1239 (w), 1239 (w), 1196 (m), 1184 (m), 1161 (s), 1136 (w), 1136 (w), 
1118 (w), 1118 (w), 1076 (m), 1019 (w), 991 (w), 981 (w), 968 (w), 968 (w), 960 (w), 911 
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(m), 884 (m), 850 (m), 814 (m), 800 (w), 800 (w), 759 (m), 743 (s), 704 (w), 704 (w), 687 
(w), 687 (w), 682 (w), 682 (w), 663 (m), 628 (w), 615 (w); Melting Point: 185.3 - 187.2°C; 
HRMS (ESI) calcd for C19H19N2O3S+ (M+H+) 355.1116; found: 355.1119. 
Methyl-N-(4-nitrophenylsulfonyl)pent-4-enamide (1m) 
 
Following a reported procedure,[19] methyltriphenylphosphonium bromide (7.50 g, 21.0 
mmol, 3.0 equiv) was suspended in THF (90 mL). The colorless suspension was cooled to 0 
°C and n-BuLi (2.5 M in hexanes) (13.1 mL, 21.0 mmol, 3.0 equiv) was added dropwise. The 
resulting bright orange solution was stirred at 0 °C for 1 h before the dropwise addition of 
levulinic acid (51) (0.81 g, 7.0 mmol, 1.0 equiv). The suspension was allowed to warm to 
room temperature and stirred overnight. The reaction was then quench by adding a 1 M HCl 
solution (30 mL) and the aqueous layer was extracted with Et2O (3 x 90 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude product was purified by column chromatography (SiO2, PET/EtOAc/AcOH 85/15/0.1) 
to afford 4-methylpent-4-enoic acid (52) (542 mg, 4.74 mmol, 62% yield) as a clear 
yellowish oil.  
1H NMR (400MHz, CDCl3) δ 9.74 (br s, 1 H, COOH), 4.77 (m, 1 H, C=CH2), 4.71 (d, 1 H, J 
= 0.7 Hz, C=CH2), 2.54 (m, 2 H, CH2COOH), 2.37 (t, 2 H, J = 8.2 Hz, CH2C=CH2), 1.75 (d, 
3 H, J = 0.4 Hz, CH3C=CH2). 
Following a slightly modified version of a reported procedure,[8] DMAP (723 mg, 5.92 mmol, 
3.70 equiv) was added to a suspension of EDCI•HCl (490 mg, 2.56 mmol, 1.60 equiv) in 
DCM (4 mL). The mixture was stirred at room temperature until all the solids dissolved and 
then it was cooled to 0°C. 4-methylpent-4-enoic acid (52) (183 mg, 1.60 mmol, 1.00 equiv) 
was added, followed by p-nitrobenzenesulfonamide (453 mg, 2.24 mmol, 1.40 equiv) and the 
mixture was stirred at room temperature for 24 h. Et2O (10 mL) was then added and the 
organic mixture was washed with 2 N HCl (15 mL). The aqueous layer was extracted with 
EtOAc (3 x 15 mL). The combined organic layers were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. Purification by column chromatography (SiO2, 
DCM/EtOAc 90/10 to 70/30) afforded 4-methyl-N-(4-nitrophenylsulfonyl)pent-4-enamide 
(1m) (387 mg, 1.30 mmol, 81% yield) as a colorless solid. 
Rf  0.30 (PET/EtOAc/AcOH = 15/5/0.2); 1H NMR (400 MHz, CDCl3) δ 8.47 (br s, 1 H, NH), 
8.39 (m, 2 H, Nosyl CH), 8.28 (m, 2 H, Nosyl CH), 4.74 (d, 1 H, J = 0.6 Hz, C=CH2), 4.60 
(d, 1 H, J = 0.5 Hz, C=CH2), 2.44 (m, 2 H, COCH2CH2), 2.28 (t, 2 H, J = 7.5 Hz, 
COCH2CH2), 1.68 (s, 3 H, CH3); 13C NMR (101 MHz, CDCl3) δ 170.1, 150.8, 143.8, 143.0, 
130.0, 124.2, 111.4, 34.5, 31.7, 22.3; IR 3250 (w), 3109 (w), 3090 (w), 2977 (w), 2909 (w), 
                                                            
[19] S. Nicolai, S. Erard, D. Fernández González, J. Waser,  Org. Lett., 2010, 12, 384. 
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1724 (m), 1651 (w), 1609 (w), 1535 (s), 1505 (w), 1442 (s), 1352 (s), 1315 (m), 1294 (w), 
1179 (s), 1124 (m), 1088 (s), 1051 (w), 1014 (w), 961 (w), 910 (m), 869 (m), 849 (s), 815 
(w), 782 (w), 772 (w), 764 (w), 740 (s), 711 (w), 702 (w), 697 (w), 685 (m), 650 (w), 638 
(w), 626 (m), 612 (s); Melting point: 73.3 – 75.8°C; HRMS (ESI) calcd for C12H15N2O5S+ 
(M+H+) 299.0702; found: 299.0709. 
Procedure for the preparation of allyl tosylcarbamates (6a,b,e) 
 
Following a reported procedure,[20] triethyl amine (0.56 mL, 4.0 mmol, 1.0 equiv) was added 
dropwise to a solution of allyl alcohol (4.0 mmol, 1.0 equiv) in Et2O (4 mL) at 0°C. p-tosyl 
isocyanate (789 mg, 4.00 mmol, 1.0 equiv) was then added at 0°C. The resulting off-white 
suspension was allowed to warm to rt and stirred for 2.5 h. The mixture was then diluted with 
EtOAc (4 mL) and the organic layer was washed with 2 N HCl (4 mL). The aqueous layer 
was extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine 
(10 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography afforded allyl tosylcarbamate 6a,b,e. 
Allyl tosylcarbamate (6a) 
Column chromatography (SiO2, PET/EtOAc 90/10 to 80/20) afforded 
product 6a (1.02 g, 4.00 mmol, quantitative) as a viscous, colorless oil. 
Rf 0.26 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.17 (br s, 1 H, 
NH), 7.92 (m, 2 H, tosyl CH), 7.32 (m, 2 H, tosyl CH), 5.80 (m, 1 H, CH=CH2), 5.25 (ddd, 1 
H, J = 17.2, 2.9, 1.5 Hz, CH=CH2), 5.20 (d, 1 H, J = 10.3 Hz, CH=CH2), 4.55 (dt, 2 H, J = 
5.7, 1.2 Hz, CH2CH=CH2), 2.43 (s, 3 H, tosyl CH3); 13C NMR (101 MHz, CDCl3) δ 150.3, 
145.0, 135.3, 130.8, 129.5, 128.3, 119.2, 67.3, 21.6; IR 3613 (w), 3238 (w), 3237 (w), 2993 
(w), 2884 (w), 2826 (w), 2362 (w), 2344 (w), 1750 (m), 1650 (w), 1598 (w), 1495 (w), 1448 
(m), 1421 (m), 1345 (m), 1308 (w), 1291 (w), 1284 (w), 1223 (m), 1187 (m), 1158 (s), 1122 
(w), 1090 (s), 1069 (w), 1020 (w), 994 (w), 950 (w), 914 (w), 858 (s), 816 (m), 770 (m), 734 
(m), 705 (w), 687 (w), 678 (w), 670 (s), 664 (s), 636 (w), 620 (w), 609 (w); the reported 
values for 6a corresponded to the ones in literatures.[21] 
But-3-en-2-yl tosylcarbamate (6b) 
Column chromatography (SiO2, DCM/EtOAc/AcOH 95/5/0.1) afforded 
product 6b (907 mg, 3.37 mmol, 84%) as a viscous, colorless oil. 
Rf 0.47 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.92 (m, 2 H, 
tosyl CH), 7.51 (br s, 1 H, NH), 7.34 (m, 2 H, tosyl CH), 5.73 (ddd, 1 H, J = 17.4, 10.5, 6.0 
Hz, CH=CH2), 5.25-5.10 (m, 3 H, CH=CH2 and OCHCH3), 2.45 (s, 3 H, tosyl CH3), 1.27 (d, 
                                                            
[20] Y. Tamaru, M. Kimura, S. Tanaka, S. Kure, Z. Yoshida, Bull. Chem. Soc. Jpn. 1994, 67, 2838. 
[21] D. Xing, D. Yang, Org. Lett.  2010, 12, 1068. 
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3 H, J = 6.5 Hz, OCHCH3); 13C NMR (101 MHz, CDCl3) δ 149.9, 144.9, 136.2, 135.5, 129.5, 
128.3, 116.7, 74.3, 21.6, 19.7; IR 3616 (w), 3320 (w), 3238 (w), 2986 (w), 1743 (m), 1650 
(w), 1598 (w), 1441 (m), 1351 (m), 1308 (w), 1291 (w), 1290 (w), 1226 (m), 1187 (w), 1160 
(s), 1121 (w), 1108 (w), 1089 (s), 1039 (m), 992 (w), 915 (m), 874 (m), 816 (m), 771 (m), 
733 (m), 706 (w), 665 (s); HRMS (ESI) calcd for C12H15NNaO4S+ [M+Na]+ 292.0614; found 
292.0625.  
But-3-enyl tosylcarbamate (6d) 
Column chromatography (SiO2, DCM/EtOAc/AcOH 90/10/0.2) afforded product 6d (1.00 g, 
3.73 mmol, 93%) as a viscous, colorless oil.  
Rf 0.39 (Hex/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.91 (m, 2 
H, tosyl CH),[22] 7.42-7.31 (m, 3 H, tosyl CH and NH), 5.67 (m, 1 H, 
CH=CH2), 5.06 (m, 1 H, CH=CH2), 5.03 (m, 1 H, CH=CH2), 4.13 (t, 2 
H, J = 6.7 Hz, OCH2), 2.45 (s, 3 H, tosyl CH3), 2.33 (m, 2 H, CH2CH=CH2); 13C NMR (101 
MHz, CDCl3) δ 150.6, 144.9, 135.4, 133.0, 129.5, 128.2, 117.6, 65.8, 32.6, 21.5; IR 3541 
(w), 3242 (w), 3234 (w), 3080 (w), 3079 (w), 2980 (w), 2965 (w), 2259 (w), 1748 (m), 1644 
(w), 1598 (w), 1445 (m), 1382 (w), 1382 (w), 1348 (m), 1306 (w), 1306 (w), 1292 (w), 1224 
(m), 1185 (w), 1185 (w), 1160 (s), 1089 (m), 994 (w), 912 (m), 864 (w), 817 (m), 771 (w), 
733 (m), 703 (w), 662 (s); 1H and 13C values correspond to the ones in literature.[23] 
1-Cyclohexylallyl tosylcarbamate (6c) 
 
Following a reported procedure,[24] vinyl magnesium bromide (0.7 M in THF, 12 mL, 8.4 
mmol, 1.2 equiv) was diluted in THF (10 mL) and the reaction mixture was stirred at 0°C for 
10 min. Cyclohexanecarboxaldehyde (53) (785 mg, 7.00 mmol, 1.00 equiv) was added 
dropwise and the resulting mixture was stirred at 0°C for 4 h. The reaction was then 
quenched by addition of a saturated solution of NH4Cl (ca 15 mL). The aqueous layer was 
separated from the organic one and extracted with EtOAc (3 x 20 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography affored 1-cyclohexylprop-2-en-1-ol (54) (780 mg, 5.54 mmol, 79%) as a 
colorless oil. 
1-Cyclohexylprop-2-en-1-ol (54) (780 mg, 5.54 mmol, 1.00 equiv) was dissolved in DCM 
(11 mL) and the solution was cooled to 0°C. p-Tosyl isocyanate (1.11 g, 5.65 mmol, 1.02 
equiv) was added dropwise and, after 10 min, the mixture was allowed to warm to rt under 
                                                            
[22] The value for the peak at 7.91 ppm is different from the reported one in the literature (7.81 ppm) but 
corresponds better to what is expected for this proton signal. 
[23] F. Nahra, F. Liron, G. Prestat, G. Poli, C. Mealli, A. Messaoudi, Chem. Eur. J.  2009, 15, 11078. 
(24) Bergmeier, S.C.; Stanchina, D. M. J. Org. Chem 1997, 62, 4449. 
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stirring. After 1.5 h, DCM was evaporated and the resulting oil was dissolved in EtOAc (11 
mL) and washed with water (11 mL). The aqueous layer was extracted with EtOAc (2 x 11 
mL) and the combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. Purification by column chromatography (SiO2, PET/EtOAC 90/10 to 75/25) afforded 
1-cyclohexylallyl tosylcarbamate (6c) (1.76 g, 5.22 mmol, 94% yield) as a colorless solid. 
Rf 0.47 (PET/EtOAc 2/1); 1H NMR (400 MHz, CDCl3) δ 7.90 (m, 2 H, tosyl CH), 7.70 (br s, 
1 H, NH), 7.33 (d, 2 H, J = 8.2 Hz, tosyl CH), 5.63 (ddd, 1 H, J = 17.2, 10.9, 7.0 Hz, 
CH=CH2), 5.16 (m, 1 H,  CH=CH2), 5.12 (m, 1 H, CH=CH2), 2.44 (s, 3 H, tosyl CH3), 1.76-
1.37 (m, 6 H, cy), 1.20-0.99 (m, 3 H, cy), 0.94-0.77 (m, 2 H, cy); 13C NMR (101 MHz, 
CDCl3) δ 150.0, 144.9, 135.7, 133.6, 129.5, 128.2, 118.4, 82.4, 41.4, 28.2, 28.0, 26.1, 25.7, 
21.6;25 IR 3245 (w), 2929 (m), 2854 (w), 1748 (m), 1595 (w), 1449 (m), 1355 (m), 1305 (w), 
1287 (m), 1226 (m), 1187 (w), 1162 (s), 1117 (w), 1091 (m), 1049 (w), 1021 (w), 989 (w), 
954 (m), 894 (w), 860 (m), 842 (w), 816 (w), 769 (w), 737 (w), 736 (w), 705 (w), 665 (m), 
619 (w); Melting point: 84.0 – 88.0°C; HRMS (ESI) calcd for C17H23NNaO4S+ [M+Na]+ 
360.1240; found 360.1232. 
N-(Allylcarbamoyl)-4-methylbenzenesulfonamide (6e) 
 
Allyl amine (55) (342 mg, 5.99 mmol, 1.0 equiv) was dissolved in DCM (12 mL) and the 
solution was cooled to 0°C. p-Tosyl isocyanate (1.21 g, 6.12 mmol, 1.02 equiv) was added 
dropwise and, after 10 min,  the mixture was allowed to warm to rt under stirring. After 1.5 h, 
DCM was evaporated and the resulting oil was dissolved in EtOAc (12 mL) and washed with 
water (10 mL). The aqueous layer was extracted with EtOAc (2 x 12 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. No further 
purification was required. 2-Methylbut-3-en-2-yl tosylcarbamate 6e (1.14 g, 4.50 mmol, 75% 
yield) was obtained as a colorless solid. 
Rf 0.10 (Hex/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.78 (m, 2 H, tosyl CH), 7.33 (m, 2 
H, tosyl CH), 6.67 (s, 1 H, NH), 5.78 (m, 1 H, CH2CH=CH2), 5.15 (m, 1 H, CH2CH=CH2), 
5.12 (m, 1 H, CH2CH=CH2), 3.85 (m, 2 H, CH2CH=CH2), 2.45 (s, 3 H, tosyl CH3); 13C NMR 
(101 MHz, CDCl3) δ 151.6, 144.9, 136.6, 133.4, 129.9, 126.9, 116.5, 42.6, 21.6; IR 3339 (w), 
3187 (w), 3099 (w), 2914 (w), 1668 (s), 1646 (w), 1598 (w), 1543 (m), 1495 (w), 1458 (m), 
1342 (m), 1275 (w), 1265 (w), 1247 (w), 1241 (w), 1188 (w), 1165 (s), 1091 (m), 1055 (w), 
991 (w), 943 (w), 917 (w), 877 (w), 815 (w), 734 (w), 715 (w), 705 (w), 693 (w), 669 (s), 641 
(m); Melting point: 140.5 – 144.0°C; HRMS (ESI) calcd for C11H15N2O3S+ [M+H]+ 
255.0798; found 255.0808 
N-(Diallylcarbamoyl)-4-methylbenzenesulfonamide (6f) 
                                                            
(25) One 13C signal could not be resolved. 
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p-Tosylisocyanate (1.0 mL, 4.1 mmol, 1.02 equiv) was added to a solution of diallylamine 
(56) (0.31 mL, 4.0 mmol, 1.0 equiv) in DCM (8.0 mL) at 0°C. The reaction mixture was 
allowed to warm to rt and stirred for 1 h. The DCM was then evaporated under reduced 
pressure and ethyl acetate (8 mL) was added. The organic solution was washed with water (8 
mL). The aqueous layer was extracted with EtOAc (8 mL) and the combined organic layers 
washed with brine (8 mL), dried over MgSO4, filtered and concentrated under reduced 
pressure. Purification by column chromatography (SiO2, DCM/AcOEt 9/1) afforded N-
(diallylcarbamoyl)-4-methylbenzenesulfonamide (6f) (0.94 g, 3.2 mmol, 80% yield) as a 
colorless oil. 
Rf  0.49 (DCM/EtOAc 9/1); 1H NMR (400 MHz, CDCl3) δ 7.90 (m, 2 H, tosyl CH), 7.30 (m, 
2 H, tosyl CH), 5.71 (m, 2 H, CH2CH=CH2), 5.19 (d, 2 H, J = 10.3 Hz, CH2CH=CH2), 5.14 
(dd, 2 H, J = 17.2, 1.0 Hz, CH2CH=CH2), 3.84 (d, 4 H, J = 5.4 Hz, CH2CH=CH2), 2.41 (s, 3 
H, tosyl CH3). 13C NMR (101 MHz, CDCl3) δ 151.6, 144.3, 136.3, 132.4, 129.3, 128.1, 
117.7, 48.9, 21.5. IR 3495 (w), 3495 (w), 3275 (w), 3085 (w), 3025 (w), 2987 (w), 2926 (w), 
2871 (w), 2253 (w), 1673 (s), 1646 (m), 1598 (w), 1459 (s), 1420 (m), 1384 (m), 1337 (m), 
1308 (w), 1292 (w), 1232 (m), 1187 (m), 1164 (s), 1142 (m), 1122 (w), 1090 (m), 1020 (w), 
995 (w), 910 (s), 891 (m), 847 (m), 814 (m), 755 (w), 730 (s), 706 (m), 698 (w), 665 (s), 649 
(m), 603 (w). HRMS (ESI) calculated for C14H19N2O3S+ (M+H+) 295.1116; found 295.1104. 
2-Benzyl-N-tosylpent-4-enamide (6g) 
 
Following a reported procedure,[26] benzyl bromide (0.72 mL, 6.0 mmol, 1.0 equiv) was 
added dropwise to allyamine (55) (2.7 mL, 36 mmol, 6.0 equiv) at 0°C. The mixture was 
allowed to warm to rt and stirred overnight. The reaction was quenched by adding NaHCO3 
(6 mL, saturated solution). The aqueous layer was extracted with Et2O (3 x 10 mL). The 
combined organic layers were dried over K2CO3, filtered and concentrated under reduced 
pressure. Purification by column chromatography (SiO2, Petroleum ether/AcOEt 8/1) 
afforded N-benzylprop-2-en-1-amine (57) (338 mg, 2.30 mmol, 38% yield) as a colorless oil. 
p-Tosylisocyanate (0.56 mL, 2.3 mmol, 1.0 equiv) was added to a solution of N-benzylprop-
2-en-1-amine (57) (338 mg, 2.30 mmol, 1.00 equiv) in DCM (5 mL) at 0°C. The reaction 
mixture was allowed to warm to rt and stirred for 1 h. The DCM was then evaporated under 
reduced pressure and ethyl acetate (5 mL) was added. The organic solution was washed with 
water (5 mL). The aqueous layer was extracted with EtOAc (5 mL) and the combined organic 
layers washed with brine (8 mL), dried over MgSO4, filtered and concentrated under reduced 
                                                            
[26]  D. F. Harvey, D. M. Sigano, J. Org. Chem. 1996, 61, 2268. 
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pressure. Purification by column chromatography (SiO2, DCM/AcOEt/AcOH 90/10/2) 
afforded 2-benzyl-N-tosylpent-4-enamide (6g) (0.555 g, 1.62 mmol, 70% yield) as a colorless 
amorphous solid. 
Rf 0.43 (DCM/AcOEt 9/1);  1H NMR (400 MHz, CDCl3) δ 7.88 (m, 2 H, J = 8.0 Hz, tosyl 
CH), 7.36-7.27 (m, 5 H, CH2Ph), 7.17 (m, 2 H, tosyl CH), 5.71 (m, 1 H, CH2CH=CH2), 5.24 
(d, 1 H, J = 10.2 Hz, CH2CH=CH2), 5.17 (dd, 1 H, J = 17.2, 0.7 Hz, CH2CH=CH2), 4.43 (s, 2 
H, CH2Ph), 3.81 (d, 2 H, J = 1.2 Hz, CH2CH=CH2), 2.43 (m, 3 H, tosyl CH3); 13C NMR (101 
MHz, CDCl3) δ 152.1, 144.3, 136.3, 132.3, 129.4, 128.8, 128.2, 127.8, 127.5, 126.4, 117.9, 
49.9, 49.1, 21.6; IR 3281 (w), 3256 (w), 3065 (w), 3032 (w), 2927 (w), 2854 (w), 2364 (w), 
1746 (w), 1739 (w), 1730 (w), 1677 (m), 1670 (m), 1598 (w), 1573 (w), 1495 (m), 1464 (s), 
1453 (s), 1386 (w), 1338 (m), 1308 (w), 1293 (w), 1230 (m), 1187 (w), 1164 (s), 1134 (w), 
1086 (m), 1067 (w), 1032 (w), 1021 (w), 996 (w), 912 (w), 893 (w), 857 (m), 816 (w), 743 
(m), 738 (m), 702 (m), 665 (s); HRMS (ESI) calculated for C18H21N2O3S+ (M+H+) 345.1273; 
found 345.1265.  
 
5. Optimization of the Reaction 
General procedure for reaction optimization: 
Tosyl amide 1a (18 mg, 0.071 mmol, 1.0 equiv), the catalyst (0.014 mmol, 0.20 equiv), 
benziodoxolone reagent (0.084 mmol, 1.2 equiv) and the additive (when applicable) were 
dissolved in the solvent (1.75 mL). The mixture was stirred overnight at room temperature, 
before being filtered through a short celite plug. The latter was washed with CHCl3 (5 x 2 
mL) and the resulting solution was concentrated in vacuo. The residue was then dissolved in 
CDCl3 (ca 1 mL) and a standard hexamethyldisiloxane solution (0.1 M, 0.088 mL) was added. 
Yield was determined by 1H-NMR, based on the following calibration. 
1H-NMR Quantification 
The 0.1 M standard solution was prepared by dissolving hexamethyldisiloxane (0.10 mL, 4.7 
mmol) in CDCl3 (4.6 mL).  
1-Tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3a) (28 mg, 0.065 mmol) was 
dissolved in CDCl3 (ca 0.5 mL) (solution A). Different volumes of 0.1 M standard solution 
were added to solution A: 0.050 mL (solution B); 0.100 mL (solution C); 0.150 mL (solution 
D); 0.200 mL (solution E), 0.250 mL (solution F), 0.300 mL (solution G). 1H NMR spectra 
were acquired for solution A-G. For each 1H NMR spectrum, the ratio between the integrals 
of the signal at δ 2.91 (dd, 1 H, J = 17.1, 6.5 Hz, CH2C≡C) of 3a and the signal at δ 0.06 (s, 1 
H, TMS) of hexamethyldisiloxane was calculated. These observed ratios by integration of the 
1H-NMR peaks and the ratios (mmol 3a / mmol hexamethyldisiloxane) were used as the axis 
of the calibration graph. 
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Detailed results for the optimization studies 
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Table S1: Solvent screening for the reaction of 1a with 2a. 
Entry Solvent Yield (%)  Entry Solvent Yield (%)
1 CH2Cl2 44 (33)b  10 THF - 
2 CHCl3 57  11 PhCH3 < 5 
3 DCE 43  12 MeOH 31 
4 CH2Cl2/Hexane (10%) 15  13 EtOH 34 
5 Acetone -  14 iPrOH 30 
6 Acetonitrile -  15 CHCl3/EtOH (1/1) 43 
7 AcOH -  16 CHCl3/EtOH (9/1) 52 
8 DMSO -  17 CHCl3/AcOH (9/1) 31 
9 DMF -  18 CHCl3/H2O (1/1) 10 
a Reaction conditions: 0.069 mmol 1a, 0.014 mmol Pd(hfacac)2, 0.084 mmol TIPS-EBX (2a), in 
1.75 mL solvent, 15 h, rt. Yield was determined via 1H NMR. b Isolated Yield. 
Table S2: Catalyst screening for the reaction of 1a with 2a. 
Entry Catalyst (20 mol %) Additive Solvent Yield (%) 
1 Pd(hfacac)2 - CHCl3 57 
2 Pd(hfacac)2 TFA (1.2 equiv) CHCl3 22 
3 Pd(tfa)2 - CHCl3 10 
4 Pd(OAc)2 - CHCl3 < 5 
5 Pd(acac)2 - CHCl3 15 
6 PdCl2 - CHCl3 19 (conv.: 54 %) 
7 PdCl2(MeCN)2 - CHCl3 31 
8 Pd(dba)2 - CHCl3 - 
9 Pd(MeCN)4(BF4)2 - CHCl3 < 5 
10 Catalyst 2 - CHCl3 21 (conv.: 56 %) 
11 PdCl2 - EtOH 57 
12 PdCl2(PPh3)2 - EtOH - 
Reaction conditions: 0.069 mmol 1a, 0.014 mmol catalyst, 0.084 mmol TIPS-EBX (2a), 0.084 
mmol additive in 1.75 mL solvent, 15 h, rt. Yield was determined via 1H NMR. 
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Table S3: Optimization of the Pd(hfacac)2/CHCl3 conditions 
Entry Additive (1.2 equiv.) Yield (%)
1 TFA 22 
2 CF3CH2OH 55 
3 (CF3)2CHOH 47 
4 2,5-ditertbutyl pyridine 70 
5 pyridine - 
6 LiCl 55 
7 CuI < 10 
Reaction conditions: 0.069 mmol 1a, 0.0028 
mmol Pd(hfacac)2, 0.084 mmol TIPS-EBX (2a), 
0.084 mmol additive in 1.75 mL solvent, 15 h, 
rt. Yield was determined via 1H NMR. 
Table S3: Optimization of the PdCl2/Alcohol conditions (effect of additives and solvents) 
Entry Additive  n. equiv. Solvent Yield (%) 
1 LiI 1.2 EtOH 11 
2 LiBr 1.2 EtOH 20 
3 LiCl 1.2 EtOH 76 
4 LiCl 1.2 MeOH 93 
5 LiCl 1.2 n-PrOH 80 
6 LiCl 1.2 i-PrOH 70 
7 LiCl 10 EtOH 93 
8 KCl 1.2 EtOH 64 
9 Bu4NCl 1.2 EtOH 48 
10 LiBF4 1.2 EtOH 20 
11 CuI 1.2 EtOH 23 
12 2,5-ditertbutyl pyridine 1.2 EtOH 62 
13 K2CO3 1.2 EtOH - 
14 LiCl/2,5-ditertbutyl pyridine 1.2 EtOH 62 
Reaction conditions: 0.069 mmol 1a, 0.014 mmol PdCl2, 0.084 mmol TIPS-
EBX (2a), 0.084 mmol additive in 1.75 mL solvent, 15 h, rt. Yield was 
determined via 1H NMR. 
 
Table S4: Application of the optimized conditions (Upscaling/Isolation) 
Entry Conditions Alkynylating Solvent Time (h) Isol. Yield (%)
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Reagent 
1 PdCl2/LiCl (1.2 equiv) TIPS-EBX MeOH 1 77 
2 PdCl2/LiCl (3.6 equiv) TIPS-EBX MeOH 1 81 
3 PdCl2/LiCl (1.2 equiv) TIPS-EBX EtOH 3.5 75 
4 PdCl2/LiCl (3.6 equiv) TIPS-EBX EtOH 5 87 
5 
Pd(hfacac)2/ 
ditertbutyl Py (1.2 equiv) 
TIPS-EBX CHCl3 15 55 
6 PdCl2/LiCl (3.6 equiv) TMS-EBX EtOH 5 23 
7 PdCl2/LiCl (3.6 equiv) EtOH 5 < 5 
8a PdCl2/LiCl (3.6 equiv)  EtOH 5 < 5 
9b PdCl2/LiCl (3.6 equiv)   EtOH 5 - 
Isolated yield using 0.40 mmol 1a, 0.040 mmol catalyst, 0.48 mmol TIPS-EBX (2a), additive in 10 
mL solvent. aReaction performed using 0.069 mmol 1a, 0.014 mmol PdCl2, 0.25 mmol LiCl, 0.084 
mmol CuI, 0.084 mmol TIPS-EBX (2a), 1.75 mL solvent, 15 h, rt. No conversion was observed with 
and without CuI. bReaction performed using 0.069 mmol 1a, 0.014 mmol PdCl2, 0.25 mmol LiCl, 
0.084 mmol CuI, 0.084 mmol TIPS-EBX (2a), 1.75 mL solvent, 15 h, rt. No conversion was 
observed with and without CuI. 
  
6. Scope of the Reaction 
General Procedure for the intramolecular aminoalkynylation: 
 
The tosyl amide (0.40 mmol, 1.0 equiv) was added to a solution of LiCl (61.0 mg, 1.44 
mmol, 3.60 equiv) in EtOH (10 mL), followed by PdCl2 (7.1 mg, 0.040 mmol, 0.10 equiv) 
and benziodoxolone reagent (0.480 mmol, 1.20 equiv). The mixture was stirred for 2-5 h at 
room temperature. EtOH was then removed under reduced pressure and the residue was 
diluted with 20 mL Et2O. The organic solution was washed with a saturated solution of 
Na2CO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 20 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The resulting 
crude product was purified by column chromatography. 
1-Tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3a) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded 
product 3a (152 mg, 0.350 mmol, 88% yield) as a yellow solid.  
Large scale reaction: Tosyl amide 1a (1.93 g, 7.61 mmol, 1.00 equiv) 
was added to a solution of LiCl (1.21 g, 27.4 mmol, 3.60 equiv) in EtOH 
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(100 mL), followed by PdCl2 (71 mg, 0.40 mmol, 0.052 equiv) and TIPS-EBX (2a) (3.91 g, 
9.12 mmol, 1.20 equiv). The mixture was stirred for 4 h at room temperature. EtOH was then 
removed under reduced pressure and the residue was diluted with 100 mL Et2O. The organic 
solution was washed with a saturated solution of Na2CO3 (100 mL). The aqueous layer was 
extracted with Et2O (3 x 100 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. Column chromatography (SiO2, PET/EtOAc 95/5 to 
90/10) afforded product 3a (2.50 g, 5.77 mmol, 76% yield) as a yellow solid.  
Rf 0.59 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.97 (m, 2 H, tosyl CH), 7.31 (d, 2 
H, J = 8.1 Hz, tosyl CH), 4.53 (m, 1 H, NCH), 2.91 (dd, 1 H, J = 17.1, 6.5 Hz, CH2C≡C), 
2.83-2.68 (m, 2 H, CH2C≡C and CH2C=O), 2.42 (s, 3 H, tosyl CH3), 2.42-2.05 (m, 3 H, 
CH2CH2C=O), 1.19-0.78 (m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 173.5, 145.0, 
135.7, 129.5, 128.5, 102.6, 84.5, 58.1, 31.0, 26.5, 23.6, 21.7, 18.5, 11.2; IR 2943 (m), 2891 
(w), 2865 (m), 2257 (w), 2175 (w), 1738 (m), 1686 (w), 1598 (w), 1495 (w), 1463 (m), 1431 
(w), 1362 (m), 1307 (w), 1292 (w), 1272 (w), 1220 (w), 1187 (m), 1170 (s), 1111 (m), 1090 
(m), 1074 (w), 1045 (w), 1031 (w), 1014 (w), 997 (w), 955 (m), 912 (m), 884 (m), 814 (w), 
800 (w), 772 (w), 766 (w), 735 (s), 705 (w), 678 (s), 642 (m), 634 (s), 626 (w), 617 (w); 
Melting Point: 68.8 - 71.5°C; HRMS (ESI) calcd for C23H36NO3SSi+ (M+H+) 434.2185; 
found: 434.2183. 
1-Tosyl-5-(3-(trimethylsilyl)prop-2-ynyl)pyrrolidin-2-one (4) 
Column chromatography (SiO2, PET/EtOAc 85/15) afforded product 4 
(33 mg, 0.094 mmol, 24% yield) as a yellow amorphous solid. 
Rf  0.41 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.96 (m, 2 H, 
tosyl CH), 7.31 (d, 2 H, J = 8.2 Hz, tosyl CH), 4.51 (m, 1 H, NCH), 2.91 
(dd, 1 H, J = 17.2, 6.3 Hz, CH2C≡C), 2.77-2.60 (m, 1 H, CH2CO), 2.64 (dd, 1 H, J = 17.2, 2.9 
Hz, CH2C≡C), 2.45-2.23 (m, 2 H, COCH2CH2), 2.42 (s, 3 H, tosyl CH3), 2.07 (m, 1 H, 
COCH2CH2), 0.01 (m, 9 H, TMS); 13C NMR (101 MHz, CDCl3) δ 173.5, 144.9, 135.6, 
129.4, 128.5, 101.1, 88.6, 57.9, 31.0, 26.5, 23.8, 21.6, -0.4; IR 2960 (w), 2924 (w), 2258 (w), 
2178 (w), 1913 (w), 1737 (s), 1653 (w), 1598 (w), 1494 (w), 1457 (w), 1410 (w), 1360 (s), 
1309 (w), 1291 (w), 1251 (m), 1221 (m), 1188 (m), 1168 (s), 1111 (s), 1091 (m), 1071 (w), 
1044 (w), 1015 (w), 955 (m), 912 (m), 845 (s), 815 (m), 763 (m), 733 (s), 705 (m), 676 (s), 
646 (m), 626 (w), 608 (m); HRMS (ESI) calcd for C17H24NO3SSi+ [M+H]+ 350.1241; found 
350.1245. 
5-(3-Phenylprop-2-ynyl)-1-tosylpyrrolidin-2-one (5) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded 
product 5 (83 mg, 0.23 mmol, 58% yield; 95% pure) as a yellow 
amorphous solid. 
Rf 0.34 (PET/EtOAc = 4/1); 1H NMR (400 MHz, CDCl3) δ 8.03 (d, 2 H, J 
= 8.3 Hz, tosyl CH), 7.37-7.19 (m, 5 H, Ph), 7.15 (m, 2 H, tosyl CH), 4.65 (m, 1 H, NCH), 
3.17 (dd, 1 H, J = 17.2, 6.3 Hz, CH2C≡C), 2.92-2.67 (m, 2 H, CH2C≡C and CH2C=O), 2.49-
2.30 (m, 2 H, CH2CH2C=O), 2.36 (s, 3 H, tosyl CH3), 2.15 (m, 1 H, CH2CH2C=O). 13C NMR 
(101 MHz, CDCl3) δ 173.7, 145.0, 135.5, 131.4, 129.4, 128.5, 128.1, 128.1, 122.6, 84.2, 83.9, 
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58.1, 31.0, 26.2, 24.1, 21.6; IR 3058 (w), 2992 (w), 2926 (w), 2362 (w), 2338 (w), 1735 (s), 
1735 (s), 1597 (m), 1575 (w), 1541 (w), 1513 (w), 1491 (w), 1464 (w), 1442 (w), 1356 (m), 
1295 (w), 1268 (w), 1222 (m), 1168 (s), 1109 (m), 1089 (m), 1062 (w), 1042 (w), 1017 (w), 
956 (m), 913 (m), 865 (w), 847 (w), 815 (m), 761 (m), 731 (m), 710 (w), 672 (s), 610 (m); 
HRMS (ESI) calcd for C20H20NO3S+ (M+H+) 354.1164; found: 354.1159. 
1-(4-Methoxyphenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3b) 
Column chromatography (SiO2, PET/EtOAc 92/8) afforded product 
3b (144 mg, 0.320 mmol, 80% yield) as a yellow solid. 
Rf 0.59 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.02 (m, 2 
H, p-OMe-phenylsulfonyl CH), 6.97 (m, 2 H, p-OMe-
phenylsulfonyl CH), 4.52 (m, 1 H, NCH), 3.86 (s, 3 H, OCH3), 2.91 
(dd, 1 H, J = 17.1, 6.5 Hz, CH2C≡C), 2.83-2.66 (m, 2 H, CH2C≡C 
and COCH2CH2), 2.45-2.23 (m, 2 H, COCH2CH2), 2.13 (m, 1 H, COCH2CH2), 1.02-0.91 (m, 
21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 173.4, 163.9, 130.8, 130.0, 114.0, 102.6, 84.5, 
58.1, 55.6, 30.9, 26.4, 23.5, 18.5, 11.1; IR 2958 (w), 2944 (w), 2865 (w), 2361 (w), 2343 (w), 
2174 (w), 1738 (m), 1596 (m), 1580 (w), 1499 (m), 1463 (w), 1416 (w), 1362 (m), 1338 (w), 
1312 (w), 1264 (m), 1222 (m), 1197 (m), 1185 (m), 1164 (s), 1112 (m), 1093 (m), 1070 (w), 
1045 (w), 1029 (m), 998 (w), 955 (m), 930 (w), 911 (w), 884 (w), 834 (m), 805 (m), 784 (w), 
770 (w), 762 (w), 736 (m), 718 (w), 708 (w), 683 (s), 671 (m), 661 (m), 650 (w), 631 (m), 
616 (m); Melting point: 69.5 – 71.8°C; HRMS (ESI) calcd for C23H36NO4SSi+ (M+H+) 
450.2144; found: 450.2129. 
1-(4-Nitrophenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-nyl)pyrrolidin-one (3c) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded 
product 3c (92 mg, 0.20 mmol, 50% yield) as a yellowish solid. 
Rf 0.44 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.36 (m, 2 H, 
Nosyl CH), 8.27 (m, 2 H, Nosyl CH), 4.58 (m, 1 H, NCH), 3.00 (dd, 1 H, 
J = 17.4, 5.6 Hz, CH2C≡C), 2.87-2.67 (m, 2 H, CH2C≡C and 
COCH2CH2), 2.52-2.31 (m, 2 H, COCH2CH2), 2.15 (m, 1 H, COCH2CH2), 1.07-0.87 (m, 21 
H, TIPS); 13C NMR (101 MHz, CDCl3) δ 173.8, 150.7, 143.7, 130.0, 124.0, 101.8, 85.3, 58.1, 
30.9, 26.5, 23.6, 18.4, 11.0; IR 3392 (w), 2944 (m), 2927 (w), 2866 (w), 2361 (w), 2143 (w), 
1749 (w), 1657 (w), 1656 (w), 1650 (w), 1536 (w), 1463 (w), 1433 (w), 1415 (w), 1403 (w), 
1371 (w), 1370 (w), 1351 (w), 1317 (w), 1293 (w), 1248 (w), 1217 (w), 1178 (m), 1141 (w), 
1111 (w), 1110 (w), 1089 (w), 1068 (w), 1033 (m), 1020 (m), 1000 (w), 978 (w), 968 (w), 
958 (w), 937 (w), 925 (w), 900 (w), 884 (m), 853 (w), 852 (w), 832 (w), 815 (w), 800 (w), 
792 (w), 784 (w), 728 (m), 700 (m), 675 (s), 660 (s), 643 (m), 633 (s), 623 (s), 608 (m); 
Melting point: 106.5 – 108.5°C; HRMS (ESI) calcd for C22H33N2O5SSi+ (M+H+) 465.1880; 
found: 465.1873. 
3,3-Dimethyl-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3d) 
Column chromatography (SiO2, PET/EtOAc 95/5) afforded 
product 3d (154 mg, 0.334 mmol, 84% yield) as a pale yellow 
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solid.  
Rf 0.84 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.95 (d, 2 H, J = 8.4 Hz, tosyl CH), 
7.30 (d, 2 H, J = 8.1 Hz, tosyl CH), 4.32 (m, 1 H, NCH), 3.00 (dd, 1 H, J = 17.0, 3.7 Hz, 
CH2C≡C), 2.93 (dd, 1 H, J = 16.8, 7.0 Hz, CH2C≡C), 2.41 (s, 3 H, tosyl CH3), 2.10 (dd, 1 H, 
J = 13.2, 7.8 Hz, C(CH3)2CH2), 2.03 (dd, 1 H, J = 13.2, 7.1 Hz, C(CH3)2CH2), 1.16 (s, 3 H, 
COC(CH3)2), 1.06 (s, 3 H, COC(CH3)2), 1.04-0.93 (m, 21 H, TIPS); 13C NMR (101 MHz, 
CDCl3) δ 179.1, 144.9, 135.7, 129.5, 128.4, 102.6, 84.7, 54.9, 41.1, 38.6, 26.9, 25.6, 24.6, 
21.7, 18.6, 11.2; IR 2960 (m), 2942 (m), 2891 (w), 2866 (m), 2360 (w), 2342 (w), 2176 (w), 
1739 (m), 1657 (w), 1598 (w), 1496 (w), 1463 (m), 1401 (w), 1385 (w), 1361 (s), 1307 (w), 
1293 (w), 1235 (m), 1212 (w), 1188 (m), 1172 (s), 1114 (s), 1090 (s), 1069 (w), 1051 (w), 
1025 (m), 1000 (w), 953 (w), 904 (m), 884 (m), 838 (w), 814 (m), 758 (w), 736 (m), 719 (m), 
707 (w), 675 (s), 664 (s), 645 (m). Melting Point: 144.0 – 145.9°C; HRMS (ESI) calcd for 
C25H40NO3SSi+ (M+H+) 462.2498; found: 462.2510. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-2-azaspiro[4.5]decan-1-one (3e) 
Column chromatography (SiO2, PET/EtOAc 95/5) afforded 
product 3e (176 mg, 0.351 mmol, 88% yield) as a yellow 
amorphous solid. 
Rf 0.80 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.93 (d, 2 H, J = 8.4 Hz, tosyl CH), 
7.28 (d, 2 H, J = 8.2 Hz, tosyl CH), 4.32 (m, 1 H, NCH), 3.00 (dd, 1 H, J = 17.0, 3.5 Hz, 
CH2C≡C), 2.88 (dd, 1 H, J = 16.9, 7.5 Hz, CH2C≡C), 2.41 (s, 3 H, tosyl CH3), 2.24 (dd, 1 H, 
J = 13.4, 8.3 Hz, COCCH2), 2.01 (dd, 1 H, J = 13.4, 6.3 Hz, COCCH2), 1.63 (m, 4 H, 
cyclohexane), 1.44 (m, 2 H, cyclohexane), 1.26 (m, 4 H, cyclohexane), 1.09-0.89 (m, 21 H, 
TIPS); 13C NMR (101 MHz, CDCl3) δ 178.6, 144.7, 135.7, 129.4, 128.3, 102.8, 84.6, 55.1, 
45.3, 34.6, 33.3, 33.2, 33.2, 27.2, 25.1, 21.7, 21.6, 18.5, 11.1; IR 2938 (m), 2892 (m), 2863 
(m), 2364 (w), 2340 (w), 2175 (w), 1735 (m), 1655 (w), 1598 (w), 1495 (w), 1462 (m), 1451 
(m), 1401 (w), 1362 (m), 1338 (w), 1308 (w), 1283 (w), 1267 (w), 1240 (w), 1206 (m), 1188 
(m), 1171 (s), 1112 (m), 1091 (m), 1075 (w), 1053 (m), 1038 (w), 1018 (w), 996 (w), 940 
(w), 914 (w), 884 (m), 851 (w), 839 (w), 814 (m), 801 (w), 788 (w), 735 (s), 716 (w), 706 
(w), 678 (s), 665 (s), 634 (w), 620 (w); HRMS (ESI) calcd for C28H44NO3SSi+ (M+H+) 
502.2811; found 502.2805. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-2-azaspiro[4.4]nonan-1-one (3f) 
Column chromatography (SiO2, PET/EtOAc 95/5) afforded 
product 3f (150 mg, 0.308 mmol, 77% yield) as a colorless solid.  
Rf 0.70 (PET/EtOAc 5/1); 1H NMR (400 MHz, CDCl3) δ 7.94 (m, 
2 H, tosyl CH), 7.30 (d, 2 H, J = 8.0 Hz, tosyl CH), 4.36 (m, 1 H, NCH), 3.02 (dt, 1 H, J = 
17.0, 3.1 Hz, CH2C≡C), 2.84 (dd, 1 H, J = 16.8, 8.1 Hz, CH2C≡C), 2.42 (s, 3 H, tosyl CH3), 
2.16 (d, 2 H, J = 6.7 Hz, COCCH2), 1.96 (m, 1 H, cyclopentyl), 1.86-1.40 (m, 7 H, 
cyclopentyl), 1.14-0.88 (m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 179.3, 144.9, 135.8, 
129.5, 128.3, 102.9, 84.6, 55.7, 51.0, 38.4, 38.4, 37.3, 26.7, 25.7, 25.4, 21.7, 18.6, 11.2; IR 
2957 (m), 2943 (m), 2900 (w), 2888 (w), 2865 (m), 2360 (w), 2342 (w), 2259 (w), 2175 (w), 
1737 (m), 1655 (w), 1598 (w), 1495 (w), 1463 (m), 1401 (w), 1361 (m), 1308 (w), 1292 (w), 
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1220 (w), 1200 (w), 1188 (m), 1171 (s), 1106 (m), 1091 (m), 1074 (w), 1063 (w), 1031 (w), 
1012 (w), 998 (w), 957 (w), 911 (m), 884 (m), 814 (m), 733 (s), 706 (m), 665 (s), 639 (w), 
624 (w), 619 (w), 607 (w). Melting Point: 118.7 - 120.8 °C; HRMS (ESI) calcd for 
C27H42NO3SSi+ [M+H]+ 488.2649; found 488.2638. 
4-Phenyl-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3g) 
Column chromatography (SiO2, PET/EtOAc 93/7) afforded product 
3g (145 mg, 0.284 mmol, 71% yield) as a viscous, pale yellow oil 
(unseparable diastereoisomers; dr 90:10).  
Rf 0.79 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3, signals for 
the minor diastereoisomer are reported in italics) δ 8.02 (m, 2 H, 
tosyl CH), 7.88 (m, 2 H, tosyl CH), 7.36 (m, 2 H, tosyl CH), 7.29 
(m, 2 H, tosyl CH), 7.22 (m, 3 H, Ph, both diastereoisomers), 7.01 (m, 2 H, Ph, both), 4.68 
(ddd,1 H,  J = 8.1, 5.0, 1.9 Hz, CHN), 4.33 (m, 1 H, CHN), 3.94 (dt,1 H,  J = 13.6, 8.1 Hz, 
CHPh), 3.68-3.50 (m, 2 H, CHPh and COCH2), 3.18 (dd, 1 H, J = 17.9, 9.2 Hz, COCH2), 
3.07-2.87 (m, 1 H, CH2C≡C, both), 2.60 (dd, 1 H, J = 16.7, 8.2 Hz, COCH2), 2.53 (dd, 1 H, J 
= 17.9, 2.6 Hz, COCH2), 2.47 (s, 3 H, tosyl CH3), 2.44 (s, tosyl CH3). 1.16-0.79 (m, TIPS, 
both); 13C NMR (101 MHz, CDCl3)[27] δ 172.7, 172.1, 145.0, 144.7, 142.7, 135.4, 135.2, 
129.4, 129.0, 128.6, 128.6, 128.3, 128.0, 127.7, 127.3, 126.0, 103.1, 102.5, 85.6, 84.9, 66.3, 
61.3, 43.0, 41.3, 38.0, 35.7, 26.5, 21.6, 18.5, 18.4, 18.3, 11.1; IR 3067 (w), 3032 (w), 3014 
(w), 2943 (w), 2891 (w), 2865 (w), 2361 (w), 2344 (w), 2257 (w), 2174 (w), 1738 (m), 1598 
(w), 1495 (w), 1463 (w), 1429 (w), 1401 (w), 1362 (m), 1333 (w), 1308 (w), 1293 (w), 1241 
(w), 1216 (w), 1187 (w), 1170 (s), 1143 (w), 1113 (m), 1090 (w), 1042 (w), 1034 (w), 1020 
(w), 997 (w), 989 (w), 961 (w), 947 (w), 909 (s), 884 (m), 814 (w), 764 (w), 731 (s), 702 (m), 
675 (s), 668 (s), 650 (m), 631 (w), 612 (m); HRMS (ESI) calcd for C29H40NO3SSi+ (M+H+) 
510.2498; found 510.2518. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)octahydro-1H-isoindol-1-one (3h) 
Column chromatography (SiO2, PET/EtOAc 98/2) afforded product 
3h (130 mg, 0.267 mmol, 67% yield) as a pale yellow oil 
(unseparable diastereoisomers; dr 70:30). 
Rf 0.86 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.92 (d, 2 
H, J = 8.0 Hz, tosyl CH, major diastereoisomer), 7.85 (d, 2H, J = 7.9 
Hz, tosyl CH, minor diastereoisomer), 7.30 (d, 2 H, J = 8.0 Hz, tosyl CH, both 
diasteroisomers), 4.14 (m, 1 H, NCH, minor), 3.88 (dd, 1 H, J = 8.9, 3.3 Hz, NCH, major), 
3.61 (dd, 1 H, J = 16.5, 4.5 Hz, CH2C≡C, minor), 2.98 (m, 1 H, CHCHCHN, major), 2.92 
(dd, 1 H, J = 16.9, 3.2 Hz, CH2C≡C, major), 2.72 (dd, 1 H, J = 16.8, 9.0 Hz, CH2C≡C, 
major), 2.56-2.36 (m, 1 H, CHCHCHN, major, 3H, CHCHCHN and CH2C≡C, minor), 2.41 
(s, 3 H, tosyl CH3, both), 2.15-1.96 (m, (CH2)4, both), 1.85-1.27 (m, (CH2)4, both), 1.12-0.92 
(m, TIPS and (CH2)4, both);[28] 13C NMR (101 MHz, CDCl3, δ 175.8, 174.1, 144.9, 144.7, 
136.1, 135.5, 129.6, 129.4, 128.2, 127.7, 103.6, 102.9, 84.0, 83.5, 63.1, 61.1, 46.2, 43.4, 40.3, 
                                                            
[27] Some signals corresponding to the minor diastereoisomer were not detected. 
[28] Partial assignment of the spectrum was possible on the basis of 2D-NMR experiments. 
NTs
O
TIPS
S34 
 
37.1, 35.6, 29.1, 24.4, 23.6, 23.4, 22.4, 22.3, 22.2, 22.2, 22.1, 21.0, 18.5, 18.4, 11.1, 11.1; IR 
2941 (m), 2900 (w), 2892 (w), 2864 (m), 2364 (w), 2343 (w), 2334 (w), 2175 (w), 1743 (m), 
1598 (w), 1495 (w), 1463 (m), 1451 (w), 1400 (w), 1365 (m), 1307 (w), 1299 (w), 1281 (w), 
1250 (w), 1237 (w), 1214 (w), 1187 (m), 1170 (s), 1136 (m), 1108 (m), 1092 (m), 1062 (w), 
1053 (w), 1031 (w), 1018 (w), 994 (w), 971 (w), 950 (w), 914 (m), 883 (m), 863 (w), 827 
(w), 814 (m), 800 (w), 778 (w), 760 (w), 735 (s), 705 (m), 667 (s), 636 (m), 619 (m); HRMS 
(ESI) calcd for C27H42NO3SSi+ (M+H+) 488.2655; found 488.2645. 
1-Tosyl-6-(3-(triisopropylsilyl)prop-2-ynyl)piperidin-2-one (3i) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded 
product 3i (102 mg, 0.228 mmol, 57% yield) as a pale yellow solid.  
Rf 0.51 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.93 (m, 2 H, 
tosyl CH), 7.30 (m, 2 H, tosyl CH), 4.74 (m, 1 H, CHN), 2.95 (dd, 1 H, 
J = 16.6, 3.5 Hz, CH2C≡C), 2.75 (dd, 1 H, J = 17.1, 9.5 Hz, CH2C≡C), 2.55-2.34 (m, 3 H, 
COCH2CH2), 2.43 (s, 3 H, tosyl CH3), 2.06 (m, 1 H, COCH2CH2CH2), 1.88 (m, 1 H, 
COCH2CH2CH2), 1.77 (m, 1 H, COCH2CH2CH2), 1.18-0.92 (m, 21 H, TIPS); 13C NMR (101 
MHz, CDCl3) δ 170.0, 144.6, 136.3, 129.1, 128.9, 103.1, 84.5, 54.9, 33.4, 26.5, 26.2, 21.5, 
18.5, 16.0, 11.1; IR 2943 (m), 2927 (m), 2891 (w), 2865 (m), 2174 (w), 1698 (m), 1597 (w), 
1597 (w), 1495 (w), 1463 (m), 1429 (w), 1429 (w), 1382 (w), 1352 (m), 1306 (w), 1306 (w), 
1292 (w), 1259 (m), 1234 (w), 1217 (w), 1217 (w), 1188 (w), 1164 (s), 1121 (m), 1088 (m), 
1034 (w), 1019 (w), 1007 (w), 992 (w), 953 (w), 911 (w), 884 (m), 860 (w), 845 (w), 813 
(m), 768 (w), 732 (m), 705 (w), 673 (s), 663 (s), 626 (m), 618 (m); Melting Point: 72.2 – 
73.9°C; HRMS (ESI) calcd for C24H38NO3SSi+ (M+H+) 448.2342; found 448.2360. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydroisoquinolin-1(2H)-one (3j) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) 
afforded product 3j (167 mg, 0.337 mmol, 84% yield) as a pale 
yellow amorphous solid.  
Rf 0.57 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.01 (m, 
2 H, tosyl CH), 7.98 (dd, 1 H, J = 8.0, 1.0 Hz, ArH), 7.50 (td, 1 H, J = 7.5, 1.1 Hz, ArH), 
7.38-7.28 (m, 3 H, tosyl CH and ArH), 7.20 (d, 1 H, J = 7.5 Hz, ArH), 5.09 (m, 1 H, CHN), 
3.49 (dd, 1 H, J = 16.1, 1.5 Hz, CH2C≡C), 3.34 (dd, 1 H, J = 16.1, 5.5 Hz, CH2C≡C), 2.54-
2.37 (m, 2 H, CH2CHN), 2.41 (s, 3 H, tosyl CH3), 1.19-0.94 (m, 21 H, TIPS); 13C NMR (101 
MHz, CDCl3) δ 162.3, 144.8, 136.4, 136.2, 133.8, 129.3, 128.9, 128.8, 128.3, 127.7, 127.5, 
103.1, 84.5, 54.1, 31.2, 24.9, 21.6, 18.6, 11.1; IR 2957 (w), 2943 (m), 2901 (w), 2865 (m), 
2175 (w), 1692 (m), 1603 (w), 1493 (w), 1461 (w), 1429 (w), 1381 (w), 1353 (m), 1295 (w), 
1274 (w), 1243 (m), 1188 (w), 1168 (s), 1113 (w), 1089 (w), 1060 (m), 1032 (w), 1019 (w), 
1019 (w), 1000 (w), 884 (w), 834 (w), 814 (w), 794 (w), 761 (w), 740 (m), 719 (w), 703 (w), 
682 (m), 666 (s), 656 (m), 646 (w), 637 (m), 625 (w), 614 (w); HRMS (ESI) calcd for 
C28H38NO3SSi+ (M+H+) 496.2342; found 496.2340. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one 
(3k) 
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Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) 
afforded product 3k (170 mg, 0.351 mmol, 88% yield) as a pale 
yellow solid. 
Rf 0.50 (Hex/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 8.00 (m, 
2 H, tosyl CH), 7.33 (m, 2 H, tosyl CH), 6.98 (dd, 1 H, J = 3.9, 1.1 Hz, pyrrole), 6.74 (m, 1 
H, pyrrole), 6.25 (dd, 1 H, J = 3.9, 2.5 Hz, pyrrole), 5.06 (m, 1 H, CHN), 4.67 (dd, 1 H, J = 
13.0, 1.2 Hz, NCH2), 4.28 (dd, 1 H, J = 13.0, 3.8 Hz, NCH2), 2.83 (ddd, 1 H, J = 16.6, 4.5, 
1.0 Hz, CH2C≡C), 2.56-2.32 (m, 1 H, CH2C≡C), 2.42 (s, 3 H, tosyl CH3), 1.16-0.96 (m, 21 H, 
TIPS); 13C NMR (101 MHz, CDCl3) δ 155.5, 145.0, 136.4, 129.4, 128.9, 125.4, 122.2, 117.1, 
111.3, 102.3, 85.5, 54.5, 45.9, 23.9, 21.7, 18.6, 11.2; IR 2943 (m), 2891 (w), 2865 (m), 2176 
(w), 1738 (w), 1686 (s), 1597 (w), 1536 (m), 1487 (m), 1463 (w), 1403 (m), 1354 (s), 1320 
(w), 1293 (w), 1259 (w), 1233 (w), 1204 (m), 1189 (w), 1168 (s), 1135 (w), 1087 (m), 1075 
(m), 1058 (s), 1034 (w), 1018 (w), 1007 (m), 913 (w), 899 (w), 884 (w), 813 (w), 758 (w), 
737 (s), 706 (w), 679 (m), 661 (s), 639 (w), 625 (w), 609 (w); Melting Point: 158.2 – 
161.0°C; HRMS (ESI) calcd for C26H37N2O3SSi+ (M+H+) 485.2294; found 485.2299. 
2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydropyrazino[1,2-a]indol-1(2H)-one 
(3l) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) 
afforded product 3l (191 mg, 0.357 mmol, 89% yield) as a 
pale yellow amorphous solid.  
Rf 0.67 (PET/EtOAc 5/1); 1H NMR (400 MHz, CDCl3) δ 8.06 
(m, 2 H, tosyl CH), 7.68 (d, 1 H, J = 8.1 Hz, indole), 7.43-7.27 (m, 5 H, tosyl CH and indole), 
7.17 (m, 1 H, indole), 5.23 (m, 1 H, CHN), 5.01 (dd, 1 H, J = 12.8, 1.2 Hz, NCH2), 4.26 (dd, 
1 H, J = 12.8, 3.8 Hz, NCH2), 2.86 (dd, 1 H, J = 16.8, 3.8 Hz, CH2C≡C), 2.51 (dd, 1 H, J = 
16.7, 11.4 Hz, CH2C≡C), 2.44 (m, 3 H, tosyl CH3), 1.14-1.05 (m, 21 H, TIPS); 13C NMR 
(101 MHz, CDCl3) δ 156.6, 145.1, 137.1, 136.0, 129.4, 128.9, 127.2, 126.4, 126.0, 122.9, 
121.3, 109.8, 109.4, 102.1, 85.4, 54.8, 42.3, 24.4, 21.6, 18.6, 11.1; IR 3064 (w), 3060 (w), 
3056 (w), 3041 (w), 2943 (w), 2891 (w), 2865 (w), 2362 (w), 2343 (w), 2331 (w), 2256 (w), 
2175 (w), 1690 (m), 1617 (w), 1597 (w), 1569 (w), 1538 (m), 1493 (w), 1487 (w), 1469 (w), 
1449 (w), 1416 (w), 1379 (m), 1350 (m), 1319 (w), 1307 (w), 1294 (w), 1255 (m), 1233 (w), 
1210 (m), 1187 (m), 1168 (s), 1140 (m), 1119 (w), 1088 (m), 1056 (m), 1034 (w), 1019 (w), 
998 (w), 969 (w), 909 (m), 884 (m), 864 (w), 842 (w), 815 (w), 731 (s), 717 (s), 666 (s), 648 
(m), 628 (w), 612 (w); HRMS (ESI) calcd for C30H39N2O3SSi+ (M+H+) 535.2451; found 
535.2461. 
3-Tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7a) 
Column chromatography (SiO2, PET/EtOAc 94/6 to 93/7) afforded product 7a (144 mg, 
0.331 mmol, 83% yield) as a colorless solid. 
Rf 0.56 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.97 (m, 2 H, 
tosyl CH), 7.34 (m, 2 H, tosyl CH), 4.61 (m, 1 H, CHN), 4.46 (m, 1 H, 
OCH2), 4.34 (m, 1 H, OCH2), 2.93 (dd, J = 17.0, 6.4 Hz, CH2C≡C), 2.82 
(m, 1 H, CH2C≡C), 2.44 (s, 3 H, tosyl CH3), 1.05-0.88 (m, 21 H, TIPS); 
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13C NMR (101 MHz, CDCl3) δ 151.8, 145.6, 134.8, 129.8, 128.5, 100.0, 85.6, 66.8, 55.1, 
25.4, 21.7, 18.4, 11.0; IR 2943 (m), 2891 (w), 2865 (m), 2362 (w), 2177 (w), 1783 (s), 1598 
(w), 1495 (w), 1463 (w), 1430 (w), 1394 (m), 1368 (m), 1335 (w), 1293 (w), 1218 (w), 1187 
(s), 1173 (s), 1135 (s), 1093 (m), 1054 (w), 1016 (w), 998 (w), 976 (w), 913 (w), 884 (m), 
815 (w), 761 (w), 751 (w), 735 (m), 718 (w), 704 (w), 679 (s), 669 (s), 639 (w); Melting 
Point: 88.7 – 90.8°C; HRMS (ESI) calcd for C22H34NO4SSi+ (M+H+) 436.1978; found 
436.1974. 
5-Methyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7b) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded product 7b (119 mg, 
0.265 mmol, 66% yield) as a pair of separable diastereoisomers (dr 61:39; relative 
stereochemistry assigned on the basis of NOESY). 
Major diastereoisomer: colorless solid (72 mg, 0.16 mmol, 40% 
yield). Rf 0.69 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 
7.95 (d, 2 H, J = 8.3 Hz, tosyl CH), 7.34 (d, 2 H, J = 8.2 Hz, tosyl 
CH), 4.60 (qd, 1 H, J = 6.3, 3.4 Hz, OCHCH3), 4.10 (m, 1 H, CHN), 
2.89 (dd, 1 H, J = 17.1, 3.5 Hz, CH2C≡C), 2.82 (dd, 1 H, J = 17.1, 
7.0 Hz, CH2C≡C), 2.43 (s, 3 H, tosyl CH3), 1.39 (d, 3 H, J = 6.4 Hz, OCHCH3), 1.13-0.88 
(m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 151.2, 145.5, 134.8, 129.7, 128.4, 100.4, 
85.5, 75.7, 61.5, 25.3, 21.6, 21.0, 18.4, 11.0; IR 2943 (m), 2892 (w), 2865 (m), 2361 (w), 
2341 (w), 2177 (w), 1785 (s), 1784 (s), 1597 (w), 1508 (w), 1495 (w), 1463 (w), 1369 (s), 
1328 (w), 1310 (w), 1292 (w), 1279 (w), 1252 (w), 1244 (w), 1220 (w), 1189 (s), 1174 (s), 
1138 (s), 1092 (m), 1054 (m), 1019 (w), 997 (w), 986 (w), 918 (w), 884 (m), 837 (w), 814 
(w), 801 (w), 794 (w), 786 (w), 754 (m), 736 (m), 706 (w), 676 (s), 649 (m), 641 (m), 612 
(m); Melting Point: 62.5 – 64.2°C; HRMS (ESI) calcd for C23H36NO4SSi+ (M+H+) 450.2134; 
found 450.2135. 
Minor diastereoisomer: colorless solid (47 mg, 0.10 mmol, 26% 
yield). Rf 0.57 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.99 
(m, 2 H, tosyl CH), 7.33 (d, 2 H, J = 8.2 Hz, tosyl CH), 4.81 (quint, 1 
H, J = 6.7 Hz, OCHCH3), 4.50 (m, 1 H, CHN), 2.94 (dd, 1 H, J = 
17.6, 6.0 Hz, CH2C≡C), 2.69 (dd, 1 H, J = 18.1, 2.5 Hz, CH2C≡C), 
2.43 (s, 3 H, tosyl CH3), 1.61 (d, 3 H, J = 6.6 Hz, OCHCH3), 0.98-0.91 (m, 21 H, TIPS); 13C 
NMR (101 MHz, CDCl3) δ 151.3, 145.3, 135.0, 129.7, 128.7, 100.8, 86.3, 75.1, 58.7, 21.7, 
20.8, 18.4, 14.1, 11.1; IR 2942 (w), 2902 (w), 2865 (w), 2360 (w), 2343 (w), 2175 (w), 1790 
(m), 1598 (w), 1507 (w), 1495 (w), 1464 (w), 1426 (w), 1392 (w), 1367 (m), 1322 (w), 1285 
(w), 1214 (w), 1195 (m), 1186 (m), 1172 (s), 1137 (m), 1115 (s), 1091 (w), 1072 (w), 1042 
(w), 1019 (w), 998 (w), 981 (w), 913 (w), 901 (w), 884 (w), 825 (w), 815 (w), 802 (w), 757 
(w), 736 (w), 729 (w), 707 (m), 695 (m), 681 (m), 661 (s), 645 (w), 623 (m), 615 (m), 610 
(m); Melting Point: 109.0 – 111.2°C; HRMS (ESI) calcd for C23H36NO4SSi+ (M+H+) 
450.2134; found 450.2135. 
5-Cyclohexyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7c) 
O NTs
TIPS
O
Me
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Column chromatography (SiO2, PET/EtOAc 97/3 to 90/10) afforded product 7c (120 mg, 
0.232 mmol, 58% yield) as a pair of separable diastereoisomers (dr 66:34; relative 
stereochemistry assigned on the basis of NOESY). 
Major diastereoisomer: yellow solid (79 mg, 0.15 mmol, 38% 
yield). Rf 0.87 (PET/EtOAc 4/1);1H NMR (400 MHz, CDCl3) δ 
7.94 (m, 2 H, tosyl CH), 7.32 (m, 2 H, tosyl CH), 4.29 (m, 1 H, 
OCH), 4.20 (m, 1 H, CHN), 2.87 (dd, 1 H, J = 17.1, 7.0 Hz, 
CH2C≡C), 2.77 (dd, 1 H, J = 17.1, 3.0 Hz, CH2C≡C), 2.42 (s, 3 H, 
tosyl CH3), 1.85-1.47 (m, 5 H, cyclohexane), 1.30-0.80 (m, 27 H, 
cyclohexane and TIPS); 13C NMR (101 MHz, CDCl3) δ 151.4, 145.4, 135.0, 129.6, 128.3, 
100.5, 85.3, 82.8, 57.3, 41.8, 27.7, 26.2, 26.0, 25.9, 25.5, 25.3, 21.6, 18.4, 11.0; IR 2929 (m), 
2864 (m), 2360 (w), 2344 (w), 2176 (w), 1783 (s), 1597 (w), 1495 (w), 1463 (w), 1452 (w), 
1431 (w), 1367 (m), 1320 (w), 1307 (w), 1293 (w), 1254 (w), 1217 (w), 1189 (m), 1174 (s), 
1138 (s), 1092 (m), 1046 (w), 1031 (w), 1018 (w), 992 (w), 911 (w), 884 (w), 815 (w), 758 
(w), 736 (m), 705 (w), 678 (s), 669 (s), 633 (w), 620 (w), 606 (m); Melting Point: 80.0 – 
83.0°C; HRMS (ESI) calcd for C28H44NO4SSi+ (M+H+) 518.2761; found 518.2759. 
Minor diastereoisomer (90% pure due to contamination by the 
major diastereoisomer): colorless solid (41 mg, 0.080 mmol, 20% 
yield). Rf 0.70 (PET/EtOAc 4/1) 1H NMR (400 MHz, CDCl3) δ 
7.99 (m, 2 H, tosyl CH), 7.31 (m, 2 H, tosyl CH), 4.53 (m, 1 H, 
OCH), 4.23 (dd, 1 H, J = 10.8, 6.6 Hz, CHN), 2.97 (dd, 1 H, J = 
18.0, 4.3 Hz, CH2C≡C), 2.59 (dd, 1 H, J = 18.0, 2.0 Hz, 
CH2C≡C), 2.49-2.36 (m, 1 H, cyclohexane), 2.41 (s, 3 H, tosyl CH3), 2.00 (d, 1 H, J = 12.9 
Hz, cyclohexane), 1.83-1.50 (m, 5 H, cyclohexane), 1.35-0.80 (m, 25 H, cyclohexane and 
TIPS); 13C NMR (101 MHz, CDCl3) δ 151.3, 145.2, 135.2, 129.7, 128.7, 100.5, 86.3, 82.6, 
58.0, 36.2, 29.3, 29.1, 26.1, 25.1, 24.9, 21.7, 20.3, 18.4, 18.4; IR 2931 (m), 2864 (m), 2361 
(w), 2178 (w), 1773 (s), 1597 (w), 1493 (w), 1463 (w), 1453 (w), 1420 (w), 1360 (s), 1326 
(w), 1306 (w), 1295 (w), 1272 (w), 1263 (w), 1236 (w), 1199 (m), 1174 (s), 1147 (m), 1120 
(w), 1102 (s), 1090 (m), 1060 (w), 1047 (w), 1028 (m), 989 (w), 943 (w), 912 (w), 884 (m), 
842 (w), 815 (m), 800 (w), 791 (w), 757 (m), 730 (m), 704 (w), 668 (s), 639 (w), 618 (m), 
608 (m); Melting Point: 162.4 – 164.9°C; HRMS (ESI) calcd for C28H44NO4SSi+ (M+H+) 
518.2761; found 518.2759. 
3-Tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)-1,3-oxazinan-2-one (7d) 
Column chromatography (SiO2, PET/EtOAc 95/5 to 90/10) afforded 
product 7d (106 mg, 0.236 mmol, 59% yield) as a pale yellow oil.  
Rf 0.45 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 7.91 (m, 2 
H, tosyl CH), 7.29 (m, 2 H, tosyl CH), 4.71 (m, 1 H, OCH2 or CHN), 4.50 (td, J = 11.0, 3.0 
Hz, OCH2 or CHN), 4.28 (dt, 1 H, J = 11.3, 3.9 Hz, OCH2 or CHN), 2.97 (dd, 1 H, J = 17.1, 
4.0 Hz, CH2C≡C), 2.77 (dd, 1 H, J = 17.1, 9.5 Hz, CH2C≡C), 2.55-2.37 (m, 1 H, OCH2CH2), 
2.40 (s, 3 H, tosyl CH3), 2.23 (m, 1 H, OCH2CH2), 1.08-0.93 (m, 21 H, TIPS); 13C NMR (101 
MHz, CDCl3) δ 148.2, 144.9, 135.5, 129.2, 129.0, 101.9, 85.4, 64.3, 53.3, 25.7, 25.6, 21.5, 
18.4, 11.0; IR 2957 (w), 2944 (w), 2926 (w), 2901 (w), 2891 (w), 2865 (w), 2361 (w), 2342 
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(w), 2256 (w), 2175 (w), 1734 (s), 1598 (w), 1507 (w), 1463 (w), 1436 (w), 1410 (m), 1357 
(m), 1307 (w), 1292 (w), 1271 (m), 1242 (w), 1195 (m), 1185 (m), 1173 (s), 1154 (s), 1087 
(m), 1037 (w), 1027 (w), 1017 (w), 999 (w), 956 (w), 913 (m), 884 (m), 827 (w), 814 (w), 
800 (w), 783 (w), 754 (m), 734 (s), 704 (w), 668 (s), 649 (m), 608 (s); HRMS (ESI) calcd for 
C23H36NO4SSi+ (M+H+) 450.2151; found 450.2134. 
1-Tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7e) 
Column chromatography (SiO2, DCM/EtOAc 95/5) afforded product 
7e (137 mg, 0.315 mmol, 79% yield) as an off-white amorphous 
solid.  
Rf 0.61 (DCM/EtOAc 10/1); 1H NMR (400 MHz, CDCl3) δ 7.87 (m, 2 H, tosyl CH), 7.27 (m, 
2 H, tosyl CH), 6.66 (s, 1 H, NH), 4.41 (m, 1 H, CHN), 3.56 (t, 1 H, J = 9.0 Hz, HNCH2), 
3.42 (dd, 1 H, J = 9.0, 4.0 Hz, HNCH2), 2.87 (dd, 1 H, J = 17.1, 3.5 Hz, CH2C≡C), 2.74 (dd, 
1 H, J = 17.1, 8.0 Hz, CH2C≡C), 2.38 (s, 3 H, tosyl CH3), 1.07-0.90 (m, 21 H, TIPS); 13C 
NMR (101 MHz, CDCl3) δ 155.9, 144.4, 136.1, 129.4, 127.7, 101.7, 84.2, 55.2, 42.6, 26.2, 
21.4, 18.4, 11.0; IR 3268 (w), 3143 (w), 2943 (w), 2892 (w), 2865 (m), 2361 (w), 2342 (w), 
2256 (w), 2176 (w), 1738 (s), 1598 (w), 1489 (w), 1463 (w), 1431 (w), 1363 (m), 1362 (m), 
1318 (w), 1309 (w), 1282 (w), 1255 (w), 1188 (w), 1169 (s), 1134 (w), 1090 (m), 1063 (m), 
1018 (w), 997 (w), 981 (w), 910 (s), 884 (m), 814 (w), 801 (w), 764 (w), 731 (s), 705 (m), 
678 (s), 668 (s), 650 (m), 633 (m), 607 (w); HRMS (ESI) calcd for C22H35N2O3SSi+ (M+H+) 
445.2138; found 435.2153. 
1-Allyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7f) 
Column chromatography (SiO2, PET/EtOAc 9/1) afforded 
product 7f (127 mg, 0.268 mmol, 67% yield) as a yellow oil.  
Rf 0.65 (PET/EtOAc 9/1); 1H NMR (400 MHz, CDCl3) δ 7.95 
(m, 2 H, tosyl CH), 7.30 (m, 2 H, tosyl CH), 5.66 (ddt, 1 H, J = 
16.7, 10.1, 6.4 Hz, CH2CH=CH2), 5.22-5.13 (m, 2 H, CH2CH=CH2), 4.44 (ddt, 1 H, J = 9.3, 
7.9, 4.0 Hz, NCH), 3.76 (m, 2 H, CH2CH=CH2), 3.52 (t, 1 H, J = 9.3 Hz, NCHCH2), 3.35 
(dd, 1 H, J = 9.3, 4.2 Hz, NCHCH2), 2.91 (dd, 1 H, J = 16.9, 3.6 Hz, CH2C≡C), 2.81 (dd, 1 
H, J = 16.9, 7.7 Hz, CH2C≡C), 2.42 (s, 3 H, tosyl CH3), 1.17-0.83 (m, 21 H, TIPS); 13C NMR 
(101 MHz, CDCl3) δ 153.1, 144.4, 136.1, 131.5, 129.4, 128.1, 119.0, 101.7, 84.4, 52.2, 46.3, 
46.1, 26.1, 21.5, 18.4, 11.0; IR 3075 (w), 2943 (m), 2891 (w), 2865 (m), 2363 (w), 2256 (w), 
2175 (w), 1733 (s), 1646 (w), 1629 (w), 1598 (w), 1489 (w), 1462 (w), 1439 (m), 1418 (m), 
1357 (m), 1307 (w), 1291 (w), 1290 (w), 1264 (m), 1212 (w), 1188 (m), 1168 (s), 1143 (m), 
1120 (m), 1093 (m), 1074 (w), 1055 (w), 1029 (w), 1019 (w), 995 (m), 968 (w), 918 (m), 884 
(m), 814 (m), 801 (w), 778 (w), 754 (m), 740 (m), 732 (m), 706 (w), 698 (w), 667 (s), 635 
(w), 627 (w), 620 (w), 612 (w). HRMS (ESI) calculated for C25H39N2O3SSi+ (M+H+) 
475.2451; found 475.2454.  
1-Benzyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7g) 
N NTs
O
TIPS
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Column chromatography (SiO2, PET/EtOAc 9/1) afforded product 7g (137 mg, 0.261 mmol, 
65% yield) as a brownish oil.  
Rf 0.55 (PET/EtOAc 9/1); 1H NMR (400 MHz, CDCl3) δ 7.97 (m, 2 H, tosyl CH), 7.40-7.23 
(m, 6 H, tosyl CH and NCH2Ph), 7.14 (m, 2 H, NCH2Ph), 4.45 (d, 1 H, J = 14.8 Hz, 
NCH2Ph), 4.38 (m, 1 H, NCH), 4.16 (d, 1 H, J = 14.7 Hz, NCH2Ph), 3.39 (t, 1 H, J = 9.3 Hz, 
NCH2), 3.25 (dd, 1 H, J = 9.3, 4.1 Hz, NCH2), 2.90 (dd, 1 H, J = 16.9, 3.6 Hz, CH2C≡C), 
2.74 (dd, 1 H, J = 16.8, 8.1 Hz, CH2C≡C), 2.44 (s, 3 H, tosyl CH3), 1.05-0.90 (m, 21 H, 
TIPS); 13C NMR (101 MHz, CDCl3) δ 153.5, 144.6, 136.2, 135.2, 129.6, 128.8, 128.3, 128.0, 
101.8, 84.5, 52.4, 47.7, 46.4, 26.3, 21.7, 18.6, 11.1;[29] IR 2942 (m), 2865 (m), 2176 (w), 
1735 (s), 1598 (w), 1495 (w), 1462 (w), 1440 (m), 1365 (m), 1265 (w), 1210 (w), 1170 (s), 
1119 (m), 1093 (m), 1056 (w), 997 (w), 912 (w), 885 (w), 815 (w), 757 (m), 703 (m), 670 (s). 
HRMS (ESI) calculated for C29H41N2O3SSi+ (M+H+) 525.2607; found 525.2592.  
5-methyl-1-(4-nitrophenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one 
(3m) 
 
TIPS-EBX (2a) (206 mg, 0.480 mmol, 1.20 equiv) was added to a solution of nosyl amide 
1m (119 mg, 0.400 mmol, 1.00 equiv) and Pd(hfacac)2 (21 mg, 0.040 mmol, 0.10 equiv) in 
DCM (10 mL). 4-Chlorosalicylic acid (83 mg, 0.48 mmol, 1.2 equiv) was added and the 
mixture was stirred at room temperature overnight. The solvent was then evaporated under 
reduced pressure and the residue was diluted in Et2O (10 mL) and washed with a saturated 
solution of Na2CO3 (10 mL). The aqueous layer was extracted with Et2O (3 x 10 mL) and the 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. 
Purification by column chromatography (SiO2, hexane/EtOAc 95/5 to 90/10) afforded 5-
methyl-1-(4-nitrophenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3m) 
(118 mg, 0.246 mmol, 62% yield) as a yellow solid. 
Rf 0.61 (PET/EtOAc/AcOH 15/5/0.2); 1H NMR (400 MHz, CDCl3) δ 8.39-8.26 (m, 4 H, 
Nosyl CH), 3.19 (d, 1 H, J = 17.1 Hz, CH2C≡C), 2.91 (d, 1 H, J = 17.1 Hz, CH2C≡C), 2.60 
(m, 1 H, COCH2CH2), 2.44 (m, 2 H, COCH2CH2), 2.00 (m, 1 H, COCH2CH2), 1.78 (s, 3 H, 
Me), 1.07-0.91 (m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 174.2, 150.5, 144.2, 130.5, 
123.7, 103.0, 85.0, 69.0, 32.7, 32.1, 29.8, 27.7, 18.5, 11.1; IR 3108 (w), 2944 (m), 2892 (w), 
2866 (m), 2174 (w), 1742 (s), 1608 (w), 1535 (s), 1464 (w), 1404 (w), 1367 (s), 1352 (s), 
1315 (w), 1282 (m), 1243 (w), 1212 (m), 1198 (m), 1178 (s), 1141 (m), 1108 (m), 1088 (m), 
1045 (w), 1014 (w), 999 (w), 959 (w), 944 (m), 912 (w), 885 (w), 856 (m), 840 (w), 819 (w), 
812 (w), 779 (w), 741 (s), 711 (w), 711 (w), 684 (s), 666 (m), 653 (m), 643 (m), 633 (m), 626 
                                                            
[29] One 13C signal could not be resolved. 
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(m), 608 (m); Melting point: 117.5 – 119.7°C; HRMS (ESI) calcd for C23H35N2O5SSi+ 
(M+H+) 479.2030; found 479.2041. 
 
7. Deprotection and Second Cyclization 
5-(Prop-2-ynyl)pyrrolidin-2-one (8a) 
 
Following a slightly modified version of a reported procedure,[30] naphthalene (4.48 g, 35.0 
mmol) was dissolved in previously degassed THF (70 mL). Lithium (250 mg, 35.0 mmol) 
was added and the mixture was sonicated for 30 min and then stirred at room temperature for 
2 h in order to obtain a 0.5 M dark green Li-naphthalenide solution. N-tosyl lactam 3a (2.40 g, 
5.53 mmol) was dissolved in THF (11.5 mL) and the resulting solution was cooled to -78°C. 
The Li-naphthalenide was then added dropwise until the reaction mixture stayed permanently 
dark green (ca 40 mL, ca 4.0 equiv). The mixture was stirred at -78°C for 30 min and at room 
temperature for 30 min, before quenching with 1 M NaHCO3 (ca 10 mL). The aqueous layer 
was extracted with EtOAc (3 x 15 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. Purification by column chromatography (SiO2, 
PET/EtOAc 80/20 to 33/66) afforded 5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one 
(58) (1.51 g, 5.40 mmol, 97% yield as a yellow oil). 
Following a reported procedure,[19] 5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (58) 
(1.51 g, 5.40 mmol, 1.0 equiv) was dissolved in THF (25 mL) and the resulting solution was 
cooled to 0°C. TBAF (1.0 M in THF) (10.8 mL, 10.8 mmol, 2.0 equiv) was added dropwise 
and the mixture was allowed to warm to room temperature over 2 h. 1 M NaHCO3 was then 
added (ca 25 mL). The aqueous layer was extracted with EtOAc (6 x 25 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography (SiO2, DCM to DCM/MeOH 97/3) afforded 5-(prop-2-
ynyl)pyrrolidin-2-one (8a) (578 mg, 4.69 mmol, 87 % yield) as a pale yellow solid. 
Rf 0.28 (DCM/EtOAc 1/1); 1H NMR (400 MHz, CDCl3) δ 6.91 (br s, 1 H, NH), 3.80 (m, 1 H, 
NCH), 2.54-2.19 (m, 5 H, COCH2CH2 and CH2C≡CH), 2.01 (t, 1 H, J = 2.4 Hz, CH2C≡CH), 
1.85 (m, 1 H, COCH2CH2); 13C NMR (101 MHz, CDCl3) δ 178.2, 79.9, 70.7, 53.0, 29.9, 
26.1, 26.0; IR 3210 (m), 3098 (w), 2939 (w), 1677 (s), 1465 (w), 1464 (w), 1436 (w), 1389 
(w), 1348 (w), 1322 (w), 1294 (w), 1269 (w), 843 (w), 818 (w), 798 (w), 785 (w), 762 (w), 
733 (m), 707 (w), 672 (w), 659 (w), 645 (w), 633 (w); Melting point: 108.7 – 111.2°C; 
HRMS (ESI) calcd for C7H10NO+ (M+H+) 124.0762; found 124.0763. 
                                                            
[30] D. J. Ager, J. Organomet. Chem.1983, 241, 139. 
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4-(Prop-2-ynyl)oxazolidin-2-one (8b) 
 
Following a reported procedure,[19] the N-tosyl carbamate 7a (1.0 g, 2.3 mmol, 1.0 equiv) was 
dissolved in THF (11 mL) and the resulting solution was cooled to 0°C. TBAF (1.0 M in 
THF) (4.6 mL, 4.6 mmol, 2.0 equiv) was added dropwise and the mixture was allowed to 
warm to room temperature over 2 h. 1 M NaHCO3 was then added (ca 10 mL). The aqueous 
layer was extracted with EtOAc (6 x 10 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. Purification by column chromatography (SiO2, 
DCM) afforded 4-(prop-2-ynyl)-3-tosyloxazolidin-2-one (59) (388 mg, 1.39 mmol, 60 % 
yield) as a colorless solid. 
Following a slightly modified version of a reported procedure,[30] naphthalene (4.48 g, 35.0 
mmol) was dissolved in previously degassed THF (70 mL). Lithium (250 mg, 35.0 mmol) 
was added and the mixture was sonicated for 30 min and then stirred at room temperature for 
2 h in order to obtain a 0.5 M dark green Li-naphthalenide solution. N-tosyl carbamate 59 
(388 mg, 1.39 mmol) was dissolved in THF (2.9 mL) and the resulting solution was cooled to 
-78°C. The Li-naphthalenide was then added dropwise until the reaction mixture stayed 
permanently dark green (ca 11 mL, ca 4.0 equiv). The mixture was stirred at -78°C for 30 
min and at room temperature for 30 min, before being quenched with 1 M NaHCO3 (ca 5 
mL). The aqueous layer was extracted with EtOAc (3 x 10 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (SiO2, DCM to DCM/MeOH 98/2) afforded 4-(prop-2-ynyl)oxazolidin-2-
one (8b) (155 mg, 1.24 mmol, 87% yield) as a yellow solid. 
Rf 0.40 (DCM/MeOH 95/5); 1H NMR (400 MHz, CDCl3) δ 5.72 (br s, 1 H, NH), 4.53 (t, 1 H, 
J = 8.6 Hz, OCH2), 4.20 (dd, 1 H, J = 8.9, 4.9 Hz, NCH), 4.04 (m, 1 H, OCH2), 2.48 (dd, 2 H, 
J = 6.2, 2.6 Hz, CH2C≡CH), 2.08 (t, 1 H, J = 2.6 Hz, CH2C≡CH); 13C NMR (101 MHz, 
CDCl3) δ 159.0, 78.2, 71.6, 69.2, 51.1, 25.2; IR 3369 (w), 3294 (w), 3287 (w), 2916 (w), 
2135 (w), 1751 (s), 1651 (w), 1630 (w), 1611 (w), 1480 (w), 1454 (w), 1410 (m), 1359 (w), 
1346 (w), 1330 (w), 1323 (w), 1288 (w), 1251 (w), 1205 (w), 1104 (w), 1075 (w), 1026 (m), 
932 (w), 786 (w), 771 (w), 747 (w), 739 (w), 729 (w), 709 (w), 681 (m), 669 (m), 637 (m), 
629 (w), 612 (w); Melting point: 72.3 – 74.6°C; HRMS (ESI) calcd for C6H8NO2+ (M+H+) 
126.0555; found 126.0556. 
6-(Prop-2-ynyl)piperidin-2-one (8c) 
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Following a slightly modified version of a reported procedure,[30] naphthalene (4.48 g, 35.0 
mmol) was dissolved in previously degassed THF (70 mL). Lithium (250 mg, 35.0 mmol) 
was added and the mixture was sonicated for 30 min and then stirred at room temperature for 
2 h in order to obtain a 0.5 M dark green Li-naphthalenide solution. N-tosyl lactam 3i (630 
mg, 1.41 mmol) was dissolved in THF (2.5 mL) and the resulting solution was cooled to -
78°C. The Li-naphthalenide was then added dropwise until the reaction mixture stayed 
permanently dark green (ca 10 mL, ca 4.0 equiv). The mixture was stirred at -78°C for 30 
min and at room temperature for 30 min, before quenching with 1 M NaHCO3 (ca 5 mL). The 
aqueous layer was extracted with EtOAc (3 x 10 mL). The combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (SiO2, PET/EtOAc 80/20 to 0/100) afforded 6-(3-(triisopropylsilyl)prop-2-
ynyl)piperidin-2-one (60) (356 mg, 1.21 mmol, 87% yield) as a colorless solid. 
Following a reported procedure,[19] 6-(3-(triisopropylsilyl)prop-2-ynyl)piperidin-2-one (64) 
(356 mg, 1.21 mmol, 1.0 equiv) was dissolved in THF (5.6 mL) and the resulting solution 
was cooled to 0°C. TBAF (1.0 M in THF) (2.5 mL, 2.5 mmol, 2.0 equiv) was added dropwise 
and the mixture was allowed to warm to room temperature over 2 h. 1 M NaHCO3 was then 
added (ca 10 mL). The aqueous layer was extracted with EtOAc (6 x 10 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography (SiO2, DCM to DCM/MeOH 97/3) afforded 6-(prop-2-
ynyl)piperidin-2-one (8c) (157 mg, 1.14 mmol, 94% yield) as a pale yellow solid. 
Rf 0.30 (DCM/MeOH 40/1); 1H NMR (400 MHz, CD2Cl2) δ 5.96 (br s, 1 H, NH), 3.56 (m, 1 
H, NCH), 2.44 (ddd, 1H, J = 16.6, 5.5, 2.5 Hz, CH2C≡CH), 2.40-2.21 (m, 3 H, CH2C≡CH 
and COCH2CH2CH2), 2.17 (t, 1 H, J = 2.6 Hz, CH2C≡CH), 2.06-1.87 (m, 2 H, 
COCH2CH2CH2), 1.74 (m, 1 H, COCH2CH2CH2), 1.49 (m, 1 H, COCH2CH2CH2); 13C NMR 
(101 MHz, CD2Cl2) δ 171.4, 79.9, 71.1, 51.8, 31.4, 28.1, 26.6, 19.6; IR 3286 (m), 3260 (w), 
3228 (m), 3227 (m), 3077 (w), 2953 (m), 2879 (w), 1655 (s), 1484 (w), 1452 (w), 1409 (m), 
1348 (m), 1315 (w), 1292 (w), 1291 (w), 1225 (w), 1191 (w), 1156 (w), 1133 (w), 1132 (w), 
1080 (w), 957 (w), 866 (w), 836 (w), 813 (w), 771 (w), 714 (w), 700 (w), 661 (m), 654 (m), 
620 (w); Melting point: 98.0 – 100.4°C; HRMS (ESI) calcd for C8H12NO+ (M+H+) 138.0919; 
found 138.0923. 
4-(Benzyloxymethyl)-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (12) 
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Following a reported procedure,[31] cis-4-benzyloxy-2-buten-1-ol (10) (4.00 g, 22.4 mmol, 
1.00 equiv) was mixed with triethyl orthoacetate (20.4 mL, 112 mmol, 5.00 equiv) and 
propionic acid (0.167 mL, 2.24 mmol, 0.10 equiv). The mixture was heated to 100°C until the 
complete distillation of EtOH and then to 160°C until full conversion was observed by TLC 
(ca 4 h). After this time, triethyl orthoacetate was removed by distillation under reduced 
pressure to afford the ester 65 as an orange oil. The latter was dissolved in MeOH (25 mL) 
and KOH (3.1 g, 56 mmol) was added. The mixture was refluxed for 4 h; it was then allowed 
to cool to room temperature, diluted with water (50 mL), washed with Et2O (3 x 50 mL) and 
acidified to pH 1 by slow addition of 37% HCl. The aqueous layer was extracted with DCM 
(3 x 50 mL) and the combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo to afford pure 3-(benzyloxymethyl)pent-4-enoic acid (3.93 g, 17.8 
mmol, 80% yield over two steps) as a viscous yellow oil. 
Following a reported procedure,[7] p-tosyl isocyanate (2.69 g, 13.6 mmol, 1.00 equiv) was 
added to a solution of 3-(benzyloxymethyl)pent-4-enoic acid (3.00 g, 13.6 mmol, 1.00 equiv) 
in THF (42 mL). After stirring the resulting clear solution at room temperature for 10 min, 
triethylamine (1.89 mL, 13.6 mmol, 1.0 equiv) was added dropwise, with release of gas. 
After 2 h, the mixture was diluted with EtOAc (40 mL) and washed with 2 M HCl (50 mL) 
and NaCl (saturated solution, 50 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by column chromatography (SiO2, DCM to DCM/AcOH 
98/2) afforded 3-(benzyloxymethyl)-N-tosylpent-4-enamide (11) (4.58 g, 12.6 mmol, 80%) as 
a yellow solid.  
Rf 0.22 (PET/EtOAc 4/1); 1H NMR (400 MHz, CDCl3) δ 9.41 (br s, 1 H, NH), 7.93 (m, 2 H, 
tosyl CH), 7.44-7.23 (m, 7 H, tosyl CH and OCH2Ph), 5.66 (ddd, 1 H, J = 17.7, 10.1, 7.7 Hz, 
CHCH=CH2), 5.11-4.94 (m, 2 H, CHCH=CH2), 4.48 (s, 2 H, OCH2Ph), 3.47 (dd, 1 H, J = 
9.4, 5.1 Hz, CH2OCH2Ph), 3.34 (dd, 1 H, J = 9.2, 7.4 Hz, CH2OCH2Ph), 2.83 (m, 1 H, 
CHCH=CH2), 2.54 (dd, 1 H, J = 15.2, 6.3 Hz, COCH2), 2.43 (s, 3 H, tosyl CH3), 2.35 (dd, 1 
H, J = 15.2, 7.0 Hz, COCH2); 13C NMR (101 MHz, CDCl3) δ 169.9, 144.8, 137.6, 136.8, 
135.6, 129.4, 128.4, 128.2, 127.7, 127.7, 116.7, 73.1, 72.4, 39.7, 38.9, 21.6; IR 3249 (w), 
                                                            
[31] S. Couty, C. Meyer, J. Cossy, Tetrahedron 2009, 65, 1809. 
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3174 (w), 2864 (w), 2361 (w), 2256 (w), 1718 (w), 1643 (w), 1598 (w), 1493 (w), 1438 (w), 
1344 (w), 1309 (w), 1293 (w), 1241 (w), 1210 (w), 1163 (w), 1086 (m), 1026 (w), 996 (w), 
908 (s), 856 (w), 816 (w), 729 (s), 702 (m), 666 (m); Melting point: 73.8 – 77.4°C; HRMS 
(ESI) calcd for C20H24NO4+ (M+H+) 374.1426; found 374.1437. 
3-(Benzyloxymethyl)-N-tosylpent-4-enamide (11) (2.2 g, 5.9 mmol, 1.0 equiv), TIPS-EBX 
(2a) (3.03 g, 7.07 mmol, 1.2 equiv), PdCl2 (52 mg, 0.29 mmol, 0.05 equiv) and LiCl (899 mg, 
20.1 mmol, 3.6 equiv) were dissolved in EtOH (70 mL) and the mixture was stirred at room 
temperature for 2 h. EtOH was then evaporated and the residue was diluted with Et2O (70 
mL) and washed with Na2CO3 (70 mL, saturated solution). The aqueous layer was extracted 
with Et2O (5 x 70 mL) and the combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. Column chromatography (SiO2, PET/EtOAc 90/10) afforded 4-
(benzyloxymethyl)-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (12) (2.36 g. 
4.26 mmol, 72% yield, mixture of inseparable diastereoisomers, dr 83:17) as a yellow oil. 
Rf 0.80 (Pet/EtOAc = 4/1); 1H NMR (400 MHz, CDCl3, signals for the minor diastereoisomer 
are reported in italics) δ 8.01 (m, 2 H, tosyl CH), 7.95 (d, 2 H, tosyl CH), 7.44-7.23 (m, 7 H, 
tosyl CH and OCH2Ph, both diastereisomers), 4.57 (m, 1 H, CHN), 4.55 (d, 1 H, J = 11.9 Hz, 
OCH2Ph), 4.49 (d, 1 H, J = 11.8 Hz, OCH2Ph), 4.44 (d, 1 H, J = 12.2 Hz, OCH2Ph), 4.40 (d, 
1 H, J = 12.2 Hz, OCH2Ph). 4.38 (ddd, 1 H, J = 6.4, 3.0, 1.2 Hz, CHN), 3.88 (t, 1 H, J = 9.6 
Hz, CH2O), 3.66 (dd, 1 H, J = 9.5, 5.5 Hz, CH2O), 3.40 (dd, 1 H, J = 9.2, 5.5 Hz, CH2O), 
3.33 (dd, 1 H, J = 9.1, 6.8 Hz, CH2O), 3.09 (dd, J = 18.0, 4.7 Hz, COCH2CH or CH2C≡C), 
2.98 (dd, J = 17.2, 6.6 Hz, COCH2CH or CH2C≡C), 2.90 (dd, J = 18.0, 9.5 Hz, COCH2CH or 
CH2C≡C), 2.83 (dd, J = 17.2, 3.2 Hz, COCH2CH or CH2C≡C), 2.78-2.55 (m, COCH2CH 
(major diastereoisomer) and CH2C≡C, COCH2CH (minor diastereoisomer)), 2.47-2.32 (m, 
COCH2 (minor diastereoisomer)), 2.43 (s, 3 H, tosyl CH3), 2.41 (s, 3 H, tosyl CH3), 2.20 (dd, 
1 H, J = 17.9, 1.9 Hz, COCH2), 1.07-0.95 (m, 21 H, TIPS), 0.96-0.87 (m, 21 H, TIPS); 13C 
NMR (101 MHz, CDCl3) δ 172.7, 144.8, 137.5, 135.5, 129.4, 129.4, 128.5, 128.5, 128.5, 
128.4, 128.0, 127.8, 127.8, 127.6, 103.4, 102.6, 84.5, 73.4, 73.2, 71.7, 68.2, 61.1, 59.1, 36.6, 
36.4, 34.8, 34.3, 26.7, 21.6, 21.2, 18.5, 18.4, 11.1;[32] IR 3033 (w), 2944 (w), 2891 (w), 2865 
(w), 2362 (w), 2338 (w), 2257 (w), 2174 (w), 1737 (w), 1599 (w), 1494 (w), 1462 (w), 1430 
(w), 1413 (w), 1401 (w), 1363 (w), 1312 (w), 1290 (w), 1242 (w), 1191 (w), 1170 (m), 1113 
(w), 1091 (w), 1022 (w), 997 (w), 957 (w), 908 (s), 885 (w), 814 (w), 730 (s), 703 (m), 678 
(m), 652 (m), 624 (w); HRMS (ESI) calcd for C31H44NO4SSi+ (M+H+) 554.2761; found 
554.2773. 
4-(Benzyloxymethyl)-5-(prop-2-ynyl)pyrrolidin-2-one (13) 
                                                            
[32] Seven 13C signals mostly from the minor diastereoisomer could not be resolved. 
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Following a slightly modified version of a reported procedure,[30] naphthalene (1.79 g, 14.0 
mmol) was dissolved in previously degassed THF (28 mL). Lithium (98 mg, 14 mmol) was 
added and the mixture was sonicated for 30 min and then stirred at room temperature for 2 h 
in order to obtain a 0.5 M dark green Li-naphthalenide solution. N-tosyl lactam 12 (2.36 g, 
4.26 mmol) was dissolved in THF (7.5 mL) and the resulting solution was cooled to -78°C. 
The Li-naphthalenide was then added dropwise until the reaction mixture stayed permanently 
dark green (ca 25 mL, ca 3.0 equiv). The mixture was stirred at -78°C for 30 min and at room 
temperature for 30 min, before quenching with 1 M NaHCO3 (ca 30 mL). The aqueous layer 
was extracted with EtOAc (3 x 30 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. Purification by column chromatography (SiO2, 
PET/EtOAc 80/20 to 50/50) gave 4-(benzyloxymethyl)-5-(3-(triisopropylsilyl)prop-2-
ynyl)pyrrolidin-2-one (62) (1.31 g, 3.27 mmol, 77% yield) as a yellow oil. 
Following a reported procedure,[19] 4-(benzyloxymethyl)-5-(3-(triisopropylsilyl)prop-2-
ynyl)pyrrolidin-2-one (62) (1.30 g, 3.27 mmol, 1.0 equiv) was dissolved in THF (15 mL) and 
the resulting solution was cooled to 0°C. TBAF (1.0 M in THF) (6.5 mL, 6.5 mmol, 2.0 
equiv) was added dropwise and the mixture was stirred at 0°C for two hours and then allowed 
to warm to room temperature overnight. 1 M NaHCO3 was then added (ca 20 mL). The 
aqueous layer was extracted with EtOAc (6 x 20 mL). The combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (SiO2, DCM to DCM/MeOH 95/5) afforded 4-(benzyloxymethyl)-5-(prop-2-
ynyl)pyrrolidin-2-one (13) (778 mg, 3.20 mmol, 98% yield, mixture of inseparable 
diastereoisomers, dr 88:12) as an off-white solid.  
Rf  0.36 (PET / EtOAc = 1/1); 1H NMR (400 MHz, CDCl3, signals for the minor 
diastereoisomer are reported in italics) δ 7.48-7.23 (m, 5 H, Ph, both diastereoisomers), 6.79 
(br s, 1 H, both diastereoisomers), 4.51 (s, 2 H, OCH2Ph), 4.49 (s, 2 H, OCH2Ph), 3.85 (td, 
1H, J = 7.6, 5.1 Hz, CHN), 3.64 (m, 1 H, CHN), 3.58-3.52 (m, 2 H, CH2O), 3.50-3.43 (m, 2 
H, CH2O), 2.87 (m, 1 H, CHCH2O), 2.60-2.41 (m, COCH2CH and CH2C≡CH, both 
diastereoisomers), 2.41-2.22 (m, COCH2CH and CH2C≡CH, both diastereoisomers), 2.17 
(dd, 1 H, J = 16.4, 5.4 Hz, COCH2), 2.04-2.00 (m, C≡CH, both diastereoisomers); 13C NMR 
(101 MHz, CDCl3) δ 176.8, 176.8, 137.8, 137.6, 128.4, 128.4, 127.8, 127.7, 127.6, 127.5, 
80.6, 79.9, 77.2, 73.2, 73.1, 71.2, 70.9, 68.6, 55.9, 54.4, 39.5, 37.3, 33.4, 32.8, 25.8, 21.2; IR 
3288 (w), 2788 (w), 2004 (w), 2003 (w), 1964 (w), 1963 (w), 1818 (w), 1794 (w), 1694 (s), 
1693 (s), 1581 (w), 1556 (w), 1555 (w), 1533 (w), 1521 (w), 1520 (w), 1501 (w), 1483 (w), 
1448 (w), 1423 (w), 1392 (w), 1328 (w), 1299 (w), 1270 (w), 1210 (w), 1136 (w), 1099 (w), 
1073 (w), 1048 (w), 1033 (w), 1007 (w), 982 (w), 909 (w), 853 (w), 786 (m), 735 (s), 697 
(m), 666 (w), 665 (w), 648 (m), 627 (m); Melting point: 50.2 – 53.5°C; HRMS (ESI) calcd 
for C15H18NO2+ (M+H+) 244.1332; found 244.1343. 
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7,7a-Dihydro-1H-pyrrolizin-3(2H)-one (9a).  
 
Following a slightly modified version of a reported procedure,[33] InCl3 (96 mg, 0.45 mmol, 
1.5 equiv) was introduced into a Schlenk flask and heated with a heat gun (150°C) under 
vacuum for 2 min. After being allowed to cool to room temperature, THF (1.3 mL) was 
added under Ar. The mixture was stirred at room temperature for 10 min and cooled to -78°C 
to get a whitish suspension. DIBALH (1.0 M in hexane) (0.44 mL, 0.44 mmol, 1.5 equiv) was 
added dropwise and the mixture was stirred at -78°C for 40 min. 5-(Prop-2-ynyl)pyrrolidin-2-
one (8a) (37 mg, 0.30 mmol, 1.0 equiv) was then added, followed by Et3B (1.0 M in THF, 
0.12 mL, 0.12 mmol, 0.4 equiv) and the mixture was stirred at -78°C for 4 h. A solution of 
iodine (457 mg, 1.80 mmol, 6.0 equiv) in THF (0.7 mL) was then added. After 40 min, the 
mixture was poured onto a saturated solution of NaHCO3 (ca 10 mL). Na2S2O3 was added 
under stirring until complete decoloration and the aqueous layer was extracted with EtOAc (5 
x 10 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. Purification on a short chromatography column (SiO2, DCM to DCM/MeOH 95/5) 
afforded 5-(3-iodoallyl)pyrrolidin-2-one (63) (mixture of Z and E stereoisomers, Z/E 15/1; 
74.3 mg, 0.296 mmol, 99% yield) as a yellow oil. 
1H NMR (400 MHz, CD2Cl2, Z diastereoisomer) δ 7.23 (br s, 1 H, NH), 6.46 (dt, 1 H, J = 7.5, 
1.0 Hz, CH2CH=CHI), 6.26 (q, 1 H, J = 7.1 Hz, CH2CH=CHI), 3.82 (quint, 1 H, J = 6.4 Hz, 
NCH), 2.40 (td, 2 H, J = 6.5, 1.0 Hz, CH2CH=CHI), 2.37-2.19 (m, 3 H, COCH2CH2), 1.81 
(m, 1 H, COCH2CH2). 
Following a reported procedure,[34] CuI (22 mg, 0.11 mmol, 0.4 equiv) and Cs2CO3 (113 mg, 
0.346 mmol, 1.20 equiv) were introduced into a Schlenk flask. The latter was kept under high 
vacuum for 5 min, before being refilled with Ar. Toluene (1.8 mL) was added, followed by 
N,N’-dimethylethane-1,2-diamine (25 μL, 0.23 mmol, 0.8 equiv) and the allyl iodide 63 (73 
mg, 0.29 mmol, 1.0 equiv). The mixture was stirred at 75°C until total consumption of the 
starting material was confirmed by TLC (ca 30 h). The reaction mixture was then allowed to 
cool to room temperature, diluted with DCM (5 mL) and washed with water (5 mL). The 
aqueous layer was extracted with DCM (4 x 5 mL) and the combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (SiO2, DCM to DCM/MeOH 95/5) afforded 7,7a-dihydro-1H-pyrrolizin-
3(2H)-one (9a) (27 mg, 0.22 mmol, 76% yield) as an off-white solid. 
                                                            
[33] K. Takami, S. Mikami, H. Yorimitsu, H. Shinokubo, K. Oshima, J. Org. Chem. 2003, 68, 6627. 
[34] L. L. W. Cheung, A. Yudin,  Org. Lett. 2009, 11, 1281. 
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Rf 0.36 (AcOEt); 1H NMR (400 MHz, CD2Cl2) δ 6.54 (m, 1 H, NCH=CH), 5.36 (m, 1 H, 
NCH=CH), 4.39 (m, 1 H, NCH), 2.82-2.59 (m, 2 H, COCH2CH2 and CH=CHCH2), 2.54-2.33 
(m, 3 H, COCH2CH2 and CH=CHCH2), 1.86 (m, 1 H, COCH2CH2); 13C NMR (101 MHz, 
CD2Cl2) δ 171.3, 125.5, 115.0, 61.5, 36.4, 35.7, 29.5; IR 3431 (m), 2956 (w), 2908 (w), 2849 
(w), 2360 (w), 2341 (w), 1672 (s), 1597 (m), 1446 (m), 1445 (m), 1415 (s), 1347 (w), 1336 
(w), 1302 (w), 1281 (w), 1263 (w), 1223 (w), 1197 (w), 1122 (w), 1119 (w), 1053 (w), 932 
(w), 809 (m), 730 (m), 696 (m), 672 (m), 655 (m), 645 (m), 638 (m), 617 (w), 605 (w); 
Melting point: 61.0 – 65.0°C; HRMS (ESI) calcd for C7H10NO+ (M+H+) 124.0762; found 
124.0767. 
7,7a-Dihydropyrrolo[1,2-c]oxazol-3(1H)-one (9b) 
 
Following a slightly modified version of a reported procedure,[33] InCl3 (103 mg, 0.465 
mmol, 1.55 equiv) was introduced into a Schlenk flask and heated with a heat gun (150°C) 
under vacuum for 2 min. After being allowed to cool to room temperature, THF (1.3 mL) was 
added under Ar. The mixture was stirred at room temperature for 10 min and cooled to -78°C 
to get a whitish suspension. DIBALH (1.0 M in hexane) (0.46 mL, 0.46 mmol, 1.5 equiv) was 
added dropwise and the mixture was stirred at -78°C for 40 min. 4-(Prop-2-ynyl)oxazolidin-
2-one (8b) (38 mg, 0.30 mmol, 1.0 equiv) was then added, followed by Et3B (1.0 M in THF, 
0.15 mL, 0.15 mmol, 0.5 equiv) and the mixture was stirred at -78°C for 3 h. A solution of 
iodine (460 mg, 1.80 mmol, 6.0 equiv) in THF (0.7 mL) was then added. After 40 min, the 
mixture was poured onto a saturated solution of NaHCO3 (ca 10 mL). Na2S2O3 was added 
under stirring until complete decoloration and the aqueous layer was extracted with EtOAc (5 
x 10 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. Purification by a short column chromatography (SiO2, DCM to DCM/MeOH 95/5) 
afforded 4-(3-iodoallyl)oxazolidin-2-one (64) (mixture of Z and E stereoisomers, Z/E 8/1; 62 
mg, 0.25 mmol, 82% yield) as a yellow oil. 
1H NMR (400 MHz, CDCl3, Z diastereoisomer) δ 6.89 (br s, 1 H, NH), 6.48 (dd, 1 H, J = 7.5, 
0.9 Hz, CH2CH=CHI), 6.21 (m, 1 H, CH2CH=CHI), 4.49 (m, 1 H, OCH2), 4.12-4.00 (m, 2 H, 
OCH2 and NCH), 2.46 (m, 2 H, CH2CH=CHI). 
Following a slightly modified version of a reported procedure,[34] CuI (21 mg, 0.11 mmol, 
0.45 equiv) and Cs2CO3 (96 mg, 0.29 mmol, 1.2 equiv) were introduced into a Schlenk flask. 
The latter was kept under high vacuum for 5 min, before being refilled with Ar. Toluene (1.6 
mL) was added, followed by N,N’-dimethylethane-1,2-diamine (24 μL, 0.22 mmol, 0.9 
equiv) and the allyl iodide 64 (62 mg, 0.24 mmol, 1.0 equiv; mixture of Z/E diastereoisomers, 
Z/E 8/1). The mixture was stirred at 85°C until total consumption of the starting material was 
confirmed by TLC (ca 22 h). It was then allowed to cool to room temperature, diluted with 
S48 
 
DCM (5 mL) and washed with water (5 mL). The aqueous layer was extracted with DCM (4 
x 5 mL) and the combined organic layers were dried over MgSO4, filtered and concentrated 
in vacuo. Purification by column chromatography (SiO2, DCM to DCM/MeOH 99/1) 
afforded 7,7a-dihydropyrrolo[1,2-c]oxazol-3(1H)-one (9b) (27 mg, 0.21 mmol, 88% yield 
(quantitative with respect of the Z diastereoisomer) as yellow oil. 
Rf 0.62 (DCM/MeOH 40/1); 1H NMR (400 MHz, CDCl3) δ 6.41 (m, 1 H, NCH=CH), 5.29 
(m, 1 H, NCH=CH), 4.70 (t, 1 H, J = 8.5 Hz, OCH2), 4.61 (ddd, 1 H, J = 17.6, 8.9, 8.9 Hz, 1 
H, NCH), 4.14 (t, 1 H, J = 8.4 Hz, OCH2), 2.75 (m, 1 H, CH2CH=CH), 2.53 (ddt, 1 H, J = 
16.4, 9.2, 2.5 Hz, CH2CH=CH); 13C NMR (101 MHz, CDCl3) δ 157.4, 128.1, 113.5, 71.4, 
57.9, 35.8; IR 3502 (w), 3100 (w), 2960 (w), 2911 (w), 2854 (w), 1747 (s), 1608 (w), 1541 
(w), 1481 (w), 1449 (w), 1379 (m), 1303 (m), 1260 (m), 1169 (w), 1080 (m), 1061 (s), 1003 
(m), 926 (w), 840 (w), 771 (m), 754 (w), 715 (m), 667 (w), 658 (w); HRMS (ESI) calcd for 
C6H8NO2+ (M+H+) 126.0555; found 126.0559. 
6,7,8,8a-tetrahydroindolizin-5(1H)-one (9c) 
 
Following a slightly modified version of a reported procedure,[33] InCl3 (113 mg, 0.508 
mmol, 1.55 equiv) was introduced into a Schlenk flask and heated with a heat gun (150°C) 
under vacuum for 2 min. After being allowed to cool to room temperature, THF (1.35 mL) 
was added under Ar. The mixture was stirred at room temperature for 10 min and cooled to -
65°C to get a whitish suspension. DIBALH (1.0 M in hexane) (0.49 mL, 0.49 mmol, 1.5 
equiv) was added dropwise and the mixture was stirred at -65°C for 40 min. 6-(Prop-2-
ynyl)piperidin-2-one (8c) (46 mg, 0.33 mmol, 1.0 equiv) was added, followed by Et3B (1.0 M 
in THF, 0.20 mL, 0.20 mmol, 0.6 equiv) and the mixture was stirred at -70°C for 4 h. A 
solution of iodine (500 mg, 1.97 mmol, 6.0 equiv) in THF (0.8 mL) was then added. After 40 
min, the mixture was poured onto a saturated solution of NaHCO3 (ca 10 mL). Na2S2O3 was 
added under stirring until complete decoloration and the aqueous layer was extracted with 
EtOAc (5 x 10 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. Purification by a short column chromatography (SiO2, DCM to 
DCM/MeOH 97/3) afforded (Z)-6-(3-iodoallyl)piperidin-2-one (65) (only Z diastereoisomer; 
88 mg, 0.33 mmol, 99% yield) as a yellowish solid. 
1H NMR (400 MHz, CDCl3) δ 6.49 (dt, 1 H, J = 7.5, 1.3 Hz, CH2CH=CHI), 6.20 (q, 1 H, J = 
7.2 Hz, CH2CH=CHI), 5.67 (br s, 1 H, NH), 3.56 (m, 1 H, NCH), 2.48-2.19 (m, 4 H, 
CH2CH=CHI and COCH2), 1.93 (m, 2 H, COCH2CH2CH2), 1.70 (m, 1 H, COCH2CH2CH2), 
1.47 (m, 1 H, COCH2CH2CH2). 
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Following a slightly modified version of a reported procedure,[34] CuI (24 mg, 0.13 mmol, 
0.40 equiv) and Cs2CO3 (125 mg, 0.383 mmol, 1.2 equiv) were introduced into a Schlenk 
flask. The latter was kept under high vacuum for 5 min, before being refilled with Ar. 
Toluene (2.0 mL) was added, followed by N,N’-dimethylethane-1,2-diamine (27 μL, 0.25 
mmol, 0.8 equiv) and the allyl iodide 65 (83 mg, 0.31 mmol, 1.0 equiv). The mixture was 
stirred at 85°C until total consumption of the starting material was confirmed by TLC (ca 22 
h). It was then allowed to cool to room temperature, diluted with DCM (7 mL) and washed 
with water (7 mL). The aqueous layer was extracted with DCM (4 x 7 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography (SiO2, EtOAc) afforded 6,7,8,8a-tetrahydroindolizin-5(1H)-one (9c) 
(28 mg, 0.20 mmol, 66% yield) as pale yellow oil. 
Rf 0.43 (DCM/MeOH 20/1); 1H NMR (400 MHz, CDCl3) δ 6.91 (s, 1 H, NCH=CH), 5.24 (m, 
1 H, NCH=CH), 3.91 (ddd, 1 H, J = 11.5, 9.0, 3.5 Hz, NCH), 2.66 (dddd, 1 H, J = 15.6, 8.9, 
2.9, 1.3 Hz, CH2CH=CH), 2.47-2.36 (m, 2 H, COCH2), 2.30 (ddd, 1 H, J = 18.3, 11.0, 7.3 
Hz, CH2CH=CH), 2.13 (m, 1 H, piperidone CH2), 1.95 (m, 1 H, piperidone CH2), 1.70 (m, 1 
H, piperidone CH2), 1.52 (ddd, 1 H, J = 24.4, 12.8, 3.7 Hz, piperidone CH2); 13C NMR (101 
MHz, CDCl3) δ 166.1, 128.8, 111.1, 59.3, 37.0, 30.3, 28.4, 20.7; IR 3461 (w), 3285 (w), 3110 
(w), 2948 (w), 2857 (w), 1626 (s), 1448 (s), 1409 (s), 1369 (w), 1347 (w), 1320 (w), 1299 
(m), 1274 (w), 1273 (w), 1226 (m), 1205 (w), 1179 (w), 1136 (w), 1104 (w), 1087 (w), 1045 
(w), 957 (m), 919 (w), 902 (w), 847 (w), 813 (w), 722 (m), 685 (w), 667 (w), 663 (w), 643 
(w), 622 (w); HRMS (ESI) calcd for C8H12NO+ (M+H+) 138.0919; found 138.0915. 
1-(Benzyloxymethyl)-7,7a-dihydro-1H-pyrrolizin-3(2H)-one (15). 
 
Following a slightly modified version of a reported procedure,[33] InCl3 (103 mg, 0.465 
mmol, 1.55 equiv) was introduced into a Schlenk flask and heated with a heat gun (150°C) 
under vacuum for 2 min. After being allowed to cool to room temperature, THF (1.3 mL) was 
added under Ar. The mixture was stirred at room temperature for 10 min and cooled to -50°C 
to get a whitish suspension. DIBALH (1.0 M in hexane) (0.46 mL, 0.46 mmol, 1.5 equiv) was 
added dropwise and the mixture was stirred at -50°C for 40 min. 4-(Benzyloxymethyl)-5-
(prop-2-ynyl)pyrrolidin-2-one (13) (73 mg, 0.30 mmol, 1.0 equiv) was then added, followed 
by Et3B (1.0 M in THF, 0.18 mL, 0.18 mmol, 0.6 equiv) and the mixture was stirred at -50°C 
for 2.5 h. A solution of iodine (456 mg, 1.80 mmol, 6.0 equiv) in THF (0.7 mL) was then 
added. After 40 min, the mixture was poured onto a saturated solution of NaHCO3 (ca 10 
mL). Na2S2O3 was added under stirring until complete decoloration and the aqueous layer 
was extracted with EtOAc (5 x 10 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. Purification by a short column chromatography 
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(SiO2, DCM to DCM/MeOH 95/5) afforded 4-(benzyloxymethyl)-5-(3-iodoallyl)pyrrolidin-
2-one (14) (only Z diastereoisomer; 106 mg, 0.285 mmol, 95% yield) as a yellowish oil. 
1H NMR (400 MHz, CDCl3) δ 7.39-7.27 (m, 5 H, Ph), 6.45 (dt, 1 H, J = 7.5, 1.2 Hz, 
CH2CH=CHI), 6.20 (q, 1 H, J = 7.2 Hz, CH2CH=CHI), 5.67 (br s, 1 H, NH), 4.53 (s, 2 H, 
OCH2Ph), 3.67 (m, 1 H, NCH), 3.47 (d, 2 H, J = 6.2 Hz, CH2O), 2.60-2.28 (m, 4 H, 
COCH2CH and CH2CH=CHI), 2.18 (dd, 1 H, J = 16.7, 5.8 Hz, CH2CH=CHI). 
Following a slightly modified version of a reported procedure,[34] CuI (21 mg, 0.11 mmol, 
0.40 equiv) and Cs2CO3 (111 mg, 0.342 mmol, 1.2 equiv) were introduced into a Schlenk 
flask. The latter was kept under high vacuum for 5 min, before being refilled with Ar. 
Toluene (1.8 mL) was added, followed by N,N’-dimethylethane-1,2-diamine (25 μL, 0.23 
mmol, 0.8 equiv) and the allyl iodide 14 (106 mg, 0.285 mmol, 1.0 equiv). The mixture was 
stirred at 75°C until total consumption of the starting material was confirmed by TLC (ca 40 
h). It was then allowed to cool to room temperature, diluted with DCM (5 mL) and washed 
with water (5 mL). The aqueous layer was extracted with DCM (4 x 5 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography (SiO2, DCM to DCM/MeOH 97/3) afforded 1-(benzyloxymethyl)-
7,7a-dihydro-1H-pyrrolizin-3(2H)-one (15) (46 mg, 0.19 mmol, 67% yield; 73% yield based 
on starting material recovery; mixture of separable diastereoisomers, dr 86:14) as a pale 
yellow oil and starting material 14 (11.3 mg, 0.0304 mmol, 11%). 
Major diastereoisomer: 
Rf 0.50 (EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.42-7.21 (m, 5 H, Ph), 6.52 
(ddd, 1 H, J = 4.3, 2.7, 1.7 Hz, NCH=CH), 5.32 (dt, 1 H, J = 4.6, 2.6 Hz, 
NCH=CH), 4.53 (d, 1 H, J = 12.0 Hz, OCH2Ph), 4.50 (d, 1 H, J = 12.2 Hz, 
OCH2Ph), 4.17 (m, 1 H, NCH), 3.59 (m, 1 H, CH2O), 3.49 (m, 1 H, CH2O), 2.65 
(dddd, 1 H, J = 16.5, 9.6, 2.9, 1.9 Hz, CH2CH=CH), 2.58-2.51 (m, 3 H, CHCH2O 
and COCH2), 2.44 (ddt, 1 H, J = 16.3, 10.1, 2.4 Hz, CH2CH=CH); 13C NMR (101 
MHz, CDCl3) δ 170.4, 137.9, 128.3, 127.6, 127.3, 125.6, 115.6, 73.1, 70.8, 64.8, 
44.1, 39.2, 35.3; IR 3110 (w), 2904 (w), 2880 (w), 2360 (s), 2340 (m), 1845 (m), 1811 (m), 
1701 (m), 1683 (s), 1650 (m), 1635 (m), 1621 (m), 1572 (m), 1558 (m), 1542 (s), 1521 (s), 
1488 (m), 1403 (s), 1329 (m), 1329 (m), 1301 (m), 1276 (m), 1142 (m), 1036 (s), 1007 (s), 
981 (s), 932 (s), 901 (s), 865 (s), 853 (s), 766 (s), 721 (s), 693 (s), 650 (s), 643 (s), 625 (s); 
HRMS (ESI) calcd for C15H18NO2+ (M+H+) 244.1332; found 244.1329. 
Minor diastereoisomer: 
1H NMR (400 MHz, CDCl3) δ 7.45-7.24 (m, 5 H, Ph), 6.56 (m, 1 H, NCH=CH), 5.35 (m, 1 
H, NCH=CH), 4.61 (td, 1 H, J = 10.5, 6.3 Hz, NCH), 4.48 (s, 2 H, OCH2Ph), 3.55 (dd, 1 H, J 
= 9.4, 7.1 Hz, CH2O), 3.41 (dd, 1 H, J = 9.4, 5.7 Hz, CH2O), 2.81-2.65 (m, 2 H, COCH2 and 
CH2CH=CH), 2.59 (m, 1 H, CHCH2O), 2.53-2.37 (m, 2 H, COCH2 and CH2CH=CH). 
((1S,7aR)-hexahydro-1H-pyrrolizin-1-yl)methanol (16) ((±)-Trachelanthamidine) 
N
O
15
OBn
H
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Enamide 15 (133 mg, 0.547 mmol) was dissolved in MeOH (10 mL). The solution was 
flushed with H2 as Pd/C was added portionwise until complete conversion was confirmed by 
TLC (ca 200 mg, over 36 h). The mixture was then filtered through a celite plug, which was 
then washed with MeOH (8 x 5 mL) and DCM (8 x 5 mL). The solvents were evaporated 
under reduced pressure to afford pure (1S,7aR)-1-(hydroxymethyl)tetrahydro-1H-pyrrolizin-
3(2H)-one (66) (85 mg, 0.55 mmol, quantitative) as an amorphous solid. 
Rf 0.23 (DCM/MeOH = 10/1);  1H NMR (400 MHz, CDCl3) δ 3.78 (dd, 1 H, J = 10.5, 5.5 Hz, 
CH2OH), 3.76-3.65 (m, 2 H, CH2OH and CH2N), 3.54 (dt, 1 H, J = 11.7, 7.9 Hz, NCH), 3.05 
(m, 1 H), 2.62-2.45 (m, 2 H), 2.35 (m, 1 H), 2.21-1.93 (m, 3 H), 1.62 (m, 1 H, OH), 1.43 (m, 
1 H); 13C NMR (101 MHz, CDCl3) δ 174.0, 65.1, 63.7, 44.0, 41.0, 38.1, 31.5, 26.8; IR 3399 
(m), 2963 (w), 2921 (w), 2885 (w), 2361 (w), 1664 (s), 1442 (m), 1425 (m), 1364 (w), 1334 
(w), 1310 (w), 1284 (w), 1238 (w), 1210 (w), 1168 (w), 1087 (w), 1039 (m), 976 (w), 946 
(w), 913 (w), 890 (w), 874 (w), 835 (w), 816 (w), 797 (w), 760 (w), 735 (w), 695 (w), 666 
(m), 638 (w), 612 (w);  HRMS (ESI) calcd for C8H14NO2+ (M+H+) 156.1019; found 
156.1016. 
Amide 66 (40.5 mg, 0.261 mmol, 1.0 equiv) was dissolved in THF (3.2 mL). LiAlH4 (40 mg, 
1.0 mmol, 4.0 equiv) was added and the mixture was stirred under reflux until complete 
conversion was confirmed by TLC (ca 18 h). The reaction was then quenched by addition of 
water (0.040 mL), NaOH 15% (0.060 mL) and water (0.150 mL). The mixture was stirred at 
room temperature for 1 h and filtered through a celite plug, which was then washed with 
EtOAc. The resulting solution was concentrated in vacuo. Purification by short column 
chromatography (SiO2, ULTRA/DCM 1/1 to ULTRA; ULTRA: DCM/MeOH/(NH3 25% in 
water) 75/25/5) afforded (±)-Trachelanthamidine (16) (34.5 mg, 0.244 mmol, 94% yield) as a 
pale yellow oil. 
Rf 0.27 (ULTRA); 1H NMR (400 MHz, CDCl3) δ 4.56 (s, 1 H, OH), 3.54 (d, 2 H, J = 6.4 Hz, 
CH2OH), 3.18 (apparent q, 1 H, J = 6.5 Hz, CH2N), 3.10 (ddd, 1 H, J = 10.0, 6.8, 3.2 Hz, 
CH2N), 2.92 (dt, 1 H, J = 10.7, 6.4 Hz, NCH), 2.61-2.44 (m, 2 H, CH2N), 2.03-1.45 (m, 7 H); 
13C NMR (101 MHz, CDCl3) δ 67.0, 64.2, 54.0, 53.8, 47.7, 31.2, 29.3, 24.9; IR 3368 (m), 
2950 (m), 2869 (s), 2834 (m), 2237 (w), 1699 (w), 1684 (w), 1673 (w), 1668 (w), 1662 (w), 
1653 (w), 1648 (w), 1637 (w), 1626 (w), 1559 (w), 1542 (w), 1520 (w), 1508 (w), 1497 (w), 
1488 (w), 1473 (w), 1457 (w), 1450 (w), 1419 (w), 1407 (w), 1397 (w), 1377 (w), 1355 (w), 
1338 (w), 1317 (w), 1299 (w), 1289 (w), 1259 (w), 1190 (w), 1177 (w), 1142 (w), 1136 (w), 
1086 (w), 1061 (m), 1041 (m), 1034 (m), 1009 (w), 922 (w), 906 (w), 878 (w), 860 (w), 855 
(w), 843 (w), 839 (w), 830 (w), 821 (w), 812 (w), 797 (w), 788 (w), 780 (w), 770 (w), 762 
(w), 730 (s), 708 (m), 683 (m), 675 (m), 660 (m), 647 (m), 640 (m), 633 (s), 608 (m); HRMS 
(ESI) calcd for C8H16NO+ [M+H]+ 142.1226; found 142.1224. 
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Values in the literature: [35] 
1H NMR (270 MHz, CDCl3) d 4.25–4.05 (br s, 1 H), 3.59 (d, 2 H, J = 6.3 Hz), 3.22 (dd, 1 H, 
J = 13.2, 6.3 Hz), 3.13 (ddd, 1 H, J = 10.1, 7.1, 3.5 Hz), 2.95 (dt, 1 H, J = 10.5, 6.3 Hz), 
2.64–2.48 (m, 2 H), 2.05-1.50 (m, 7 H); 13C NMR (67.8 MHz, CDCl3) d 67.6, 64.9, 54.7, 
54.4, 48.3, 31.9, 29.9, 25.6.  
After recalibration (reference signal for 1H-NMR: doublet at 3.59 ppm; reference peak for 
13C: singlet at 25.6 ppm set as identical in the measured spectra) the values reported are in 
agreement with the literature ones: 
1H NMR (400 MHz, CDCl3) δ 4.61 (s, 1 H), 3.59 (d, 2 H, J = 6.4 Hz), 3.23 (apparent q, 1 H, 
J = 6.5 Hz), 3.14 (ddd, 1 H, J = 10.0, 6.8, 3.2 Hz), 2.95 (dt, 1 H, J = 10.7, 6.4 Hz), 2.67-2.48 
(m, 2 H), 2.08-1.48 (m, 7 H); 13C NMR (101 MHz, CDCl3) δ 67.7, 64.9, 54.7, 54.4, 48.4, 
31.9, 30.0, 25.6. 
8. Mechanistic Investigations 
1H-NMR experiments 
A) Tosyl amide 1a (8.1 mg, 0.032 mmol) was dissolved in MeOH-d4 (0.8 mL) in a NMR 
tube. 1H-NMR spectrum of this solution was acquired. Li2[PdCl4]•xH2O (ca 9 mg, 
0.03 mmol, 1 equiv) was dissolved in MeOH-d4 (0.8 mL) in a NMR tube. 1H-NMR 
spectrum of this solution was acquired. Tosyl amide 1a (8.1 mg, 0.032 mmol, 1.0 
equiv) was added and 1H-NMR spectra of the resulting mixture were acquired after 2, 
4, 6, 8, and 11 min. After this time, TIPS-EBX (14 mg, 0.032 mmol) was added. 
 
Figure S1. Addition of catalyst to 3a followed by 1H NMR. 
                                                            
[35] H. Ishibashi, M. Sasaki, T. Taniguchi, Tetrahedron 2008, 64, 7771. 
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B) TIPS-EBX (2a) (14 mg, 0.032 mmol) was dissolved in MeOH-d4 (0.8 mL) in a NMR 
tube. 1H-NMR spectrum of this solution was acquired. Li2[PdCl4]•xH2O (ca 9 mg, 
0.03 mmol, 1 equiv) was dissolved in MeOH-d4 (0.8 mL) in a NMR tube. 1H-NMR 
spectrum of this solution was acquired. TIPS-EBX (2a) (14 mg, 0.032 mmol) was 
added and 1H-NMR spectra of the resulting mixture were acquired after 2, 4, 6, 8, and 
11 min. 
 
Figure S2. Addition of catalyst to TIPS-EBX (2a) followed by 1H NMR. 
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9. Spectra of New Compounds 
1-(Phenylethynyl)-1,2-benziodoxol-3(1H)-one (Ph-EBX, 2b) 
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N-(4-Methoxyphenylsulfonyl)pent-4-enamide (1b) 
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N-(4-Nitrophenylsulfonyl)pent-4-enamide (1c) 
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2,2-Dimethyl-N-tosylpent-4-enamide (1d) 
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1-Allyl-N-tosylcyclohexanecarboxamide (1e) 
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1-Allyl-N-tosylcyclopentanecarboxamide (1f) 
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3-Phenyl-N-tosylpent-4-enamide (1g) 
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N-Tosyl-2-vinylcyclohexanecarboxamide (1h) 
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N-Tosylhex-5-enamide (1i) 
 
 
 
S63 
 
2-Allyl-N-tosylbenzamide (1j) 
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1-Allyl-N-tosyl-1H-pyrrole-2-carboxamide (1k) 
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1-Allyl-N-tosyl-1H-indole-2-carboxamide (1l) 
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4-methyl-N-(4-nitrophenylsulfonyl)pent-4-enamide (1m) 
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But-3-en-2-yl tosylcarbamate (6b) 
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1-Cyclohexylallyl tosylcarbamate (6c) 
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N-(Allylcarbamoyl)-4-methylbenzenesulfonamide (6e) 
 
 
 
N
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N-(Diallylcarbamoyl)-4-methylbenzenesulfonamide (6f) 
 
 
 
N
O NHTs
6f
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2-Benzyl-N-tosylpent-4-enamide (6g) 
 
 
 
N
O NHTs
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1-Tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3a) 
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1-Tosyl-5-(3-(trimethylsilyl)prop-2-ynyl)pyrrolidin-2-one (4) 
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5-(3-Phenylprop-2-ynyl)-1-tosylpyrrolidin-2-one (5) 
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1-(4-Methoxyphenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3b) 
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1-(4-Nitrophenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-nyl)pyrrolidin-one (3c) 
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3,3-Dimethyl-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3d) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-2-azaspiro[4.5]decan-1-one (3e) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-2-azaspiro[4.4]nonan-1-one (3f) 
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4-Phenyl-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (3g) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)octahydro-1H-isoindol-1-one (3h) 
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1-Tosyl-6-(3-(triisopropylsilyl)prop-2-ynyl)piperidin-2-one (3i) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydroisoquinolin-1(2H)-one (3j) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one 
(3k) 
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2-Tosyl-3-(3-(triisopropylsilyl)prop-2-ynyl)-3,4-dihydropyrazino[1,2-a]indol-1(2H)-one 
(3l) 
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5-methyl-1-(4-nitrophenylsulfonyl)-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one 
(3m) 
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3-Tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7a) 
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5-Methyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7b, major 
diastereoisomer) 
 
 
 
7b, Major diastereoisomer
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5-Methyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7b, minor 
diastereoisomer) 
 
 
 
7b, Minor diastereoisomer
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5-Cyclohexyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7c, major 
diastereoisomer) 
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5-Cyclohexyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)oxazolidin-2-one (7c, minor 
diastereoisomer) 
 
 
 
7c, Minor diastereoisomer
O NTs
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3-Tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)-1,3-oxazinan-2-one (7d) 
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1-Tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7e) 
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1-Allyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7f) 
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1-Benzyl-3-tosyl-4-(3-(triisopropylsilyl)prop-2-ynyl)imidazolidin-2-one (7g) 
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5-(Prop-2-ynyl)pyrrolidin-2-one (8a) 
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4-(Prop-2-ynyl)oxazolidin-2-one (8b) 
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6-(Prop-2-ynyl)piperidin-2-one (8c) 
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3-(benzyloxymethyl)-N-tosylpent-4-enamide (11)  
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4-(Benzyloxymethyl)-1-tosyl-5-(3-(triisopropylsilyl)prop-2-ynyl)pyrrolidin-2-one (12) 
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4-(benzyloxymethyl)-5-(prop-2-ynyl)pyrrolidin-2-one (13) 
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7,7a-Dihydro-1H-pyrrolizin-3(2H)-one (9a).  
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7,7a-Dihydropyrrolo[1,2-c]oxazol-3(1H)-one (9b) 
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6,7,8,8a-tetrahydroindolizin-5(1H)-one (9c) 
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1-(Benzyloxymethyl)-7,7a-dihydro-1H-pyrrolizin-3(2H)-one (14). 
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((1S,7aR)-hexahydro-1H-pyrrolizin-1-yl)methanol (16) ((±)-Trachelanthamidine) 
 
 
 
